TOXICOLOGICAL PROFILE FOR

STODDARD SOLVENT

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Public Health Service

Agency for Toxic Substances and Disease Registry

June 1995
STODDARD SOLVENT ii

DISCLAIMER

The use of company or product name(s) is for identification only and does not imply endorsement by

the Agency for Toxic Substances and Disease Registry.
STODDARD SOLVENT iii

UPDATE STATEMENT

A Toxicological Profile for Stoddard solvent was released on November 1993. This edition supersedes

any previously released draft or final profile.

Toxicological profiles are revised and republished as necessary, but no less than once every three

years For information regarding the update status of previously released profiles, contact ATSDR at:

Agency for Toxic Substances and Disease Registry

Division of Toxicology/Toxicology Information Branch

1600 Clifton Road NE, E-29

Atlanta, Georgia 30333















STODDARD SOLVENT 1

1. PUBLIC HEALTH STATEMENT

This Statement was prepared to give you information about Stoddard solvent and toemphasize the human health effects

that may result from exposure to it. The Environmental Protection Agency (EPA) has identified 1,397 sites on its

“National Priorities List” (NPL). Stoddard solvent has been found in at least seven of these sites. However, we do not

know how many of the 1,397 NPL sites have been evaluated for Stoddard solvent. As EPA evaluates more sites, the

number of sites at which Stoddard solvent is found may change. This information is important for you to know because

Stoddard solvent may cause harmful health effects and because these sites are potential or actual sources of human

exposure to Stoddard solvent.

When a chemical is released from a large area, such as an industrial plant, or from a container, such as a drum or

bottle, it enters the environment as a chemical emission. This emission, which is also called a release, does not always

lead to exposure. You can be exposed to a chemical only when you come into contact with the chemical. You may be

exposed to it in the environment by breathing, eating, or drinking substances containing the chemical or by skin contact

with it.

If you are exposed to a hazardous chemical such as Stoddard solvent, several factors will determine whether harmful

health effects will occur and what the type and severity of those health effects will be. These factors include the dose

(how much), the duration (how long), the route or pathway by which you are exposed (breathing, eating, drinking, or

skin contact), the other chemicals to which you are exposed, and your individual characteristics such as age, sex,

nutritional status, family traits, life-style, and state of health.
STODDARD SOLVENT 2

1. PUBLlC HEALTH STATEMENT

1.1 WHAT IS STODDARD SOLVENT?

Stoddard solvent is a widely used, man-made organic solvent that comes from the refining of crude oil. It is a

petroleum mixture made from distilled alkanes, cycloalkanes (naphthenes), and aromatic compounds. The chemicals in

Stoddard solvent are similar to those in white spirits, which are also discussed in this profile. Stoddard solvent is

commonly referred to as dry cleaning safety solvent, naphtha safety solvent, petroleum solvent, PD-680, varnoline, and

spotting naphtha. It also goes by the registered trade names Texsolve S and Varsol 1. Stoddard solvent is used as a

paint thinner, as a solvent in some types of photocopier toners, in some types of printing inks, in some adhesives, as a

dry cleaning sollvent, and as a general cleaner and degreaser. It is produced and used as a colorless, flammable liquid

but will turn into a vapor (gas) at temperatures ranging from 150-200°C. Stoddard solvent smells and tastes like

kerosene. You can smell it when the level in the air is about 0.34 parts of Stoddard solvent in a million parts of air

(ppm) or 2 milligrams of Stoddard solvent per cubic meter of air (mg/m3

). See Chapters 3 and 4 for more information

on the physical and chemical properties of Stoddard solvent and how it is produced and used.

1.2 WHAT HAPPENS TO STODDARD SOLVENT WHEN IT ENTERS THE

 ENVIRONMENT?

Stoddard solvent is a mixture of many chemicals. Some of these evaporate into the air when Stoddard solvent spills

onto soils or surface waters. These chemicals may be broken down by sunlight or by other chemicals in the air. Also,

some of these chemicals may sorb (attach) to organic matter. Stoddard solvent itself does not dissolve well in water,

but some of the chemicals in it do dissolve when it spills on surface water or when it leaks from underground storage

tanks. Some of the chemicals in Stoddard solvent can attach to particles soil or water and, in water, may sink down to

the sediment. In water, soil, or sediment, microorganisms may break down the chemicals (a process known as

biodegradation). Although some of the chemicals that make up Stoddard solvent can attach to organic matter in the

soil, if a large amount of Stoddard solvent contaminates the soil, it will move through the soil into groundwater. It is

not known whether Stoddard solvent will accumulate in plants
STODDARD SOLVENT 3

1. PUBLIC HEALTH STATEMENT

or animals living in contaminated soil or water, or in animals eating contaminated plants or sediments. However, some

of the chemicals that make up the Stoddard solvent mixture might accumulate in these situations, depending upon the

type of chemical. Generally, smaller alkanes do not tend to bioaccumulate, while aromatics and larger alkanes,

including some cycloalkanes, tend to bioaccumulate. See Chapter 5 for more information on what happens to Stoddard

solvent when it enters the environment.

1.3 HOW MIGHT I BE EXPOSED TO STODDARD SOLVENT?

You are most likely to be exposed to Stoddard solvent if you use a product, such as paint or a paint thinner, that

contains it and the vapors get in your lungs or eyes. If you work in an industry that uses or produces dry cleaning fluid,

paints, coatings, waxes, or equipment cleaning fluid with Stoddard solvent in it, you may breathe in some of the

components of Stoddard solvent that evaporate into the air. You may be exposed to Stoddard solvent if you breathe air

that contains Stoddard solvent after it has entered the atmosphere from a dry cleaning plant or spilled or leaked onto

soils or surface water. When it is spilled, the different components that make up Stoddard solvent will react differently

in the different media of the environment (for example, in soil, water, or air). So, if you become exposed, you are no

longer being exposed to a single compound called Stoddard solvent but rather to its components. You would only

breathe the components that evaporate into the air. If Stoddard solvent has contaminated groundwater, you may be

exposed if you drink this water or use it for bathing or washing. If you use products that contain Stoddard solvent and

do not wear protective clothing, you may be exposed if it gets on your skin.

Humans may be exposed to Stoddard solvent near hazardous waste sites, but it is not known how many are being

exposed. It is unclear what routes of exposure are most significant at hazardous waste sites. It is likely that you might

be exposed to Stoddard solvent near a hazardous waste site by breathing it in the air. Although some compounds in

Stoddard solvent evaporate quickly, you may be continually exposed near hazardous waste sites if the material is

leaking from buried or above-ground drums or is slowly moving through the soil
STODDARD SOLVENT 4

1. PUBLIC HEALTH STATEMENT

and seeping through the walls of the basement of a building. If Stoddard solvent is buried in leaky drums at hazardous

waste sites, you may also be exposed if you touch contaminated soil or if you drink contaminated groundwater.

For more information on how humans can be exposed to Stoddard solvent, see Chapter 5.

1.4 HOW CAN STODDARD SOLVENT ENTER AND LEAVE MY BODY?

Stoddard solvent can enter your body if you breathe air containing it. When you breathe in Stoddard solvent, it can

quickly enter your bloodstream. The chemical components that make up Stoddard solvent will then be absorbed by

different tissues in your body. It may also enter the brain, and a large portion may be stored in body fat. Stoddard

solvent can also enter your body if you come into contact with water that is contaminated with it. However, we do not

know where the components of Stoddard solvent go once in the body after contact with your skin or after drinking

contaminated groundwater. Animal studies have shown that these components can enter tissues and the brain, as is the

case with Stoddard solvent when it is breathed in, but no human studies have been located to verify this. Components

of white spirits have been found, however, in human blood and body fat after people breathed it. We also do not know

exactly how the mixture or its components leave the body and how quickly this happens. Some components or

breakdown products probably leave in the breath and urine within a few days after exposure. For more information on

how Stoddard solvent enters and leaves the human body, see Chapter 2.

1.5 HOW CAN STODDARD SOLVENT AFFECT MY HEALTH?

Most of the information on how Stoddard solvent affects human health comes from studies where exposure is through

breathing, with fewer studies available on exposure to the eyes and skin. When Stoddard solvent is in the air, it can

cause eye, skin, or throat irritation. If you were to breath in air containing Stoddard solvent, it could affect your

nervous system and might cause dizziness or headaches. Another way that it can affect your nervous system is by
STODDARD SOLVENT 5

1. PUBLIC HEALTH STATEMENT

causing a prolonged reaction time. There are few studies of the long-term effects of exposure to Stoddard solvent alone

in humans. In experiments with rats, cats, and dogs (to suggest what may happen in humans), seizures were reported

after they breathed in large amounts for several hours. Stoddard solvent can also cause bronchitis in guinea pigs when

they breathe it. However, Stoddard solvent has not had these effects in the few known cases of human exposure.

Studies with rats show that Stoddard solvent may also cause kidney damage, but only in males. This is because of its

interaction with a protein that male rats produce but which is not found in female rats. Humans do not produce this

protein either, so it is unlikely that people would experience kidney damage. For the following effects in humans or

animals, either there were no studies or the available studies did not associate the effect with exposure to Stoddard

solvent: birth defects, reproductive effects (infertility), and immunological or lymphoreticular effects.

Very few studies have been located that study the carcinogenic (cancer-causing) effects of Stoddard solvent in humans

and animals. Stoddard solvent has not been classified by the Department of Health and Human Services (DHHS),

EPA, or the International Agency for Research on Cancer (IARC) (or by any other national or international agencies)

for carcinogenic effects in any exposure situation.

Little is known about the health effects of Stoddard solvent in humans or animals when it is ingested (swallowed); no

studies have been found. For more information on the health effects of Stoddard solvent in humans and animals, see

Chapter 2.
STODDARD SOLVENT 6

1. PUBLIC HEALTH STATEMENT

1.6 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN

 EXPOSED TO STODDARD SOLVENT?

There is no routinely used test to show whether you have been exposed to Stoddard solvent. However, Stoddard

solvent is a mixture of many chemicals, and for most of them there are analytical methods to determine whether

exposure has occurred. These chemicals can be detected in your breath, blood, urine, and fat. However, the tests cannot

tell you if you have been exposed to the specific mixture of chemicals found in Stoddard solvent. These methods also

cannot tell you whether you will have any health effects. It is unclear how long after exposure to Stoddard solvent a

test would be useful. Because Stoddard solvent can be stored in fat, any resulting health effects may continue for a few

days after exposure. See Chapters 2 and 6 for more information on the methods available to find Stoddard solvent in

human tissue.

1.7 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO PROTECT HUMAN

 HEALTH?

The government has developed regulations and guidelines for Stoddard solvent that are designed to protect the public

from potential harmful health effects. Several states have set their own regulations or guidelines for Stoddard solvent

concentrations in water and in ambient (surrounding) air. The Occupational Safety and Health Administration (OSHA)

regulates levels of hazardous material in the workplace. The maximum allowable amount of Stoddard solvent in

workroom air during an S-hour workday, 40-hour workweek, is 2,900 mg/m3

 or 500 ppm. The National Institute for

Occupational Safety and Health (NIOSH) recommends a limit of 350 mg/m3 or 60 ppm for workroom air for an 8-hour

exposure.

The Department of Transportation has identified Stoddard solvent as a hazardous substance and regulates its

packaging, shipping, and transportation. Some states have transportation regulations for Stoddard solvent. Other

regulations and guidelines that have been set for Stoddard solvent can be found in Table 7-l.
STODDARD SOLVENT 7

1. PUBLIC HEALTH STATEMENT

1.8 WHERE CAN I GET MORE INFORMATION?

If you have any more questions or concerns, please contact your community or state health or environmental quality

department or:

Agency for Toxic Substances and Disease Registry

Division of Toxicology

1600 Clifton Road NE, E-29

Atlanta, Georgia 30333

This agency can also provide you with information on the location of the nearest occupational and environmental

health clinic. These clinics specialize in the recognition, evaluation, and treatment of illnesses resulting from exposure

to hazardous substances.

STODDARD SOLVENT 9

2. HEALTH EFFECTS

2.1 INTRODUCTION

The primary purpose of this chapter is to provide public health officials, physicians, toxicologists, and

other interested individuals and groups with an overall perspective of the toxicology of Stoddard

solvent and a depiction of significant exposure levels associated with various adverse health effects. It

contains descriptions and evaluations of studies and presents levels of significant exposure for

Stoddard solvent based on toxicological studies and epidemiological investigations.

Stoddard solvent is a mixture of numerous hydrocarbons derived by refining crude oil. It is a

petroleum distillate with a boiling range of 154-202°C and a flashpoint of 38-60°C. The hydrocarbon

chain length ranges from C7 to C12 although a form of Stoddard solvent called 140 flash contains C5

and C6 hydrocarbons as well. The mixture consists of three major groups of components: linear and

branched alkanes, also known as paraffins (30-50% of the total mixture); cycloalkanes, also called

cycloparaffins or naphthenes (not to be confused with naphthalenes which are bicyclic aromatics)

(30-40%), and aromatic hydrocarbons (l0-20%). A complete list of the individual components of

Stoddard solvent is not available (Air Force 1989b); however, some possible components and common hydrocarbon

classes are presented in Chapter 3. Data are available on the health effects of the various components of Stoddard

solvent, but discussion of individual constituents is beyond the scope of the profile. Exposure to Stoddard solvent and

white spirits, a somewhat synonymous substance, is discussed in this profile.

Stoddard solvent is also considered to be a form of mineral spirits, white spirits, and naphtha;

however, not all forms of mineral spirits, white spirits, or naphtha are considered to be Stoddard

solvent. Other petroleum distillate mixtures are also the subject of ATSDR toxicological profiles,

including gasoline (ATSDR 1993). Gasoline differs from Stoddard solvent by having more smallerchained

hydrocarbons (C5-C12). Kerosene, a fuel oil, has longer-chained hydrocarbons (C10-C16), and more aromatic

components (30-40%) than Stoddard solvent (l0-20%). Stoddard solvent contains few if any alcohols, glycols, or

ketones. Stoddard solvent is not expected to contain hexane or polycyclic aromatic hydrocarbons, substances that are

also known to have a toxic potential.
STODDARD SOLVENT 10

2. HEALTH EFFECTS

Within the aromatic hydrocarbon group, there are several substances that are known to be toxic,

including substituted benzenes, naphthalenes, and substituted toluenes. The contributions of benzenes,

naphthalenes, and toluenes are slight since each contributes less than 1% of the total composition of

the Stoddard solvent mixture. However, the toxicity of the mixture is probably not governed by any

single component. The toxicity of the mixture depends on the interactions of all the components.

Some components, when found together, may act additively or synergistically to enhance toxic effects. Others

components may be antagonistic in combination, thus diminishing toxic effects. It cannot always be predicted how a

mixture will behave based on the toxicity of its individual components. However, the toxic characteristics of the

individual components may be an indicator of the potential toxicological responses of the mixture.

2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE

To help public health professionals address the needs of persons living or working near hazardous

waste sites, the information in this section is organized first by route of exposure--inhalation, oral, and

dermal--and then by health effect--death, systemic, immunological, neurological, developmental,

reproductive, genotoxic, and carcinogenic effects. These data are discussed in terms of three exposure

periods--acute (14 days or less), intermediate (15-364 days), and chronic (365 days or more).

Levels of significant exposure for each route and duration are presented in tables and illustrated in

figures. The points in the figures showing no-observed-adverse-effect levels (NOAELs) or lowest-observedadverse-effect levels (LOAELs) reflect the actual doses (levels of exposure) used in the studies. LOAELs 

have been classified into “less serious” or “serious” effects. These distinctions are intended to help the users of 

the document identify the levels of exposure at which adverse health effects start to appear. They should also 

help to determine whether or not the effects vary with dose and/or duration, and place into perspective 

the possible significance of these effects to human health.

The significance of the exposure levels shown in the tables and figures may differ depending on the

user’s perspective. For example, physicians concerned with the interpretation of clinical findings in

exposed persons may be interested in levels of exposure associated with “serious” effects. Public

health officials and project managers concerned with appropriate actions to take at hazardous waste

sites may want information on levels of exposure associated with more subtle effects in humans or

animals (LOAEL) or exposure levels below which no adverse effects (NOAEL) have been observed.
STODDARD SOLVENT 11

2. HEALTH EFFECTS

Estimates of levels posing minimal risk to humans (Minimal Risk Levels, MRLs) may be of interest to

health professionals and citizens alike.

Estimates of exposure levels posing minimal risk to humans (MRLs) have been made, where data were believed

reliable, for the most sensitive noncancer effect for each exposure duration. MRLs include adjustments to reflect

human variability and extrapolation of data from laboratory animals to humans.

Although methods have been established to derive these levels (Barnes and Dourson 1988; EPA 1990)

uncertainties are associated with these techniques. Furthermore, ATSDR acknowledges additional

uncertainties inherent in the application of the procedures to derive less than lifetime MRLs. As an

example, acute inhalation MRLs may not be protective for health effects that are delayed in

development or are acquired following repeated acute insults, such as hypersensitivity reactions,

asthma, or chronic bronchitis As these kinds of health effects data become available and methods to

assess levels of significant human exposure improve, these MRLs will be revised.

2.2.1 Inhalation Exposure

A few studies are available in which humans were acutely exposed in the laboratory to measured

levels of Stoddard solvent or white spirits in the air. No studies are available regarding health effects

in humans after intermediate-duration inhalation exposure to Stoddard solvent. Workers chronically

exposed to combinations of solvents, including Stoddard solvent, have been studied.

There are only a few studies showing acute toxic effects in animals (API 1987a; Carpenter et al.

1975a, 1975b; Riley 1984). The animals were exposed to completely vaporized Stoddard solvent, but

in real life human inhalation exposures might be primarily to the more volatile components. Data

from acute studies in cats, dogs, mice, and rats and from intermediate studies in guinea pigs, rats, and

dogs that demonstrate toxicity are shown in Table 2-l and Figure 2-l. One of the intermediate studies

(Rector et al. 1966) used a mixture of chemicals called mineral spirits, but the authors stated that this

particular mixture was similar to Stoddard solvent, so the information is included below. Other studies

testing different formulations of mineral spirits are not included. No studies are available regarding

health effects in animals after chronic-duration inhalation exposure to Stoddard solvent.











 STODDARD SOLVENT 23

2. HEALTH EFFECTS

2.2.1.1 Death

The only available study in humans regarding death following inhalation exposure is a retrospective

cohort study on workers at an aircraft maintenance facility exposed to very low levels of Stoddard

solvent as well as numerous other chemicals for at least 1 year (Spirtas et al. 1991). An exposure

index was developed by evaluating patterns of use that indicated comparative differences in exposure

to various chemicals based on occupation. However, exposures could not be quantitated from these

methods. The study did not show a statistically significant increase in mortality.

Rats that were exposed for 8 hours to 8,200 mg/m3

 of completely vaporized Stoddard solvent (48%

alkames, 26% monocycloalkanes, 12% dicycloalkanes, 14% aromatics) had no compound-related

mortality when observed for up to 10 days (Carpenter et al. 1975a, 1975b). However, in a study with

mixed breed cats, limited by the fact that there were only four, all animals died within 2.5-7.5 hours

of an initiation exposure of 10,000 mg/m3

 (Carpenter et al. 1975a, 1975b). Rats, rabbits, dogs, and

monkeys had no mortality immediately following continuous exposure to 1,271 mg/m3

 of vaporized

mineral spirits (80-86% alkanes, 13-19% aromatics) for 90 days (Rector et al. 1966). However, the

data for rabbits, dogs, and monkeys are limited by the use of three animals or less. Guinea pigs,

however, were more sensitive, and 4 of 15 died after continuous exposure to 363 mg/m3

; no

information on time of death was provided. The remaining test animals were sacrificed at the end of

the exposure period. There were no adverse hematological, biochemical, or pathological findings that

could account for the deaths of the guinea pigs. Many of the animals had liver parasites and

occasionally pulmonary congestion, which indicates that poor health, rather than chemical exposure,

could have contributed to the deaths. However, the worms and congestion were also present in the

other tested species, which did not exhibit mortality. The study authors could not otherwise account

for the species differences in mortality. When this study was repeated (continuous exposure to

892 mg/m3 of vaporized mineral spirits [20% aromatics] for 90 days), there were deaths of

13/30 guinea pigs of the Hartley strain and 20/30 of the NMRI strain (Jenkins et al. 19713. More

males than females died. In another test, male Hartley guinea pigs with a high ascorbic acid diet

survived better (2/15 deaths) than those on a low ascorbic acid diet (10/15 deaths). No deaths

occurred in guinea pigs or any of the other species after repeated exposures (6 weeks, 5 days/week,

8 hours/day) to 1,353 mg/m3

 (Rector et al. 1966). It is possible that the difference in guinea pig

mortality between the two protocols was due to recovery time during the intermittent exposures. Rats
STODDARD SOLVENT 24

2. HEALTH EFFECTS

exposed to white spirit (20% aromatics) 6 hours/day, 5 days/week for 6 months showed no compound related mortality

at doses up to 4,580 mg/m3

 (Ostergaard et al. 1993). The reason for the apparent species difference in susceptibility to

the toxic effects of Stoddard solvent is unknown. The LOAELs for death for intermediate exposure are recorded in

Table 2- 1 and plotted in Figure 2- 1.

2.2.1.2 Systemic Effects

No studies were located regarding dermal effects in humans or animals after inhalation exposure to

Stoddard solvent. Ocular effects that occurred after inhalation exposure to Stoddard solvent have

resulted from direct contact with the eyes and are discussed in Section 2.2.3.

For other systemic effects, the highest NOAEL and all reliable LOAEL values for each species, end

point, and duration category are recorded in Table 2-l and plotted in Figure 2-l.

Respiratory Effects. In an experimental study, there was no change in respiratory rate in 10 human

males who were exposed to 2,400 mg/m3

 (457 ppm) of completely vaporized Stoddard solvent for

30 minutes (Hastings et al. 1984). Men exposed in an experimental setting to up to 2,500 mg/m3

(476 ppm) of vaporized white spirits (83% aliphatic and 17% aromatic components) for 30 minutes

had no compound-related changes in oxygen uptake or alveolar ventilation measured at rest or during

exercise (Astrand et al. 1975). In a retrospective cohort study, house painters breathed paint solvents

containing Stoddard solvent for 4-42 years. Precise exposure levels were not available. Each painter

was given a health interview and a traditional medical examination 15 hours after exposure. They had

no decrease in lung vital capacity or forced expiratory volume, as compared to workers in other

industries (Hane et al. 1977). Throat irritation was noted in one out of six volunteers exposed to

2,700 mg/m3

 completely vaporized Stoddard solvent, 15 minutes/day for 3 days (Carpenter et al.

1975a, 1975b). Recovery from this effect was noted 15 minutes post-exposure.

In an acute exposure study, mice exposed to 10,000 mg/m3

 (1,905 ppm) of completely vaporized

Stoddard solvent for 1 minute had a 50% reduction in respiratory rate, which was not seen at

4,400 mg/m3

 (Carpenter et al. 1975a, 1975b). Recovery tests were not performed. Exposure of rats to

around their nostrils, while 4,600 mg/m3 completely vaporized Stoddard solvent for 8 hours 

produced bloody exudate no effects were observed in animals exposed to 2,400 mg/m3 ed to 214

(Carpenter et al. 1975a, 1975b). Rats exposmg/m3 of vaporized white spirits (61% alkanes, 20% cycloalkanes,
STODDARD SOLVENT 25

2. HEALTH EFFECTS

19% aromatics) for 4 hours/day for 4 days had irritation of the upper respiratory tract lining as

evidenced by inflammatory cell infiltrate of the nasal cavity, trachea, and larynx. Other

histopathological changes included loss of cilia, hyperplasia of basal cells, and squamous metaplasia

in the trachea and nasal cavity (Riley et al. 1984). According to the authors, these histopathological

changes are not indicative of lung injury, but represent insult to the upper respiratory tract. This study

was limited because only one dose was tested.

In an intermediate exposure study rats, rabbits, guinea pigs, dogs, and monkeys that were exposed to

I,27 1 mg/m3 of vaporized mineral spirits with a composition similar to Stoddard solvent continuously

for 90 days had congestion of the lungs, bronchitis, and mixed inflammatory cell infiltration (Rector et

al. 1966). However, some control animals had mild congestion on gross examination, but histopathology

 confirmed effects in the exposed animals only. Occasional signs of lung irritation were observed at lower

concentrations. The data for rabbits, dogs, and monkeys are limited by the use of three animals or less.

In a protocol using repeated exposures (6 weeks, 5 days/week, 8 hours/day), only guinea pigs showed

histopathological changes, which included some congestion and emphysema at 1,353 mg/m3

; this was

interpreted as a possible mild irritant effect. In another study, some guinea pigs exposed continuously for

90 days to 892 mg/m3

 of vaporized mineral spirits (20% aromatics) also had pneumonitis, but the authors

did not associate the disorder with the exposure (Jenkins et al. 1971). No other lung injury was evident in

this latter study either. No respiratory effects were noted in rats exposed to 5,620 mg/m3

 of completely

vaporized C10-C11 isoparaffins for up to 12 weeks (6 hours/day, 5 days/week) (Phillips and Egan 1984b).

Rats exposed to 2,290 mg/m3

 for 6 months (6 hours/day, 5 days/week) to white spirit (20% aromatics)

showed a bloody nasal discharge (Ostergaard et al. 1993).

Cardiovascular Effects. Men exposed in an experimental setting to up to 2,500 mg/m3

 (476 ppm)

of vaporized white spirits (83% aliphatic and 17% aromatic components) for 30 minutes had no

compound-related changes in electrocardiograms, oxygen uptake, cardiac output, alveolar ventilation,

or heart rate measured at rest or during exercise (Astrand et al. 1975). A retrospective cohort study

showed no changes in blood pressure in house painters who were exposed to unspecified levels of

various solvents for 4-42 years as compared to unexposed workers from other industries (Hane et al.

1977).
STODDARD SOLVENT 26

2. HEALTH EFFECTS

Studies in animals showed no histopathology in the hearts of rats, rabbits, guinea pigs, dogs, or

monkeys exposed to 1,271 mg/m3

 of vaporized mineral spirits with a composition similar to Stoddard

solvent continuously for 90 days or up to 1,353 mg/m3 for 6 weeks (5 days/week, 8 hours/day) 

(Rector et al. 1966). The data for rabbits, dogs, and monkeys are limited by the use of three animals or less. 

No cardiovascular effects were noted in rats exposed to 5,620 mg/m3

10-C11of completely vaporized C

 isoparaffins for up to 12 weeks (6 hours/day, 5 days/week) (Phillips and Egan 1984b).

Gastrointestinal Effects. Twelve volunteers exposed to 610 mg/m3

 of vaporized white spirits

(57% alkanes, 25% cycloalkanes, 18% aromatics) for 6 hours reported no nausea, diarrhea, or

vomiting (Pedersen and Cohr 1984a). When Stoddard solvent was used as a machine cleaner, only

one of nine workers interviewed complained of nausea (Larsen and Schmunes 1974); exposure

duration and levels were not reported.

Transient diarrhea was noted in some guinea pigs exposed to 892 mg/m3

 of vaporized mineral spirits

continuously for 90 days (Jenkins et al. 1971). No gastrointestinal effects were noted in rats exposed

to 5,620 mg/m3

 of completely vaporized C10-C11 isoparaffins for up to 12 weeks (6 hours/day,

5 days/week) (Phillips and Egan 1984b).

Hematological Effects. Case reports and epidemiological studies of humans exposed to unspecified levels of 

Stoddard solvent or white spirits in the workplace revealed mixed results. From the limited data available, 

it is not possible to conclude whether Stoddard solvent adversely affects the hematological system or not. A 

study of 45 car repair workers who were exposed to a variety of solvents showed statistically significant decreased 

red blood cell counts, increased mean erythrocyte volumes, and increased platelet volumes when compared to office 

workers who had no contact with organic solvents (Beving et al. 1991). One study of 52 house painters who 

were chronically exposed to solvents found statistically significant decreases in hemoglobin concentration as 

compared to unexposed workers from other industries (Hane et al. 1977). In one series of case reports, normal

hematological values were noted in 128 persons exposed to a variety of solvents, including white

spirits (Flodin et al. 1984). Case reports exist for persons who had aplastic anemia and who also were

exposed to Stoddard solvent, but a causal relationship was not established (Prager and Peters 1970;

Scott et al. 1959).
STODDARD SOLVENT 27

2. HEALTH EFFECTS

Normal leukocyte, hemoglobin, and hematocrit levels were found in rats, rabbits, guinea pigs, dogs,

and monkeys exposed to 1,271 mg/m3

 of vaporized mineral spirits continuously for 90 days or up to

1,353 mg/m3

 for 6 weeks (5 days/week, 8 hours/day) (Rector et al. 1966). The data for rabbits, dogs,

and monkeys is limited by the use of three animals or less. These results were repeated in another 13-

week exposure study that intermittently (5 days/week, 6 hours/day) exposed rats and dogs to higher

levels of completely vaporized Stoddard solvent (1,900 mg/m3

) (Carpenter et al. 1975a, 1975b). No

hematological effects were noted in rats exposed to 5,620 mg/m3

 of completely vaporized C10-C11

isoparaffins for up to 12 weeks (6 hours/day, 5 days/week) (Phillips and Egan l984b).

Musculoskeletal Effects. The only available human information is from two laboratory studies.

One found no changes in serum creatine kinase (an indicator of muscle cell membrane integrity) in

12 men exposed to 610 mg/m3

 of three different formulations of white spirits for 6 hours (Pedersen

and Cohr 1984a). The subjects did not complain of muscle weakness. Another study of the alkane

components did show increased creatine kinase (59% and 76% above baseline for 96 and 168 hours

post-exposure, respectively) from exposure to 616 mg/m3

 of vaporized white spirits (99% alkanes; i.e., lacking

aromatic components) for a slightly longer period (6 hours/day for 5 days) (Pedersen and Cohr 1984b).

No animal studies were located that showed musculoskeletal effects. Rats exposed to 5,620 mg/m3

 of

completely vaporized C10-C11 isoparaffins for up to 12 weeks (6 hours/day, 5 days/week) did not show

any clinical or histopathological changes in musculoskeletal parameters (Phillips and Egan 1984b).

Rats that were exposed to white spirits at concentrations of 2,290 or 4,580 mg/m3 showed significant

increases in serum creatinine, but since no dose response was evident, the results were not definitive

(Ostergaard et al. 1993).

Hepatic Effects. The few available studies regarding hepatic effects indicate that acute, low-level

exposures to Stoddard solvent have very minor, if any, effects on liver function. A laboratory study of

12 men exposed-to 610 mg/m3

 of vaporized white spirits (with a composition similar to Stoddard

solvent) for 6 hours revealed no changes in serum liver products (glucose, triglycerides, cholesterol, or

urate) (Pedersen and Cohr 1984a) as compared to pre-exposure control levels. A case report describes

painters who were exposed to unspecified levels of white spirits and other chemicals for chronic

periods; elevated levels of serum alanine aminotransferase, but normal liver biopsies (no necrosis,

steatosis, or portal tract changes), were reported (Dossing et al. 1983). A second case report describes
STODDARD SOLVENT 28

2. HEALTH EFFECTS

a group of patients exposed to a variety of solvents, including white spirits, who had mostly normal

liver parameters, except for elevated glutamyl transferase levels (Flodin et al. 1984). In a prospective

cohort study, a third group of painters showed normal serum transaminase levels when compared to

unexposed industrial workers (Hane et al. 1977).

Guinea pigs exposed to 1,271 mg/m3

 of vaporized white spirits continuously for 90 days had no

consistent pathological liver effects (Rector et al. 1966). Guinea pigs exposed to 892 mg/m3

 of

vaporized white spirits continuously for 90 days had minimal fatty changes in the liver (Jenkins et al.

1971), but the authors did not attribute this to the exposure. No consistent liver histopathology was

seen in rats or guinea pigs exposed to 1,353 mg/m3

 intermittently (8 hours/day, 5 days/week) for

6 weeks (Rector et al. 1966) or in rats exposed to 5,620 mg/m3

 of C10-C11 isoparaffins for up to

12 weeks (6 hours/day, 5 days/week) (Phillips and Egan 1984b). Serum indicators of liver function

were normal in rats and dogs exposed intermittently (13 weeks, S/days week, 6 hours/day) to

1,900 mg/m3

 of completely vaporized Stoddard solvent (Carpenter et al. 1975a, 1975b).

Renal Effects. While the available human studies do not indicate that Stoddard solvent is harmful to

human kidneys, the studies lack sufficient exposure data to draw any firm conclusions. In laboratory

studies, humans exposed to 610 mg/m3

 for 6 hours showed normal serum sodium and potassium,

normal urine albumin, and normal β-2-microglobulin levels as compared to pre-exposure levels

(Pedersen and Cohr 1984a). β-2-Microglobulin is a protein found in humans, and it should not be

confused with α2u -globulin which is primarily found in male rats. One case-control study of persons

with glomerulonephritis revealed no differences in occupational and/or household use exposures to

organic solvents between cases and controls (van der Eaan 1980). However, another case-control

study showed a significantly greater exposure of patients with glomerulonephritis to petroleum

products, in particular, to greasing/degreasing agents (Yaqoob et al. 1992), but the sample population

was small and specific agents were not identified. In a case report, patients who were exposed to

white spirits and other solvents for 3-22 years exhibited serum and urinary parameters for kidney

function within the normal range for the general population (Flodin et al. 1984). A 29-year-old male

exposed by direct dermal contact and inhalation of Stoddard solvent vapors exhibited

glomerulonephritis (Daniel1 et al. 1988). See Section 2.2.3.2 for additional details of this case. A

cause-effect relationship could not be established in one case where renal failure occurred in an

individual exposed to mineral spirits (Narvarte et al. 1989). Rats exposed to white spirit (2,290 or

4,580 mg/m3

) for 6 hours/day over a 6-month period showed increases in blood urea nitrogen (BUN)
STODDARD SOLVENT 29

2. HEALTH EFFECTS

2 weeks after treatment ended. However, possible renal effects indicated by these results are equivocal

as there was no dose response noted (Ostergaard et al. 1993).

Rabbits, guinea pigs, dogs, and monkeys that were exposed to vaporized mineral spirits at

1,271 mg/m3

 for 90 days did not have kidney pathology (Rector et al. 1966). The data for rabbits,

dogs, and monkeys are limited by the use of three animals or less. No kidney histopathology was

observed in guinea pigs exposed to 1,353 mg/m3

 (8 hours/day, 5 days/week) intermittently for 6 weeks (Rector et al.

1966). Dogs that were exposed to 1,900 mg/m3 of completely vaporized Stoddard

solvent for 6 hours/day, 5 days/week for 13 weeks had no adverse kidney effects (Carpenter et al.

1975a, 1975b). Guinea pigs exposed to 892 mg/m3

 of vaporized white spirits for 90 days showed

slight increases in blood urea nitrogen levels, but statistical analyses were not performed and no

histopathological changes in the kidneys were noted that could be attributed to exposure (Jenkins et al.

1971).

In contrast, studies with Stoddard solvent and closely related mixtures demonstrated renal damage in

male rats. When compared to controls, significantly more proximal renal tubule regeneration and

dilated, debris-filled loops of Henle were observed in male rats exposed for 13 weeks to 1,900 mg/m3

of completely vaporized Stoddard solvent (boiling range, 152.7-194.4°C; 47.7% paraffins, 26%

monocycloparaffins, 11.6% dicycloparaffins, and 14.1% alkylbenzenes) (Carpenter et al. 1975a,

1975b). Similar results were reported in a study in male rats that were exposed to 570 or 4,580 mg/m3

of Varsol 1 vapor (6 hours/day, 5 days/week) for 8 weeks (EPA 1984d), although these effects were

not observed in females even at high dose. More detailed studies were conducted with hydrocarbons

corresponding to the C10-C11 or C12 alkane fractions of Stoddard solvent.

Fischer-344 rats of both sexes were exposed to 1,840 mg/m3

 or 5,450 mg/m3 C10-C11 isoparaffinic

solvent (boiling point range, 156-176°C) for up to 8 weeks (Phillips and Egan 1984a). No differences

from unexposed controls were observed in the female rats, except that after 4 weeks of exposure to

5,450 mg/m3

, they excreted significantly more urinary protein, but this effect was not seen at other

times or doses. In contrast, exposed males consistently showed a variety of effects suggestive of mild

proximal tubule damage. At both doses, urine concentrating ability after overnight water deprivation

decreased significantly compared to controls after 4 or 8 weeks of exposure. After 4 weeks of

recovery from the 8-week exposure to 5,480 mg/m3

, the urine concentrating ability remained

significantly different from controls. Four or 8 weeks of exposure also caused a significant increase
STODDARD SOLVENT 30

2. HEALTH EFFECTS

in total urine protein and glucose excreted in the urine at either dose, but this effect disappeared after

4 weeks of recovery. In the serum, coordinate changes were seen with increased blood urea nitrogen

(BUN) and creatinine and reduced glucose levels. Creatinine clearance was significantly decreased

after 8 weeks of exposure to 5,450 mg/m3

, but recovered to control levels after 4 weeks with no

exposure. At both doses after 4 or 8 weeks of exposure, there was a remarkable increase in epithelial

cells sloughed into the tubule and recovered in the urine; this ceased after 4 weeks of recovery time.

In histological sections, epithelial regeneration and tubular dilation were scored, and their incidence

and degree increased with time at both exposure levels; the 4-week absence from exposure did not

result in complete recovery. However, the authors emphasized that this structural damage was only

observed in 5-10% of tubules Increased numbers of protein droplets were observed in the cytoplasm

of renal tubular epithelial cells from 1 week after exposure began onward, but these droplets were not

assayed to determine their α2u -globulin content (Phillips and Egan 1984a).

A parallel experiment using both electron and light microscopy showed an increase in the number of

hyaline droplets, which are characteristic of resorbed protein; this increase was proportional to

exposure duration and concentration and could be observed after 5 days of exposure (Phillips and

Cockrell 1984). The S2 portion of the proximal convoluted tubule was most affected. The severity of

the droplet accumulation and other pathological changes decreased after the 4-week recovery period.

Positive acid phosphatase staining was consistent with the droplets being lysosomes, and electron

microscopy demonstrated that the droplets were membrane enclosed, as expected of lysosomes

(Phillips and Cockrell 1984). Parallel experiments in Sprague-Dawley rats with dearomatized white

spirit (aromatics <0.5%, 58% paraffins, 42% cycloalkanes, mainly C11-C12; boiling range, 155-193°C) 

and C10-C11 isoparaffins (boiling range, 156-176°C) resulted in similar, but less pronounced, 

renal histopathology (Phillips and Egan 1984b). In male but not female Fischer-344 rats, similar

experiments with Stoddard solvent of unspecified composition showed comparable pathological

changes and significant differences from control in urinary glucose and protein excretion and urine

concentration at 570 mg/m3

 and 4,580 mg/m3, respectively, after as few as 4 weeks of exposure

(Phillips 1983). All-the pathological and functional changes observed in this experimental series are

consistent with an α2u -globulin mechanism for renal toxicity to the proximal tubule (Phillips 1983;

Phillips and Cockrell 1984; Phillips and Egan 1984a, 1984b).

Similarly, male Sprague-Dawley rats exposed to completely vaporized white spirits (99% C10-C12

alkanes) at 6,500 mg/m3 for 5 weeks (8 hours/day, 5 days/week) or more showed increased excretion
STODDARD SOLVENT 31

2. HEALTH EFFECTS

of albumin; female rats and castrated males were unaffected (Viau et al. 1986). The authors attributed

this albuminuria to glomerular leakage since tubular resorption of a smaller filtered blood protein,

β2-microglobulin, was unaffected. After 5 weeks of exposure to 6,500 mg/m3

, there was a significant

decrease in the ability to concentrate urine after 24 hours of water deprivation in exposed male rats,

but not in female rats or castrated males. Histopathology in male rats exposed to 6,500 mg/m3

revealed many hyaline droplets in S2 proximal tubule cells (seen after 5.5, 46, or 68 weeks of

exposure), tubular dilation with granular casts (seen only in rats after 5.5 weeks of exposure), and

regenerative epithelia in both the proximal and distal tubules. Both intact and castrated males exposed

to 6,500 mg/m3 for 5.5 weeks had significant increases (10-fold) in kidney levels of α2u -globulin compared

to their respective controls; the baseline level in castrates was an order of magnitude lower

initially. No differences were observed in levels of this protein in the liver, the site of synthesis. The

exposed intact males also had significantly increased plasma concentrations of α2u -globulin (Viau et al. 1986).

Monitoring of urinary enzyme activities suggested renal damage at sites other than the proximal

tubule. After 2 weeks of exposure to either 6500 or 580 mg/m3

, there was a significant increase in

urinary lactate dehydrogenase, but not in β-N-acetyl-D-glucosaminidase activity, in male rats exposed

to 6,500 or 580 mg/m3

; lactate dehydrogenase activity was unchanged in castrated males and females

exposed similarly (Viau et al. 1986). Since β-N-acetyl-D-glucosaminidase is a proximal tubule

lysosomal enzyme while lactate dehydrogenase is a cytosolic enzyme characteristic of lower nephron

regions including the loop of Henle, distal tubule, and collecting duct, the authors’ interpretation of

their results was that the damage is in the distal tubule rather than the proximal tubule (Viau et al.

1986; WHO 1991). However, this conclusion should be regarded with caution since activities rather

than enzyme molecules were measured and other substances in urine can sometimes effect these

enzyme activities (WHO 1991).

A number of the observed renal effects of Stoddard solvent are consistent with a mechanism which

appears to be unique to male rats. Male rodents scent mark their territories with pheromones secreted

in the urine. These pheromones are transported to the urine by low molecular weight serum binding

proteins which are members of the lipocalin family (Bocskei et al. 1992). In male rats, the carrier

protein is α2u -globulin, which is synthesized in large quantities in the liver (EPA 1991a). X-ray

crystallography has demonstrated that α2u -globulin is a tetramer which has a doughnut hole in the

center for transport of the ligand (Bocskei et al. 1992). Although the preferred pheromone ligand for
STODDARD SOLVENT 32

2. HEALTH EFFECTS

the analogous dimeric mouse protein, mouse urinary protein, has been identified through x-ray

crystallography of the bound complex, the particular pheromone with the best fit to the α2u -globulin

tetramer has not yet been identified (Bocskei et al. 1992). After glomerular filtration with their ligand,

these carrier proteins are resorbed in massive amounts in the P2 section of the proximal renal tubule

and then catabolized in lysosomes (EPA 1991a; Kimura et al. 1991a).

Unfortunately, the α2u -globulin tetramer seems to be proficient at transporting other hydrophobic

molecules besides pheromones through the blood and into the urine. Other substances which

apparently also bind to this carrier protein include a number of hydrophobic xenobiotics such as

petroleum-derived hydrocarbons or their constituents or metabolites, including decalin and the gasoline constituent

trimethylpentane (EPA 1991a). The xenobiotic-α2u -globulin bulin complex is then reabsorbed in the proximal tubule

and accumulates in lysosomes where it resists degradation. Accumulation of this complex is thought to trigger

pathological responses within the kidney. This α2u -globulin in nephropathy syndrome is characterized by the following

lesions (Alden 1986; EPA 1991a; Lehman-McKeeman 1993; Short et al. 1987): excessive accumulation of hyaline

droplets in the P2 segment of the proximal tubule region of the kidney; association of the hyaline droplets with the

protein α2u -globulin; singlecell necrosis in the P2 segment epithelium and exfoliation of these degenerated cells;

sustained regenerative tubule cell proliferation, often with tubular dilation and tubular epithelial necrosis; accumulation

of granular casts formed from the cellular debris and subsequent tubule dilation at the junction of the P3 segment and

the thin loop of Henle; linear mineralization of the renal papillar tubules with hyperplasia of the renal pelvic

urothelium.

The hepatic synthesis of α2u -globulin is under androgenic control, and the protein is found at

concentrations 100-300 times higher in male rat urine than in female rat urine (Shapiro and

Sachchidananda 1982; Van Doren et al. 1983). Neither female rats nor castrated male rats show the

characteristic renal pathology associated with α2u -globulin nephropathy. Aging male rats show chronic progressive

nephropathy symptoms that are similar to α2u -globulin nephropathy, so it is important to run concurrent controls when

assessing renal toxicity. α2u -globulin is not present in other rodents, but mice have a similar pheromone carrier, mouse

urinary protein, which does not cause the same effects. Although other members of the lipocalin protein family do

occur in non-rodent species, including humans, they are not produced in such massive quantities, and these species do

not exhibit renal toxicity in response to the same set of substances that produce this characteristic toxicity in male rats

(Swenberg et al. 1989).

STODDARD SOLVENT 34

2. HEALTH EFFECTS

similar xenobiotics or metabolites, as well as to determine whether any binding that occurred inhibited

catabolism.

Ocular Effects. No studies were located regarding systemic ocular effects in humans or in animals

after inhalation exposure to Stoddard solvent. Ocular effects that have been observed in humans and

in animals after inhalation exposure were probably due to direct contact of the vapor with the eyes

rather than to a systemic effect due to inhalation exposure. For details of these studies, see

Section 2.2.3.

Body Weight Effects. No studies were located regarding body weight effects in humans after

inhalation exposure to Stoddard solvent. Rats, rabbits, guinea pigs, dogs, and monkeys exposed to 1,271 mg/m3 

of vaporized mineral spirits for 90 days had normal body weight gain (Rector et al. 1966). However, the data for 

rabbits, dogs, and monkeys are limited by the use of three animals or less. Normal body weight gain was also noted 

in rats and guinea pigs following intermittent exposure 8 hours/day, 5 days/week for 6 weeks to up to 1,353 mg/m3

mineral spiritscompletely (Rector et al. 1966). No adverse effects on body weight were seen in rats or dogs exposed to

1,900 mg/m3 vaporized Stoddard solvent 6 hours/day, 5 days/week for 13 weeks (Carpenter et al. 1975a, 1975b). 

Decreased body at weight was noted in rats exposed to white spirit (20% aromatic) for 6 months (6 hours/day,

5 days/week) levels of4,580 mg/m3

, but the percent change was not quantified (Ostergaard et al. 1993).

2.2.1.3 Immunological and Lymphoreticular Effects

In a laboratory study, humans exposed to 616 mg/m3

 of vaporized white spirits (Shellsol,

approximately 99% alkanes) for 5 days, 6 hours/day, showed no changes in serum immunoglobulins

(IgG, IgA, IgM) (Pedersen and Cohr 1984b). However, this is not a complete test of immune

function. No further studies were located regarding lymphoreticular effects in humans after inhalation

exposure to Stoddard solvent.

No studies were located regarding immunological or lymphoreticular effects in animals after inhalation exposure to

Stoddard solvent.
STODDARD SOLVENT 35

2. HEALTH EFFECTS

2.2.1.4 Neurological Effects

The most sensitive indicator of toxic effects of Stoddard solvent is effects on the nervous system.

Sensitive neurological tests have revealed neurological dysfunction in humans. In a laboratory

experiment, eight sedentary men were exposed to 4,000 mg/m3

 of completely vaporized white spirits

for 50 minutes (Gamberale et al. 1975). Changes were found in simple reaction time but not in

perceptual speed, short-term memory, numerical ability, or manual dexterity when compared with preand postexposure self controls. Another human study also showed minor neurological effects

(dizziness in two of six men tested) from a 15-minute exposure to 2,700 mg/m3

 Stoddard solvent

(Carpenter et al. 1975a, 1975b). However, controls were not used for comparison in this study.

Additional data from human studies indicate levels at which neurological effects did not occur. Men

exposed for 30 minutes to up to 2,400 mg/m3

 of completely vaporized Stoddard solvent at 0, 600,

1,800, and 2,400 mg/m3

 had no dose-related changes in hand-eye coordination, reaction time/decision

making or video game visual motor skill/band-eye coordination challenges. When results were

compared to control values from unexposed men, there was a statistically significant difference

observed in both the eye-hand coordination test and the video game visumotor test at 600 mg/m3

.

Since the results at higher exposure levels were not different from controls, 2,400 mg/m3

 was

considered to be the tentative level at which no effect was observed (Hastings et al. 1984). Similarly,

perceptual speed, numerical ability, manual dexterity, reaction time, and short-term memory were not

altered by exposure to white spirits for 30 minutes at 625 mg/m3

, followed by 30 minutes at

1,250 mg/m3

, followed by 30 minutes at 1,875 mg/m3, followed by 30 minutes at 2,500 mg/m3.

Testing began after only 10 minutes of the 2,500 mg/m3 exposure, and the time-weighted average

exposure when testing ended was 1,563 mg/m3

 (Gamberale et al. 1975). Twelve human volunteers

exposed to 610 mg/m3

 of Varnoline (57% alkanes, 25% cycloalkanes, 1% alkenes, and 17.8%

alkylbenzenes) or two other white spirit formulations (99% paraffins or 52% paraffins and 48%

cycloalkanes) for 6 hours had no complaints of headache, dizziness, visual disturbances, tremor,

muscle weakness, incoordination, sleep disturbances, or skin paraesthesia within 48 hours.of the

initiation of the exposure (Pedersen and Cohr 1984a).

Neurological effects have been described in several case reports (Bruhn et al. 1981; Daniel1 et al.

11988; Flodin et al. 1984), epidemiological studies (Hane et al. 1977), and cohort studies (ArlienSoborg et al. 1979; Gregersen et al. 1984; Mergler et al. 1988; Mikkelsen et al. 1988; Olson 1982) in
STODDARD SOLVENT 36

2. HEALTH EFFECTS

which workers were chronically exposed to Stoddard solvent, white spirit, or other solvents via the

inhalation or dermal routes. In these retrospective studies, the exposure concentrations were not

measured. In most cases, the exposure levels were not known and the estimated exposure did not

correlate well with the degree of impairment. Additionally, the workers were exposed to a variety of

solvents in addition to Stoddard solvent. Therefore, cause-effect relationships cannot be established.

Exposed persons have had a variety of neurological findings including headaches (in 29/50; ArlienSoborg et al. 1979), color blindness (66.6% of printshop workers; Mergler et al. 1988), dementia

(Mikkelsen et al. 1988), cerebral atrophy (Mikkelsen et al. 1988), memory deficits (in 45/50; ArlienSoborg et al. 1979; in 38/65; Gregersen et al. 1984; Hane et al. 1977), discoordination (Mikkelsen et

al. 1988), and fatigue (in 38/50; Arlien-Soborg et al. 1979; in 28/65; Gregersen et al. 1984; Hane et al.

1977). The reversibility of headaches and fatigue was not addressed in studies by Arlien-Soborg et al.

(1979), Gregersen et al. (1984), and Hane (1977). In another study however, the headaches and

fatigue did not occur once the workers were off the job for a few days (Daniell et al. 1988). In

contrast, the cerebral atrophy and memory deficits persisted several years after the workers were no

longer exposed (Bruhn et al. 1981; Gregersen 1988). The cerebral atrophy was measured by a

computerized tomography scan, and the memory deficits were revealed by a psychological

examination. Neurological examinations were also performed on these subjects. Significant decreases

on test performances of visual-biological ability and psychomotor coordination were noted among a

group of 52 housepainters in Sweden, when compared to a group of 52 non-solvent-exposed referents

(Hane et al. 1977). Information regarding dermal-exposure toxicity is also discussed for some studies

(Daniel1 et al. 1988; Mergler et al. 1988) because both inhalation and dermal exposures may have

occurred in these cases (see Section 2.2.3.4.).

When exposed for 8 hours, rats showed incoordination at 8,200 mg/m3

 that was not observed at

4,600 mg/m3

 and dogs had tremors and convulsions at 8,000 mg/m3; cats, exposed for 2.5-7.5 hours,

exhibited slowed light reaction, convulsions, and tremors at 10,000 mg/m3

 before their death

(Carpenter et al. 1975a, 1975b). The reversibility of the effects short of death were not studied. The

data are limited for dogs and cats because only one female dog and four male cats were-tested. Rats

exposed to white spirit (20% aromatics) (6 hours/day, 5 days/week, for 6 months) showed no changes

in histopathology of the brain or in brain weight, motor or neurobehavioral activity, although a

transient narcotic effect was noted. However, neurochemical analyses showed significant increases in

noradrenaline, dopamine, and 5-hydroxytryptamine levels in certain regions of the brain at 2,290 and

4,580 mg/m3

. No effects on motor activity were noted on weekends between weekday exposures. The
STODDARD SOLVENT 37

2. HEALTH EFFECTS

study was limited in that neurobehavioral testing occurred 2 months after exposure and only two doses

were tested (Ostergaard et al. 1993). Stoddard solvent does not contain the short-chained alkanes

hydrocarbons that are known to cause anesthesia (Haydon et al. 1977). There are no available

intermediate- or chronic-duration studies of neurophysiological or behavioral effects in animals. All

reliable NOAELs and LOAELs for neurological effects in humans and animals are recorded in Table

2-l and plotted in Figure 2-1.

2.2.1.5 Reproductive Effects

Seven men who were exposed for 6 hours/day for 5 days to 616 mg/m3

 of vaporized white spirits

(with a composition of 99% alkanes, as compared to 30-50% alkanes in Stoddard solvent) had a

decrease (p<0.05) in serum follicle-stimulating hormone levels at 24 and 96 hours after the initiation

of exposure as compared to pre-exposure levels (Pedersen and Cohr 1984b). This change did not

correspond to blood or adipose levels of white spirits. No tests of reproductive function were

performed. In another study, 11 men in a printing factory were occupationally exposed to a wide

variety of solvents, including 294 mg/m3

 of white spirits for 1-17 years. Sperm counts, motility, and

morphology were monitored for 2 months, and all values were normal (Tuohimaa and Wichmann

1981).

No studies were located regarding reproductive effects in animals after inhalation exposure to Stoddard solvent.

2.2.1.6 Developmental Effects

No studies were located regarding developmental effects in humans after inhalation exposure to

Stoddard solvent.

Offspring of rats exposed to up to 2,356 mg/m3 of Stoddard solvent vapor for 6 hours/day during

gestation days 6-15 had no compound-related skeletal or visceral abnormalities. Average fetal weights

were not changed, nor was the mean litter size (API 1977). There was no compound-related maternal

toxicity. Some of the litters included animals with skeletal variations, but the incidences of these

variations were not dose related and were not considered to be malformations by the study authors.

The NOAEL value is recorded in Table 2- 1 and plotted in Figure 2- 1.
STODDARD SOLVENT 38

2. HEALTH EFFECTS

2.2.1.7 Genotoxic Effects

No studies were located regarding genotoxic effects in humans after inhalation exposure to Stoddard

solvent.

Exposure to vaporized white spirits at 50,000 mg/m3

 for five periods lasting 5 minutes each failed to

significantly increase bone marrow micronuclei in four male mice (Gochet et al. 1984). Each 5-minute

period of exposure was separated from the next by an additional 5 minutes.

Other genotoxicity studies are discussed in Section 2.4.

2.2.1.8 Cancer

Human data are available from a case-control study of 32-100 individuals who had cancer and who

were questioned on their exposure to petroleum products (Siemiatycki et al. 1987). Statistically

significant positive odds ratios were found for mineral spirits and prostate cancer. Nonsignificant but

positive odds ratios were also reported for Hodgkin’s lymphoma and squamous cell carcinoma of the

lung. However, squamous cell carcinoma of the lung was of “borderline” significance since the OR

was determined to be 1.2 (90% CI: 1.0-1.5). The study only tested one hypothesis, based on the

association between exposure and cancer. The study authors could not provide a mechanistic

explanation for the association between solvent exposure and prostate cancer or lymphomas. The

study did not have the statistical power to establish a link between exposure to mineral spirits and lung

cancer because the confidence intervals (90%) around the odds ratio estimates were too wide to

suggest a correlation. A case-referent study using cases of Hodgkin’s disease and non-Hodgkin’s

lymphoma among Swedish workers exposed to white spirits implied a slight increase in crude odds

ratios, but the study was limited by an insufficient number of cases (Persson et al. 1993).

No studies were located regarding cancer in animals after inhalation exposure to Stoddard solvent,

2.2.2 Oral Exposure

No studies were located regarding human or animal health effects following oral exposure to Stoddard

solvent for any end point or duration category. In general, ingestion of most petroleum distillates at
STODDARD SOLVENT 39

2. HEALTH EFFECTS

doses less than 1,000 mg/kg causes little toxicity (Ellenhorn and Barceloux 1988). For further

information, see the ATSDR toxicological profiles on gasoline, jet fuels, or fuel oils (ATSDR 1993).

It is possible that if Stoddard solvent were swallowed, some would be taken into the lungs by

aspiration, and this would be expected to cause pneumonitis (Ellenhorn and Barceloux 1988).

No studies were located regarding the following end points after oral exposure to Stoddard solvent:

2.2.2.1 Death

2.2.2.2 Systemic Effects

2.2.2.3 Immunological and Lymphoreticular Effects

2.2.2.4 Neurological Effects

2.2.2.5 Reproductive Effects

2.2.2.6 Developmental Effects

2.2.2.7 Genotoxic Effects

Genotoxicity studies are discussed in Section 2.4.

2.2.2.8 Cancer

No studies were located regarding carcinogenic effects in humans or animals following inhalation

exposure to Stoddard solvent.

2.2.3 Dermal Exposure

Because of the lack of quantifiable exposure data for other effects, only studies showing ocular effects

after dermal exposure are suitable for presentation in a table on levels of significant exposure. See

Table 2-2. Ocular effects noted in this section occurred after inhalation exposure to Stoddard solvent.

However, these ocular effects are probably due to direct contact with the eyes rather than as a systemic effect

due to inhalation exposure. See Section 2.2.1.2.

STODDARD SOLVENT 41

2. HEALTH EFFECTS

2.2.3.1 Death

No studies were located regarding death in humans or animals after dermal exposure to Stoddard

solvent.

2.2.3.2 Systemic Effects

No studies were located regarding respiratory, cardiovascular, gastrointestinal, hematological,

musculoskeletal, or hepatic effects in humans or animals after dermal exposure to Stoddard solvent.

Renal Effects. The only information on the possible effects of Stoddard solvent on the kidneys of

humans after dermal exposure comes from an occupational case study. A 29-year-old man handled

brushes soaked in Stoddard solvent while not wearing gloves for 1 year and developed glomerulonephritis

(Daniell et al. 1988). On a typical day, he spent about 6 hours using the solvent. The patient’s glomerulonephritis

was associated with antibodies to the glomerular basement membrane. Exposure concentrations were not reported.

Both dermal and inhalation exposure are likely in this case.

No studies were located regarding renal effects in animals after dermal exposure to Stoddard solvent.

Dermal Effects. Five men who wore coveralls that were damp from dry cleaning with Stoddard

solvent developed sores on the penis and buttocks (Nethercott et al. 1980). None had an allergic

reaction in a patch test. Standard texts and review articles on industrial hygiene list Stoddard solvent

or Varsol as a possible eye, skin, nose, and throat irritant (Birmingham 1988; McDermott 1975;

NIOSH 1990; Sax and Lewis 1989).

Dermal exposure to white spirits (three times daily for 3 days) resulted in skin irritation in guinea pigs as evidenced by

an increase in mean epidermal thickness, visible redness, palpable induration, and evident swelling (Anderson et al.

1986).

Ocular Effects. Humans exposed to 600 mg/m3 or up to 1,800 mg/m3 of completely vaporized

Stoddard solvent for 30 minutes in separate experiments in a controlled laboratory setting showed no
STODDARD SOLVENT 42

2. HEALTH EFFECTS

eye irritation as indicated by eye blinks but individuals exposed to 2,400 mg/m3

 exhibited eye irritation as measured by

eye blink rate (Hastings et al. 1984). However, subjectively reported slight eye irritation occurred in individuals

exposed to 2,700 mg/m3

 of completely vaporized Stoddard solvent for 15 minutes (Carpenter et al. 1975a, 1975b).

Eye irritation was also seen in rats during acute inhalation exposure to 4,600 mg/m3

 of completely

vaporized Stoddard solvent and in dogs exposed to 8,000 mg/m3

 (Carpenter et al. 1975a, 1975b).

Lacrimation was noted in rats exposed by inhalation for 6 months (5 days/week, 6 hours/day) to

2,290 mg/m3

 white spirit (20% aromatics) (Ostergaard et al. 1993). Although these effects were

reported after inhalation exposure to Stoddard solvent, they are probably due to direct contact of the

vapor with the eyes rather than to a systemic effect.

2.2.3.3 Immunological and Lymphoreticular Effects

No studies were located regarding immunological or lymphoreticular effects in humans or animals

after dermal exposure to Stoddard solvent.

2.2.3.4 Neurological Effects

A 29-year-old man who used Stoddard solvent as a cleaning agent while not wearing gloves, for

approximately 6 hours per day for 1 year, occasionally reported feeling “high” and experienced

bifrontal headaches that began during work and subsided in the evenings and over weekends (Daniel1

et al. 1988). Exposure concentrations were not reported. Both dermal and inhalation exposure are

likely in this case.

In another occupational study, the incidence of acquired color vision loss (dyschromatopsia) was

investigated in 30 printshop employees exposed by the inhalation and dermal routes (Mergler et al.

1988). The employees were divided into three groups based on product exposure: (1) graphics

department workers with occasional exposure to heated wax, (2) photo- and polycopy operators with

exposure to solvents containing alcohols, perchloroethylene, and Stoddard solvent, and (3) bookbinders and printers

with exposure to solvents containing methylene chloride, xylene, toluene, and Stoddard solvent. When compared to the

controls, the printshop employees as a whole had a significantly higher mean color confusion index. Furthermore,

groups 2 and 3 of the solvent-exposed employees
STODDARD SOLVENT 43

2. HEALTH EFFECTS

had higher incidences of color confusion than group 1. The employees in groups 2 and 3 also

exhibited complex color vision loss (i.e., both blue-yellow and red-green loss), whereas the controls

and exposure group 1 only had blue-yellow loss. The color confusion index was related to both age

and job type, but complex color loss was only related to job type. This study suggests that solvents,

possibly including Stoddard solvent, may cause neurological damage in the form of acquired color

vision loss. However, since the workers were exposed to multiple solvents simultaneously, it is

impossible to determine which solvent or combination of solvents may have produced the

dyschromatopsia. In addition, neither exposure doses nor durations were discussed.

Only one study was located regarding neurological effects fn animals after dermal exposure to

Stoddard solvent. Rats had a daily 3-hour exposure to white spirits for 6 weeks on a 12-cm2

 area of

the tail (Verkkala et al. 1984). The absorbed dose was calculated by the authors to be 210 mg, but

they did not describe how the calculation was performed. Exposure had little effect on motor

conduction velocity or motor amplitudes in response to stimulation. Histological analysis revealed

axonal prenodal swellings. No other functional or behavioral tests were performed.

No studies were located regarding the following health effects in humans or animals after dermal

exposure to Stoddard solvent:

2.2.3.5 Reproductive Effects

2.2.3.6 Developmental Effects

2.2.3.7 Genotoxic Effects

Genotoxicity studies are discussed in Section 2.4.

2.2.3.8 Cancer

A case-referent study using cases of Hodgkin’s disease and non-Hodgkin’s lymphoma among Swedish workers

exposed to white spirit implied a slight increase in crude odds ratios, but the study was limited by an insufficient

number of cases (Persson et al. 1993).
STODDARD SOLVENT 44

2. HEALTH EFFECTS

Squamous cell carcinomas were found in 6 out of 50 exposed mice from a lifetime skin-painting study

using a rust-preventive compound consisting of 90% Stoddard solvent, 7% calcium petroleum

sulfonate, and 3% ethylene glycol monobutyl ether (EPA 1984~). No tumors were found in mineral

oil controls. Since the test involved three constituents, it is not possible to determine which one or

combination was responsible for the tumors. In fact, none of the three substances has previously been

identified as a carcinogen. The design of this study makes the results too ambiguous to determine

whether Stoddard solvent is carcinogenic, but it does suggest a potential area of concern. The

possibility that Stoddard solvent could initiate or promote squamous cell carcinomas should not be

completely discounted until a similar experiment using Stoddard solvent alone is conducted.

2.3 TOXICOKINETICS

The toxicokinetic properties of Stoddard solvent are not well defined by the available data. Some

toxicokinetic data that are specific to the three classes of Stoddard solvent components (i.e., alkanes,

cycloalkanes, and aromatics) are available.

Studies in humans and animals have shown that Stoddard solvent and white spirits are readily

absorbed through the lungs. In general, it can be expected that Stoddard solvent components such as

the aromatics, which have higher blood/gas solubility ratios, would be more completely absorbed

through the lungs that those with lower ratios (Klaassen 1991). Aliphatic components of white spirit

have been shown to have only limited blood solubility, while aromatic components were relatively

soluble (Astrand et al. 1975). No studies were located that reported the absorption of Stoddard solvent

after oral exposure in either humans or animals. However, from studies of other petroleum distillates,

it is expected that certain components of Stoddard solvent (smaller alkanes or aromatics) might be

more readily absorbed than other components such as longer (C10-C16). alkane chains. Neither human

nor animal studies evaluating the absorption of Stoddard solvent after dermal exposure were located,

but dermal absorption in rats is known to have occurred after application of white spirits. Aromatic

components would be expected to have greater dermal absorption than aliphatic components.

White spirits has been found to accumulate in the blood and subcutaneous fat of humans following

inhalation exposure. The uptake of aliphatic components in blood was lower than the uptake of

aromatic components (Astrand et al. 1975). It is believed that white spirits can enter the brain of

humans since neurological effects have been reported; however, no human data are available to verify
STODDARD SOLVENT 45

2. HEALTH EFFECTS

this. White spirits has been shown to accumulate in the rat brain after inhalation exposure (Lam et al.

1992). There is no information available on the distribution of Stoddard solvent following oral or

dermal exposure.

Elevated levels of dimethylbenzoic acid, a metabolite of trimethylbenzene (a constituent of Stoddard

solvent) were identified in the urine of humans exposed to a mist of white spirits (Pfaffli et al. 1985).

Correlations were found between exposure concentrations of 1,2,4-trimethylbenzene and urinary

concentrations of its metabolite, 3,4-dimethylhippuric acid (Fukaya et al. 1994). No other studies were

located regarding metabolism following exposure to Stoddard solvent.

Although no studies were found that reported the excretion of Stoddard solvent after inhalation or oral

exposure in humans and animals, or after dermal exposure in humans, it is expected that volatile

components or metabolites of Stoddard solvent that have low blood solubility would be most easily

excreted in exhaled breath (Klaassen and Rozman 1991). Aromatic components, which have high

blood/gas solubility ratios, would be expected to be excreted primarily in urine. After dermal

exposure to white spirits, rats were found to excrete dimethylbenzoic acid isomers in the urine

(Verkkala et al. 1984).

The mechanism of action on the target organ (i.e., the brain) of humans is not known.

2.3.1 Absorption

2.3.1.1 Inhalation Exposure

Following acute inhalation exposure of humans to white spirits (600 mg/m3

 in a laboratory setting),

white spirits were found in the blood and subcutaneous fat (Pedersen et al. 1984, 1987). The white

spirits consisted of 99% alkanes (C8-C12), which is greater than the 30-50% alkanes found in Stoddard

solvent. The spectrometrical pattern produced by the evaporation of the biopsy samplesindicated that

the approximately 200 constituents of the white spirits were absorbed differently. The calculated

pulmonary uptake from an exposure to 600 mg/m3

 for 3 hours was about 400 mg (133 mg/hour) in

men who weighed an average of 73±8 kg (Pedersen et al. 1987). Mean residence time was 47.5 hours

(Pedersen et al. 1987). The volume of distribution at steady state was 749 L, indicating that

concentration was occurring in a compartment such as adipose tissue. Total body clearance was
STODDARD SOLVENT 46

2. HEALTH EFFECTS

263 mL/minute (Pedersen et al. 1987). The calculated uptake for exposure to the same level for a

longer period (5 days, 6 hours/day) was 3,464±329 mg (115±211 mg/hour). Thus, the rate of inhalation absorption was

fairly constant over the different exposure intervals measured here. Mean blood concentration was 2 mgL on day 1 and

2.54 mg/L on day 5, showing accumulation of white spirits in the blood (Pedersen et al. 1984). There are no other

studies from animals or humans that can be used to verify these results.

In general, it can be expected that the more highly volatile components of Stoddard solvent would

cross from the lungs into the bloodstream more readily than other components (Klaassen 1991). The

components with higher blood/gas phase solubility ratios (such as the aromatics: substituted benzenes

and toluenes) would be expected to be absorbed more completely than those with lower ratios (such as

the cyclohexanes) (Klaassen 1991).

Men exposed to up to 2,000 mg/m3

 of white spirits (83% aliphatic and 17% aromatics) for 30 minute

intervals per concentration during rest in the laboratory bad average uptakes of 50% for the aliphatic

components and 62% for the aromatics, as determined by measuring the representative components

(n-decane and 1,2,4-trimethylbenzene) in inspiratory and expiratory air (Astrand et al. 1975). The

exposure sequence of another experiment in the same study consisted of 30-minute exposure periods

interrupted by three 30-minute exercise periods. Pre-exercise concentrations of alveolar air in subjects

exposed to 1,250 mg/m3

 of white spirits for 30 minutes at rest were 256 mg/m3 of aliphatic

components and 27.8 mg/m3 of aromatic components; arterial blood concentrations were 1.7 mg/kg for the

aliphatics and 0.2 mg/kg for the aromatics (Astrand et al. 1975). After exercise, alveolar air

concentrations increased to approximately 513 mg/m3

 (aliphatics) and 40 mg/m3 (aromatics); arterial

blood concentrations increased to 3.5 mg/kg (aliphatics) and 0.9 mg/kg (aromatics) (Astrand et al.

1975). Thus, the aromatics appear to be more soluble in blood and more efficiently absorbed through

the lungs. Due to increased respiration that occurs during exercise, more of the solvent is taken up at

this time than during sedentary periods.

2.3.1.2 Oral Exposure

No studies were located regarding absorption of Stoddard solvent following oral exposure in humans

or animals. Other petroleum distillates with longer carbon chains, such as kerosene (C10-C16), are very

poorly absorbed from the gastrointestinal tract (Dice et al. 1982; Mann et al. 1977; Wolfsdorf and
STODDARD SOLVENT 47

2. HEALTH EFFECTS

Kundig 1972). The smaller (C9-C11 alkane or aromatic hydrocarbons (10-20% in Stoddard solvent)

may be more readily absorbed (Litovitz and Greene 1988). The rate and extent of gastrointestinal

absorption would be expected to be dependent on the lipophilicity and size of the various components

and the amount of food in the stomach.

2.3.1.3 Dermal Exposure

No studies were located that evaluated absorption foollowing dermal exposure to Stoddard solvent in

humans or animals. However, daily applications of white spirits (absorbed dose 690.8 mg/kg) for

6 weeks on the tail of rats were associated with axonal prenodal swellings (Verkkala et al. 1984)

indicating that dermal absorption had occurred. This study also reported that several products

(dimethylbenzoic acid isomers) of trimethylbenzene metabolism were found in the urine of treated rats, providing

further evidence of dermal absorption. The aromatic hydrocarbons are expected to have

higher skin penetration than the aliphatic hydrocarbons.

2.3.2 Distribution

2.3.2.1 Inhalation Exposure

Following acute inhalation exposure of eight male individuals to white spirits (Shellsol, 99% alkanes,

at 600 mg/m3

 for 3 hours or 6 hours/day for 5 days), white spirits was found to accumulate in the

blood and subcutaneous fat (Pedersen et al. 1984, 1987). For the single exposure, the estimated mean

half-life in fat was 46 hours. Following repeated exposures to white spirits, the mean concentration in

the fat was 41.l mg/kg (Friday afternoon) (Pedersen et al. 1984). On Monday morning, the

concentration in fat was 31.7 mg/kg, indicating that only 23% was removed over the period of

nonexposure. The concentration of white spirit in fat found each afternoon correlated significantly

with the total dose (Pedersen et al. 1984). A mathematical model was developed using measured

blood values to calculate concentrations in various tissues (Pedersen et al. 1987). The model was

considered to be a good predictor of tissue concentration since measured blood and fat values closely

followed the fitted values. The partition coefficient for adipose tissue:blood was calculated to be 47.

Estimated maximum steady-state concentrations were about 55 mg/kg for fat and 5 mg/kg for brain;

estimated minimum steady-state concentrations were 35 mg/kg for fat and 0.6 mg/kg for brain

(Pedersen et al. 1987). No other human or animal data are available to verify this calculation. Since
STODDARD SOLVENT 48

2. HEALTH EFFECTS

central nervous system effects are common following exposure to white spirits, it can probably enter

the brain The study described above uses mathematical calculations to estimate how much could

enter the brain, based on distribution to fat and to blood, but the study did not actually measure

distribution to this organ. A 3-week inhalation study in Wistar rats exposed for 6 hours/day,

5 days/week at levels of 2,290 and 4,580 mg/m3

 found that white spirits (20% aromatics) accumulated

in the brain (3.4 and 10.2 mg/kg wet weight, respectively) (Lam et al. 1992). This study also

measured the distribution of aromatic and aliphatic components; aliphatics seemed to accumulate more than 

aromatics. In the brain, aromatic compounds of white spirits increased proportionately with the exposure level 

(2.1 times), while metabolic elimination aromatic aliphatic compounds increased 3.6 times. This may be due to 

an increased metabolic elimination of the components (Zahlsen et al. 1992). No studies using Stoddard

solvent or white spirits were available in which distribution to any other organs was measured.

Distributions of some possible components of Stoddard solvent have also been examined. A

toxicokinetic study on the distributions of C9-C10, alkanes, aromatics, and cycloalkanes in blood, brain, liver, kidney,

and perirenal fat was performed in rats after inhalation exposure 12 hours/day for up to 3 days at 100 ppm (Zahlsen et

al. 1992). The compounds tested included n-nonane and n-decane (alkanes), trimethylbenzene and t-butylbenzene

(aromatics), and trimethylcyclohexane and t-butylcyclohexane (cycloalkanes). It was reported that aromatics generally

showed higher blood concentrations than alkanes and cycloalkanes. C9 cycloalkanes showed higher brain

concentrations than the corresponding aromatics and alkanes, while brain concentrations of C10 alkanes were slightly

greater than C10 cycloalkane concentrations, which in turn were greater than C10 aromatic concentrations (Zahlsen et al.

1992). Fat contained the highest concentrations of each of the hydrocarbons examined; concentrations of aromatics and

cycloalkanes in fat were higher than concentrations of alkanes. The concentrations of aromatics in fat decreased on

each successive day of exposure, which could be an indication of a higher rate of metabolic elimination (Zahlsen et al.

1992). C9 alkanes were found in particularly low concentrations in the liver compared to levels found in the brain and

kidney. Although C9 alkane levels were similar in the brain and kidney, C10 alkane levels were found to be slightly

higher in the brain. Concentrations of trimethylcyclohexane and trimethylbenzene were higher in kidney tissue than

were concentrations of the alkanes (Zahlsen et al. 1992).

Rats exposed by inhalation to 1,000 ppm of trimethylbenzene, n-nonane, or trimethylcyclohexane

(12 hours/day for up to 14 days) reported that after the first day of exposure, trimethylbenzene showed
STODDARD SOLVENT 49

2. HEALTH EFFECTS

the greatest blood concentration (537 μmol/L) followed by n-nonane (174 μmol/L) and

trimethylcyclohexane (130 μmol/L) (Zahlsen et al. 1990). However, n-nonane showed the highest

brain concentration (1,416 μmol/kg), while concentrations of trimethylcyclohexane (1,109 μmol/kg)

and trimethylbenzene (998 μmol/kg) were somewhat similar. This finding was in contrast to the later

Zahlsen et al. (1992) study in which C9 cycloalkanes showed higher brain concentrations than alkanes.

In perirenal fat, the highest concentrations were of trimethylbenzene (49,190 μmol/kg on day l),

followed by n-nonane (15,980 μmol/kg on day 3) and trimethylcyclohexane (6,860 to 9,550 μmol/kg

throughout exposure) (Zahlsen et al. 1990). The concentrations in perirenal fat in the later Zahlsen et

al. (1992) study again were different from these earlier results; concentrations of aromatics were

greater than those of cycloalkanes, which were greater than those of alkanes. It is possible that the

results of these studies differ due to saturation of metabolic pathways, since the concentrations used in

the two studies differed by 10-fold. In the Zahlsen et al. (1990) study, although there was some

overall decrease in the concentrations of all three compounds in blood, brain, and fat over the total

period of exposure, the decreases were most prominent following exposure to trimethylbenzene and, to a lesser extent,

trimethylcyclohexane. These data suggest that these two compounds may be capable

of the induction of their own metabolic conversion (Zahlsen et al. 1990).

2.3.2.2 Oral Exposure

No studies were located regarding distribution following oral exposure to Stoddard solvent in humans

or animals.

2.3.2.3 Dermal Exposure

No studies were located regarding distribution following dermal exposure to Stoddard solvent in

humans or animals.

2.3.3 Metabolism

Men who were exposed to a mist of a specific type of Finnish white spirits used for washing cars

(Pfaffli et al. 1985) had elevated levels of dimethylbenzoic acid, a metabolite of trimethylbenzene, in

their urine following the workshift. This study attempted to quantify exposure to white spirits through

the analysis of dimethylbenzoic acid isomers, which are easily detected markers. It assumed that being
STODDARD SOLVENT 50

2. HEALTH EFFECTS

in a mixture does not affect the metabolism of trimethylbenzene or any of the other constituents of

Stoddard solvent The amount excreted was linearly related to the estimated exposure level. The

composition of the white spirits in this study included 11% aromatics with 1% trimethylbenzene

isomers, which is similar to the compositions of Stoddard solvent used in the United States. A

correlation between exposure to 1,2,4-trimethylbenzene, a component of white spirits, at the TLV-TWA (25 ppm), 

and the urinary concentration of 3,4-dimethylhippuric acid (3/4-DMHA) was reported in ceramics workers 

(Fukaya et al.1994). Rats were dosed by gavage with t-butylcyclohexane (800 mg/kg), another component 

of white spirits, andseven compounds were identified as urinary metabolites (Henningsen et al. 1987). The

 primary metabolite was trans-4-t-butylcyclohenanol, with lesser amounts of 2c

-hydroxy-4t-t-butylcyclohexanol, 

2-methyl-2-cyclohexylpropanoic acid,2c

-hydroxy-4c-t-butylcyclohexanol, 2-methyl-2-cyclohexyl-1,3-propanediol,

2t-hydroxy-4t-butylcyclohexanol, and Cis-4-t-butylcyclohexanol also being detected. Rats that had a

white spirit formulation (690.8 mg/kg) applied to their tails 5 days/week for 6 weeks were reported to have 

excreted several products (dimethylbenzoic acid isomers) of trimethylbenzene metabolism in their urine.

2.3.4 Excretion

2.3.4.1 Inhalation Exposure

No studies were located regarding excretion of Stoddard solvent following inhalation exposure in

humans or animals. It is expected that components or metabolites of Stoddard solvent that are volatile

but have low solubility in the blood, would be rapidly exhaled from the lungs. Like absorption, this

process is governed by blood/gas solubility ratios (Klaassen 1991). Components with low blood/gas

ratios would be most rapidly excreted from the lungs because of their low blood solubility, while those

with high blood/gas solubility ratios would be eliminated less efficiently by the lungs due to their high

blood solubility; this situation is exactly the reverse of that for inhalation absorption (Klaassen 1991).

The aromatic hydrocarbons are expected to be excreted primarily in the urine (Klaassen 1991).

2.3.4.2 Oral Exposure

No studies were located regarding excretion of Stoddard solvent following oral exposure in humans or

animals. It is expected that the poorly absorbed components of Stoddard solvent would continue

through the gastrointestinal tract to the feces.
STODDARD SOLVENT 51

2. HEALTH EFFECTS

2.3.4.3 Dermal Exposure

No studies were located regarding excretion of Stoddard solvent following dermal exposure in humans. Rats exposed

to daily applications of white spirits (absorbed dose of 690.8 mg/kg) on the tail for 6 weeks excreted dimethylbenzoic

acid isomers (2,3-, 2,4-, 2,5-, 3,4-, 3,5-dimethylbenzoic acid) in the urine (Verkkala et al. 1984). No other metabolic

parameters have been measured.

2.3.5 Mechanisms of Action

Little is known regarding the specific mechanisms of action by which Stoddard solvent exerts its toxic

effects. Generally, it is believed that the aromatic components of Stoddard solvent would be more

readily and completely absorbed through the lungs and skin than would long-chained aliphatic

components. The mechanism of action of Stoddard solvent on the central nervous system is not

known. Exposure to white spirit increased levels of the neurotransmitters noradrenaline, dopamine,

and 5-hydroxytryptamine in the brain of exposed rats, although the biological significance of these

changes is not understood (Lam et al. 1992). Stoddard solvent does not contain the shorter chain

alkanes that have been known to cause anesthesia (Haydon et al. 1977). Inhalation exposure of rats to

white spirits for 3 weeks (6 hours/day, 7 days/week) resulted in a significant increase in the rate of

reactive oxygen species (ROS) generation in the hippocampus (Lam et al. 1994). Since the brain

contains large amounts of polyunsaturated fatty acids, proteins, and catecholamines, all of which are

targets for ROS, increased rates of ROS in the brain following white spirit exposure might provide

evidence that the mechanism for neurotoxicity involves ROS interaction with lipid peroxidation,

protein oxidation, and DNA (Lam et al. 1994).

Although renal toxicity has been reported after exposure to Stoddard solvent in rats, it has not been

reported in humans, rabbits, guinea pigs, dogs, or monkeys. A mechanism of action has been

proposed for the renal effects observed in male rats. The carrier protein α2μ-globulin is synthesized in

large quantities by these animals and is used to transport pheromones into the urine (Boeskei et al.

1992). After glomerular filtration with their ligand, these carrier proteins are resorbed in massive

quantities in the PZ section of the proximal convoluted tubule and catabolized in lysosomes (EPA

1991a; Kimura et al. 1991a). It is proposed that Stoddard solvent exerts its toxic effect by binding to

α2μ-globulin; after resorption in the proximal tubule, it is believed to accumulate in lysosomes, where

it resists degradation and causes the pathological changes that characterize α2μ-globulin nephropathy
STODDARD SOLVENT 52

2. HEALTH EFFECTS

syndrome. Since synthesis of the carrier protein, α2μ-globulin, is under androgenic control, this

hypothesis would explain why neither female rats nor castrated male rats have been found to be

afflicted with α2μ-globulin nephropathy. A more detailed discussion of this mechanism can be found

in Section 2.2.1.2.

Humans are not believed to be susceptible to proximal tubule damage by the mechanism, since they do not produce the

α2μ-globulin protein. Analogous human proteins could possibly undergo the same

interactions as α2μ-globulin if they were produced in similar quantities. But because humans are not

known to synthesize and resorb other lipocalin proteins in such massive quantities as rats do with

α2μ-globulin, it is unlikely that Stoddard solvent would cause such profound toxicity if an interaction

did occur. No reports were located that show proximal tubule damage in persons exposed to Stoddard solvent.

Epidemiology studies of persons with glomerulonephritis showed no differences in exposure

to organic solvents between cases and controls (van der kaan 1980), and patients exposed to white

spirits exhibited normal renal function (Flodin et al. 1984). However, one case study of a man

chronically exposed to Stoddard solvent reported the development of glomerulonephritis (Daniell et al.1988). This

case is discussed more fully in Section 2.3.2. Thus, it is possible that there may be other

mechanisms of action for renal toxicity in humans.

2.4 RELEVANCE TO PUBLIC HEALTH

Very little information is available on the effects other than neurotoxicity of Stoddard solvent on

humans and animals. No studies have been performed regarding oral exposure in humans or animals.

Most of the toxicological investigations of Stoddard solvent have focused on inhalation exposures. In

almost all cases, it was completely vaporized. Although Stoddard solvent as a whole is relatively

volatile, most human exposure scenarios are likely to result in greater exposure to the more volatile

fractions, including the aromatics, than to the less volatile components. If a significant amount of

toxicity is due to the less volatile fractions, the studies using completely vaporized Stoddard solvent

may exaggerate the effects expected when extrapolated to more realistic human exposuresituations.

On the other hand, if most of the toxicity is due to the more volatile components, and substituted

aromatics and naphthalenes do tend to be more toxic than alkanes in general, then the complete

vaporization experiments may fairly accurately represent the effects from exposure to Stoddard solvent fumes.

 In the absence of other data, it is reasonable to extrapolate human risk from these inhalation
STODDARD SOLVENT 53

2. HEALTH EFFECTS

exposure studies to completely vaporized Stoddard solvent. It is likely that most exposure at

hazardous waste sites would occur to the vapor of Stoddard solvent.

The effects that are the most likely to occur following inhalation or dermal exposure are neurological

effects, which are discussed below. Adverse respiratory effects have been seen in a few animal

studies, although the reliability of the findings in some of the studies is questionable because of similar 

adversefindings in the controls. Adverse respiratory effects have not been seen in humans. It is 

possible that aspiration ofStoddard solvent may result in pneumonitis, assuming that the Stoddard

solvent acts in a manner similar to the related mixture, kerosene. The reports on developmental and

reproductive effects are minimal and negative. Evidence of genotoxicity is generally negative. The

evidence of carcinogenicity is negative in humans. However, positive findings of squamous cell

carcinomas were reported in one mouse study. Conclusions specific to Stoddard solvent are limited

because the study tested a rust-preventive compound that consists of 90% Stoddard solvent, 7%

calcium petroleum sulfonate, and 3% ethylene glycol monobutyl ether. However, the data identify a

potential area of concern.

Minimal Risk Levels for Stoddard Solvent

An MRL could not be derived for acute inhalation exposure (14 days or less) to Stoddard solvent.

The best study in the acute database was a no-observed-adverse-effect level (NOAEL) at a time

weighted average of 1,560 mg/m3

 in sedentary male human volunteers exposed to completely

vaporized white spirits for 2 hours. This study was not suitable for MRL derivation because the

results from a 2-hour exposure could not be reliably extrapolated to a continuous 14-day exposure. These

humans showed no neurological effects from exposure to the white spirits (presumably the 83% aliphatic,

17% aromatic components described in Astrand et al. 1975) (Gamberale et al. 1975). In this study,

central nervous system function was evaluated in multiple tests including perceptual speed, simple

reaction time, short-term memory, numerical ability, and manual dexterity. A lowest-observed-adverse-effect

level (LOAEL) was seen in the same study when humans were exposed to 4,000 mg/m3 for 50 minutes. The subjects

had a prolonged simple reaction time compared to control results in the same volunteers during a non-exposure 

period.It should be noted that because of practical constraints, these tests were conducted on volunteers at rest and 

that parallel pharmacokinetic studies have demonstrated greater uptake during exercise (Astrand et al. 1975).
STODDARD SOLVENT 54

2. HEALTH EFFECTS

There were no human or animal studies suitable for developing MRLs for intermediate- or chronicduration

exposures to Stoddard solvent in the air. However, more serious health effects would be predicted with longer

 duration exposure. There are no oral studies in either humans or animals. The dermal effects in humans and

animals are skin irritation and possible neurological effects, but amethodology for developing MRLs based on

dermal exposure is not available.

Death. There is no reliable information regarding doses of Stoddard solvent that could cause death in humans.

It is possible that exposure to very high concentrations of this petroleum distillate could pose a serious health

hazard and possibly even cause death from central nervous system depression. However, death is unlikely unless there is an extremely high exposure, since Stoddard solvent contains very little of the smaller carbon

chains (C8 and below) which are known to be highly volatile and highly toxic (Andrews and Snyder 1986).

There is also a remote risk of death due to pulmonary pathology from aspiration (Ellenhorn and Barceloux 1988).

Levels that may pose a mortality risk to humans are not known and cannot be determined from animal studies.

Concentrations of 10,000 mg/m3

 Stoddard solvent were lethal to cats (Carpenter et al. 4975a, 1975b), and death

From unexplained causes was noted in guinea pigs exposed for 90 days to 363 and 892 mg/m3

 vaporized

mineral spirits (Jenkins et al. 1971; Rector et al. 1966). Nonlethal levels were reported for rats, rabbits, dogs, and

monkeys following a continuous exposure for 90 days to 1,271 mg/m3

 vaporized mineral spirits; for guinea pigs,

rats, rabbits, dogs, or monkeys following repeated, 6-week intermediate exposure to 1,353 mg/m3

 mineral spirits;

and for rats following acute exposures of up to 8,200 mg/m3

 of completely vaporized Stoddard solvent (Carpenter

et al. 1975a, 1975b; Rector et al. 1966).

Systemic Effects. There is very little information on the health effects of Stoddard solvent in either

humans or animals. There was a lack of gastrointestinal, musculoskeletal, hepatic, and renal effects in

a laboratory experiment in humans exposed to 610 mg/m3

 of Stoddard solvent in the air for 6 hours

(Pedersen and Cohr 1984a). Possible indications of musculoskeletal effects were noted, however, as

increased creatinine kinase levels after an exposure to 616 mg/m3

 of vaporized white spirits (99%

alkanes, no aromatics) (Pedersen and Cohr 1984b).

Respiratory Effects. It is possible that Stoddard solvent would adversely affect the lungs. There are

two human studies on respiratory effects. One found no change in respiratory rate from a 30-minute

exposure to 2,400 mg/m3

 (Hastings et al. 1984), and the other found no adverse effects on respiratory
STODDARD SOLVENT 55

2. HEALTH EFFECTS

function in men exposed to paint solvents in the air for 4-42 years (Hane et al. 1977). The data on

respiratory effects in animals are limited but show upper respiratory irritant effects in rats from acute

exposure (Carpenter et al. 1975a, 1975b; Riley et al. 1984) and decreased respiratory rate in mice

(Carpenter et al. 1975a, 1975b). No evidence of lung effects was found following acute exposures.

However, congestion, bronchitis, and mixed inflammatory cell infiltration were noted in rats, rabbits,

guinea pigs, dogs, and monkeys exposed to vaporized mineral spirits at 1,271 mg/m3

 for 90 days

(Rector et al. 1966). Also, guinea pigs exposed to concentrations of 1,353 mg/m3

 exhibited pulmonary

congestion and emphysema from intermediate exposures for 6 weeks (Rector et al. 1966). However,

the data for rabbits, dogs, and monkeys are limited by the use of three animals or less. Based on

information from other petroleum distillates, for instance, kerosene, it is possible that if Stoddard

solvent is taken into the mouth, it woulid be aspirated into the lungs and might then cause pneumonitis

(Coruh and Inal 1966; Majeed et al. 1981; Nouri and Al-Rahim 1970). Exposure of rats to 214 mg/m3

of white spirits for 4 days caused loss of cilia and squamous metaplasia in the trachea and nasal cavity

(Riley et al. 1984). However, the study was limited by use of only one dose group in addition to the

controls. No other significant adverse respiratory effects were seen in other animal studies (Carpenter

et al. 1975a, 1975b; Rector et al. 1966).

Cardiovascular Effects. No compound-related changes in cardiovascular parameters were noted after

men were exposed to up to 2,500 mg/m3

 of vaporized mineral spirits for a 30-minute period (Astrand

et al. 1975), and no changes in blood pressure were noted in painters exposed for 4-42 years to paints

and solvents (Hane et al. 1977). No histopathological changes were noted in the hearts of rats, rabbits,

guinea pigs, dogs, or monkeys exposed to 1,271 mg/m3

 of vaporized mineral spirits for an

intermediate-duration exposure (Rector et al. 1966). Although Stoddard solvent exposure does not

appear to cause any effect on the cardiovascular system, sufficient data do not exist to make an

unequivocal determination.

Gastrointestinal Effects. No adverse gastrointestinal effects were noted after inhalation of 610 mg/m3

vaporized white spirits by human volunteers for 6 hours (Pedersen and Cohr 1984a), andnausea was

reported in one of nine workers exposed to Stoddard solvent when cleaning machines (Larsen and

Schmunes 1974). No studies were located regarding gastrointestinal effects in animals after inhalation

exposure to Stoddard solvent. While it appears that Stoddard solvent might cause nausea in certain

individuals, sufficient data do not exist to make an unequivocal determination regarding gastrointestinal effects.
STODDARD SOLVENT 56

2. HEALTH EFFECTS

Hematological Effects. Studies of house painters and car repair workers exposed to mixed solvents

have shown decreased red blood cell counts and hemoglobin concentrations as well as increased mean

erythrocyte and platelet volumes in these workers (Beving et al. 1991; Hane et al. 1977). However,

normal hematological values were noted in 128 persons exposed to a variety of solvents including

white spirits (Flodin et al. 1984) and, in other case reports, and no causal relationship could be

established between persons with aplastic anemia and exposure to Stoddard solvent (Prager and Peters

1970; Scott et al. 1959). Normal leukocyte, hemoglobin, and hematocrit levels were found in rats,

rabbits, guinea pigs, dogs, and monkeys exposed to up to 1,353 mg/m3

 of vaporized mineral spirits for

6 weeks or to 1,271 mg/m3

 for 90 days (Rector et al. 1966) or in rats and dogs exposed to

1,900 mg/m3

 of vaporized Stoddard solvent for 13 weeks (Carpenter et al. 1975a, 1975b). Since there

are hmited and conflicting data regarding the hematological effects of exposure to Stoddard solvent, an unequavocal

conclusion about these end points cannot be made.

Musculoskeletal Effects. The only indicator of musculoskeletal compromise was an increase in

creatine kinase after exposure of human volunteers to 616 mg/m3

 of vaporized white spirits for 5 days

(Pedersen and Cohr 1984b). No changes in serum creatine kinase was noted after exposure of

volunteers to 610 mg/m3

 for one 6-hour period (Pedersen and Cohr 1984a). Rats that were exposed to

2,290 mg/m3

 or 4,580 mg/m3 white spirits showed increases in serum creatinine, but no dose response

was evident (Ostergaard et al. 1993). Although Stoddard solvent exposure does not appear to cause

any musculoskeletal effects, sufficient data do not exist to make an unequivocal determination.

Hepatic Effects. The few available studies regarding hepatic effects indicate that acute, low-level

exposures to Stoddard solvent have very minor, if any, effects on liver function. Men exposed to

610 mg/m3

 for 6 hours showed no changes in serum liver products (Pedersen and Cohr 1984a).

Painters exposed to white spirits and other solvents for chronic periods showed elevated levels of

serum alanine aminotransferase but had normal liver biopsies (Dossing et al. 1983). Persons exposed

to a variety of solvents, including white spirits, showed elevated glutamyl transferase levels (Flodin et

al. 1984). A group of painters showed normal serum transaminase levels compared to unexposed

controls (Hane et al. 1977). No histopathological or blood chemical indicators of liver damage were

noted in guinea pigs exposed to up to 1,271 mg/m3

 of vaporized white spirits for 90 days (Jenkins et

al. 1971; Rector et al. 1966), in rats or guinea pigs exposed to 1,353 mg/m3

 for 6 weeks (Rector et al.

1966), or in rats and dogs exposed to 1,900 mg/m3

 Stoddard solvent for 90 days (Carpenter et al.

1975a 1975b).
STODDARD SOLVENT 57

2. HEALTH EFFECTS

Renal Effects. Although no human studies have reported renal toxicity that could be attributed to

Stoddard solvent, several investigations have reported proximal tubule damage in male rats. A number

of the observed renal effects of Stoddard solvent are consistent with a mechanism which appears to be

unique to male rats. Male rodents scent mark their territories with pheromones secreted in the urine.

These pheromones are transported to the urine by low molecular weight serum binding proteins which

are members of the lipocalin family (Bocskei et al. 1992). In male rats, the carrier protein is

α2μ-globulin, which is synthesized in large quantities in the liver (Bocskei et al. 1992). X-ray

crystallography has demonstrated that α2μ-globulin is a tetramer which has a doughnut hole in the

center for transport of the ligand (Bocskei et al. 1992). Although the preferred pheromone ligand for

the analogous dimeric mouse protein, mouse urinary protein, has been identified through x-ray

crystallography of the bound complex, the particular pheromone with the best fit to the α2μ-globulin

tetramer has not yet been identified (Bocskei et al. 1992). After glomerular filtration with their ligand,

these carrier proteins are resorbed in massive amounts in the P2 section of the proximal renal tubule

and then catabolized in lysosomes (EPA 1991a; Kimura et al. 1994a).

Unfortunately, the α2μ-globulin tetramer seems to be proficient at transporting other hydrophobic

molecules besides pheromones through the blood and into the urine. Other substances which

apparently also bind to this carrier protein include a number of hydrophobic xenobiotics such as

petroleum-derived hydrocarbons or their constituents or metabolites, including decalin and the gasoline

constituent trimethylpentane (EPA 1991a). The xenobiotic-α2μ-globulin complex is then reabsorbed in the

proximal tubule and accumulates in lysosomes where it resists degradation. Accumulation of this complex

is thought to trigger pathological responses within the kidney. This α2μ-globulin nephropathy syndrome is

characterized by the following lesions (Alden 1986; EPA 1991a; Short et al. 1987): excessive accumulation

of hyaline droplets in the P2 segment of the proximal tubule region of thekidney; association of the hyaline

droplets with the protein α2μ-globulin; single cell necrosis in the P2 segment epithelium and exfoliation of

these degenerated cells; sustained regenerative tubule cell proliferation, often with tubular dilation and tubular

epithelial necrosis; accumulation of granular casts formed from the-cellular debris and subsequent tubule

dilation at the junction of the P3 segment and the thin loop of Henle; linear mineralization of the renal papillar

tubules with hyperplasia of the renal pelvic urothelium.

The hepatic synthesis of α2μ-globulin is under androgenic control, and the protein is found at

concentrations 100-300 times higher in male rat urine than in female rat urine (Shapiro and
STODDARD SOLVENT 58

2. HEALTH EFFECTS

Sachchidananda 1982; Van Doren et al. 1983). Neither female rats nor castrated male rats show the

characteristic renal pathology associated with α2μ-globulin nephropathy. Aging male rats show chronic progressive

nephropathy symptoms that are similar to α2μ-globulin nephropathy, so it is important to run concurrent controls when

assessing renal toxicity. α2μ-Globulin is not present in other rodents, but mice have a similar pheromone carrier, mouse

urinary protein, which does not cause the same effects. Although other members of the lipocalin protein family do

occur in nonrodent species, including humans, they are not produced in such massive quantities, and these species do

not exhibit renal toxicity in response to the same set of substances that produce this characteristic toxicity in male rats

(Swenberg et al. 1989).

The data discussed above suggest an α2μ-globulin interaction as the mechanism for Stoddard solventinduced

nephrotoxicity in the rat. The renal toxicity seems to be androgen dependent since it does not occur in female rats and

is absent or greatly attenuated in castrated male rats, which only have residual levels of α2μ-globulin left (Borghoff et

al. 1990). The pathological sequence is consistent with α2μ-globulin nephropathy. Hyaline droplets enclosed in

isosomes are increased in number and size in the P2 section of the proximal renal tubule; however, no

immunohistochemistry has been done to confirm that the protein in these droplets is actually α2μ-globulin, although the

levels of this protein are elevated in the kidney as a whole in symptomatic exposed male rats (Viau et al. 1986). The

fact that similar petroleum distillate mixtures and alkanes seem to cause renal toxicity via α2μ-globulin

interactions increases the plausibility that Stoddard solvent also acts via the same mechanism.

There are two respects in which the data on the renal toxicity of Stoddard solvent are less than ideal.

First, not all the studies mentioned above used complete Stoddard solvent; several focused on the

predominant alkane components, so the potential contributions of the aromatic constituents have not

been as well tested. A second question is whether all the renal toxicity observed is due to interactions

with α2μ-globulin or whether simultaneous kidney damage by another subset of components via other

mechanisms could have been overlooked. The urinary enzyme activity ratios suggesting distal tubule

damage (Viau et al. 1986) raise some doubts in this category since α2μ-globulin -induced damage is

typically confined to the proximal tubule.

Glomerulonephritis has also been raised as a possible renal effect due to Stoddard solvent exposure,

but the evidence is equivocal. A case-control study showed a significantly greater exposure of patients

with glomerulonephritis to petroleum products (Yaqoob et al. 1992). Another case-control study of
STODDARD SOLVENT 59

2. HEALTH EFFECTS

patients with end-stage renal failure showed that approximately 60% of those with glomerulonephritis

had significant exposure to hydrocarbons compared with 25% of patients with nonglomerulonephritis

renal failure (Finn et al. 1980); however, the use of hospital inpatients as the control group rather than

employed workers may have biased this study toward a positive outcome (Phillips 1984). In both of

these studies, however, patients may have been exposed to multiple hydrocarbon products. A patient

with glomerulonephritis who was exposed to Stoddard solvent by both inhalation and dermal contact

up to 6 hours/day for a year was reported by Daniel1 et al. (1988). However, both another case report

and a case-control study showed no increase in glomerulonephritis with organic solvent exposure

(Flodin et al. 1984; van der Laan 1980). A review of the literature (Bombassei and Kaplan 1992)

identified a number of other studies claiming an association between hydrocarbon exposure and antiglomerular

basement membrane antibody-mediated disease (Goodpasture’s syndrome) or other types of glomerulonephritis.

If all the renal damage caused by Stoddard solvent in rats is due to α2μ-globulin interactions, then it

probably does not pose a large risk of nephrotoxicity to humans. Since humans do not have

α2μ-globulin, the issue becomes whether analogous human proteins could possibly undergo the same

interactions as α2μ-globulin if they were produced in similar quantities. Because humans are not

known to synthesize and resorb other lipocalin proteins in such massive quantities as rats do with

α2μ-globulin, it is unlikely that Stoddard solvent would cause such remarkable toxicity even if an

interaction did occur (Olson 1990). To completely dismiss the possibility of human risk, members of

the human lipocalin family which are filtered and resorbed in the kidney could be assayed to

determine their ability to bind similar xenobiotics or metabolites and whether this binding inhibited

catabolism. Since the renal damage may be exclusive to male rats, no human MRLs have been

derived from data regarding this end point.

Dermal Effects. Dermal irritation is an effect that has been reported after exposure to Stoddard

solvent. Case studies in humans (Nethercott et al. 1980) and experimental studies in guinea pigs

(Anderson et al.-1986) indicate that skin irritation can occur following acute dermal exposure. Other

petroleum distillates, such as kerosene (Annobil 1988; Mosconi et al. 1988; Tagami and Ogino 1973)

or gasoline (Beck et al. 1983; Vernot et al. 1990), are also known to cause skin irritation.

Ocular Effects. Eye irritation is another possible effect of exposure to Stoddard solvent.

Experimental studies in humans have indicated that eye irritation may be induced by Stoddard solvent
STODDARD SOLVENT 60

2. HEALTH EFFECTS

vapors through direct contact at concentrations of 2,700 mg/m3

 (Carpenter et al. 1975a, 1975b) and

2,400 mg/m3 (Hastings et al. 1984).

Body Weight Effects. Although no human studies were located regarding body weight changes,

studies in rats, rabbits, guinea pigs, monkeys, and dogs exposed by inhalation to Stoddard solvent or

mineral spirits for intermediate durations were found to have normal body weight gain (Carpenter et

al. 1975a, 1975b; Rector et al. 1966). One study, in which rats were exposed to white spirits

(4,580 mg/m3

) for 6 months, did report decreased body weight, but the change was not quantified

(Ostergaard et al. 1993). Although Stoddard solvent exposure does not appear to cause any effect on

body weight, sufficient data do not exist to make an unequivocal determination.

Immunological and Lymphoreticular Effects. There is only one human study on immunological effects available, and

it reported no adverse effects on immunoglobulin levels when men were exposed to 616 mg/m3

 of white spirits (99%

alkanes) in the air for 6 hours/day over a 5-day period (Pedersen and Cohr 1984b). However, it is possible that

Stoddard solvent may affect the immune system in ways that cannot be measured by this type of test. No animal

studies are available. No immunological data regarding the aromatic components of Stoddard solvent were located.

Therefore, the effects induced by these components could not be determined.

Neurological Effects. Acute inhalation exposure to Stoddard solvent or white spirits has caused

nervous system effects. A NOAEL was seen in sedentary male humans exposed to a time-weighted

average of 1,563 mg/m3

 of completely vaporized white spirits for 2 hours (Gamberale et al. 1975).

These humans showed no neurological effects from exposure to the white spirits (presumably the 83%

aliphatic, 17% aromatic components described in Astrand et al. 1975) (Gamberale et al. 1975). In this

study, central nervous system function was evaluated in multiple tests including perceptual speed,

simple reaction time, short-term memory, numerical ability, and manual dexterity. A lowest-observedadverse-effect

level (LOAEL) was seen in the same study when humans were exposed to 4,000 mg/m3

 for 50 minutes. The subjects

had a prolonged simple reaction time compared to controlresults in the same volunteers during a non-exposure period.

It should be noted that because of practical constraints, these tests were conducted on volunteers at rest and that

parallel pharmacokinetic studies have demonstrated greater uptake during exercise (Astrand et al. 1975).
STODDARD SOLVENT 61

2. HEALTH EFFECTS

Other studies support the hypothesis that the central nervous system (CNS) is the most sensitive target

for acute exposure to Stoddard solvent. Several of these studies involve effects on central nervous

system-mediated motor coordination. For example, in one human study (Hastings et al. 1984), male

volunteers were exposed for 30 minutes to completely vaporized Stoddard solvent at 0, 600, 1,200,

1,800, and 2,400 mg/m3

. CNS/motor function was tested in three ways, through eye-hand

coordination, reaction time/decision making, and video game visual-motor skill/eye-hand coordination

challenges. When results during all exposures were compared to pre- and post-exposure control

performances, there was a statistically significant difference for both the eye-hand coordination test

and the video game visumotor test. However, this difference was due to impairment only at 600

mg/m3

; the results at other exposure levels did not differ from the controls. Since the putative effect

seen at 600 mg/m3

 was not observed at the higher doses, 2,400 mg/m3 was considered to be the

tentative level at which no effect was observed. Another human volunteer study of 12 males showed

no changes in subjective symptoms such as headache, dizziness, visual disturbances, tremor, muscle

weakness, incoordination, or skin paraesthesia, as determined by a questionnaire on subjective

symptoms after a 6-hour exposure to 610 mg/m3

 of Varnoline or two other white spirit formulations

(Pedersen and Cohr 1984a). This questionnaire on subjective experiences is only a crude indicator of

central nervous system effects compared to the more sensitive functional tests used in the Gamberale

et al. (1975) study. In a test of human volunteers, two out of six reported slight dizziness after a 15-

minute exposure to 2,700 mg/m3

 (Carpenter et al. 1975a, 1975b). In rats, a slight coordination loss

after an 8-hour exposure to 8,200 mg/m3

, but not to 4,600 mg/m3, was observed (Carpenter et al.

1975a, 1975b). Since the incoordination was seen during cage-side observation, rather than in more

sensitive functional tests, it is not surprising that the effect is not seen until a somewhat higher

integrated concentration is administered than that in the Gamberale et al. (1975) study. Furthermore,

much higher acute inhalation doses have caused much more blatant nervous system effects.

Cerebral atrophy, discoordination, dementia, headaches, memory deficits, and fatigue were reported in

humans from chronic exposure to several solvents, including Stoddard solvent (Daniel1 et al. 1988;

Flodin et al. 1984; Gregersen et al. 1984; Hane et al. 1977; Mikkelsen et al. 1988; Olson.1982).

These chronic effects may or may not be due to Stoddard solvent since other chemicals were also

present during exposure; however, these data imply that effects become more severe with prolonged

exposure time. No data are available for neurological effects from oral exposure. Similar neurological

effects have also been found in humans following combined dermal and inhalation exposure to

solvents which may include Stoddard solvent. Stoddard solvent does not contain the short-chained
STODDARD SOLVENT 62

2. HEALTH EFFECTS

alkanes that are known to cause anesthesia (Haydon et al. 1977). Mice exposed to propylbenzene, a

component of Stoddard solvent, at 2,000-8,000 ppm for 20 minutes showed a range of

neurobehavioral effects including a loss of righting reflex, decreased arousal, and reaction to sensory

stimuli and psychomotor impairment (Tegeris and Balster 1944). Other solvents and petroleum

distillates with longer carbon chains, such as fuel oils, have been known to cause more severe central

nervous system depression than that observed with Stoddard solvent (Kainz and White 1984; Knave et

al. 1978; Porter 1990).

Reproductive Effects. Men exposed to white spirits (composition, 99% alkanes) in the air (616 mg/m3

for 30 minutes) had slightly (9-11%) decreased (p<0.05) serum levels of folliclestimulating hormone

(Pedersen and Cohr 1984b). The possible reproductive outcome of this change isnot known. Another

study shows that men who were occupationally exposed for 1-17 years to Stoddard solvent in the air

had normal sperm counts, motility, and morphology (Tuohimaa and Wichmann 1981). This study had

several limitations including a small test population, the degree of accuracy of the exposure assessment,

exposure to mixed solvents, and variability of sperm parameters. There were no data regarding reproductive

effects in animals. It is not possible to draw conclusions from the available data regarding the possible

reproductive effects of Stoddard solvent on persons exposed at hazardous waste sites.

Developmental Effects. No human studies on developmental effects from Stoddard solvent

exposure are available for any route of exposure. Stoddard solvent vapor did not cause maternal

toxicity, structural teratogenesis, or decreased fetal weight when administered during organogenesis in

the rat, although some skeletal variations did occur (API 1977). Certain other petroleum distillates

(gasoline or fuel oils) have also shown very few adverse developmental effects (API 1979a, 1979b;

Beliles and Mecler 1983; API 1978).

Genotoxic Effects. No genotoxicity studies were located regarding in vivo human exposure to

Stoddard solvent. However, one in vitro study was located in which human peripheral lymphocytes

were incubated in the presence of white spirits (a petroleum distillate composed of 85% aliphatic and

15% aromatic hydrocarbons and also referred to as Stoddard solvent), in four different white

spirits/ethanol dilutions, and investigated for increased sister chromatid exchange. Two incubation

periods were employed for each concentration: 1 hour and 24 hours. No significant increase in sister
STODDARD SOLVENT 63

2. HEALTH EFFECTS

chromatid exchange frequency was observed for any concentration at either incubation period (Gochet

et al. 1984). Refer to Table 2-3 for a further summary of these results.

In vivo animal studies involving either Stoddard solvent or white spirits provide no evidence of

genotoxicity. Neither inhaled (50 mg/m3

 in five periods of 5 minutes each, separated by 5-minute noexposure

intervals) nor intraperitoneal (0.1, 0.05, or 0.01 mL) doses of white spirits produced a

significant increase in micronuclei in mouse bone marrow (Gochet et al. 1984). Rats given 0.087,

0.289, or 0.868 mL/kg Stoddard solvent intraperitoneally were negative for chromosomal aberrations in bone marrow

cells; the Stoddard solvent used for the study contained 18.9% aromatic hydrocarbons

(see Table 3-3, Stoddard solvent, for a further analysis of the composition) (API 1978a; Conaway et

al. 1984). In a dominant lethal study, mice were dosed subcutaneously and rats intraperitoneally with

1.0 mL/kg Stoddard solvent (API 1982). Fifteen males of each species were allowed to mate with two

or three females per week for one complete sperm cycle (8 weeks for mice and 10 weeks for rats).

The rat pregnancy index was significantly lower than the corresponding control for the 1st week only;

otherwise, the results for both species were negative (API 1982). Refer to Table 2-3 for a further

summary of these results.

In vitro tests using Salmonella typhimurium (API 1978a; Conaway et al. 1984; Gochet et al. 1984) and

mouse L5178Y lymphoma cells (API 1978a, 1987b; Conaway et al. 1984) to screen for gene

mutations support the negative results observed in the mammalian in vivo and human in vitro studies

mentioned above. One mouse L5178Y gene study does report significant mutation frequencies at high

doses (50-60 nL/mL for nonactivation and 60-80 nL/mL for activation); however, these results are

equivocal because the same doses were highly cytotoxic (API 198713). Please refer to Table 2-4 for a

further summary of these results. Based on the available genotoxicity data, Stoddard solvent and white

spirits do not appear to pose a genotoxic threat in animals. However, the available data are much too

scant to allow for definitive conclusions regarding the genotoxicity of Stoddard solvent/white spirits in

humans.

Concerns have been raised about the genotoxicity of the individual components of Stoddard solvent.

Frequency of mutations induced by methylazoxymethanol (MAM), a complete carcinogen in several

species, was increased (p<0.05) in V79 Chinese hamster cells by n-decane, while treatment with this

alkane alone did not cause mutagenesis (Lankas et al. 1978). This suggests that n-decane may be a


STODDARD SOLVENT 66

2. HEALTH EFFECTS

promoter. Further study is needed to determine whether the effects observed with individual

components would also occur in the Stoddard solvent mixture.

Cancer. There is one chronic inhalation exposure study of humans (Siemiatycki et al. 1987), which

presented epidemiological data that reported an odds ratio greater than 1 for prostate cancer, Hodgkin’s lymphoma,

and squamous cell carcinoma of the lung. However, the study was limited due to exposure to mixed substances and an

arbitrary statistical selection criteria for analysis. A mouse skin-painting study (EPA 1984c) demonstrated

carcinogenesis using a mixture containing 90% Stoddard solvent, 7% calcium petroleum sulfonate, and 3% ethylene

glycol monobutyl ether. This study indicates an area of potential concern, even though the carcinogenesis cannot be

attributed to a particular component. Thus, neither study provides conclusive results on the carcinogenic potential of

Stoddard solvent for humans exposed at hazardous waste sites. A test using Stoddard solvent alone is needed to verify

whether the findings of EPA 1984c can be attributed to Stoddard solvent.

It is also possible that the skin irritant effects of Stoddard solvent could have contributed to the

promotion of effects initiated by other components of the mixture. The alkylbenzenes present in

Stoddard solvent are not believed to be carcinogenic, based upon negative or weakly positive

genotoxicity test results (Andrews and Snyder 1991). However, further animal testing is needed to

confirm a lack of carcinogenicity. A dermal study in mice showed that dodecane was a tumor

promotor (Site 1966). Benzo[a]pyrene and benzo[a]anthracene were reported to be 1,000 times more

potent in producing tumors when dodecane was used as a diluent than when it was not used (Bingham

and Falk 1969).

Promotion activity of n-dodecane was also demonstrated in dermal tests using Swiss mice, although

dermal carcinogenicity tests were negative (Saffiotti and Shubic 1963). Decane was reported to

enhance the carcinogenicity of benzo[a]pyrene after application to mouse skin (Van Duuren and

Goldschmidt 1976). Several studies have shown that some n-alkane components of Stoddard solvent

are promoters of carcinogenicity (Site 1966; Saffioti and Shubik 1965; Van Duuren and-Goldschmidt

1976). Other studies raise questions about whether some of the n-alkane components may also be

cocarcinogens (Bingham and Falk 1969; Horten et al. 1957, 1966, 1976; Van Duuren and Goldschmidt 1976). Further

study is needed to determine whether the effects observed with these individual components would also occur in the

Stoddard solvent mixture.
STODDARD SOLVENT 67

2. HEALTH EFFECTS

There are no existing national guidelines concerning potential carcinogenicity that specifically pertain

to Stoddard solvent. The International Agency for Research on Cancer (IARC) has determined that

some petroleum distillates are probably carcinogenic to humans for occupational exposure in petroleum refining

(IARC 1989); however, petroleum solvents as a group have not yet been evaluated.

2.5 BIOMARKERS OF EXPOSURE AND EFFECT

Biomarkers are broadly defined as indicators signaling events in biologic systems or samples. They

have been classified as markers of exposure, markers of effect, and markers of susceptibility

(NAS/NRC 1989).

A biomarker of exposure is a xenobiotic substance or its metabolite(s) or the product of an interaction

between a xenobiotic agent and some target molecule(s) or cell(s) that is measured within a

compartment of an organism (NAS/NRC 1989). The preferred biomarkers of exposure are generally

the substance itself or substance-specific metabolites in readily obtainable body fluid(s) or excreta.

However, several factors can confound the use and interpretation of biomarkers of exposure. The

body burden of a substance may be the result of exposures from more than one source. The substance

being measured may be a metabolite of another xenobiotic substance (e.g., high urinary levels of

phenol can result from exposure to several different aromatic compounds). Depending on the

properties of the substance (e.g., biologic half-life) and environmental conditions (e.g., duration and

route of exposure), the substance and all of its metabolites may have left the body by the time biologic

samples can be taken. It may be difficult to identify individuals exposed to hazardous substances that

are commonly found in body tissues and fluids (e.g., essential mineral nutrients such as copper, zinc,

and selenium). Biomarkers of exposure to Stoddard solvent are discussed in Section 2.5.1.

Biomarkers of effect are defined as any measurable biochemical, physiologic, or other alteration within an organism

that, depending on magnitude, can be recognized as an established or potential health impairment or disease

(NAS/NRC 1989). This definition encompasses biochemical or cellular signals of tissue dysfunction (e.g., increased

liver enzyme activity or pathologic changes in female genital epithelial cells), as well as physiologic signs of

dysfunction such as increased blood pressure or decreased lung capacity. Note that these markers are often not

substance specific. They also may not be directly adverse, but can indicate potential health impairment (e.g., DNA

adducts). Biomarkers of effects caused by Stoddard solvent are discussed in Section 2.5.2.
STODDARD SOLVENT 68

2. HEALTH EFFECTS

A biomarker of susceptibility is an indicator of an inherent or acquired limitation of an organism’s

ability to respond to the challenge of exposure to a specific xenobiotic substance. It can be an

intrinsic genetic or other characteristic or a preexisting disease that results in an increase in absorbed

dose, biologically effective dose, or target tissue response. If biomarkers of susceptibility exist, they

are discussed in Section 2.7, “Populations That Are Unusually Susceptible.”

2.5.1 Biomarkers Used to Identify or Quantify Exposure to Stoddard Solvent

No biomarkers are available to specifically identify or quantify exposure to Stoddard solvent.

However, hydrocarbon levels in the blood can be used to document exposure to petroleum distillates in general.

Components of white spirits have been identified in human blood, fat, and alveolar air using gas chromatography-mass

spectrometry (Pedersen et al. 1984). It may be possible to identify Stoddard solvent in this way, comparing the

measured sample to the spectrometrical pattern of a known Stoddard solvent standard.

Minimal information is available on the half life of Stoddard solvent in the body. One study showed

that levels of aliphatic and aromatic components in alveolar air dropped substantially within

20 minutes of exposure (Astrand et al. 1975). However, measurable amounts remained in the blood

for at least 100 minutes post-exposure. In the second study, the rate of inhalation absorption of the

alkane components was fairly constant over the different exposure intervals (5 days, 6 hours/day) that

were measured. The mean blood concentration of white spirits was 2 mg/L on day 1 and 2.54 mg/L

on day 5, showing accumulation of white spirits in the blood (Pedersen et al. 1984, 1987).

Following repeated exposure (600 mg/m3

) to white spirits (6 hours/day for 5 days), only 23% of the

concentration in body fat was removed over a 60-hour period of non-exposure (Pedersen et al. 1984).

Studies of certain components of Stoddard solvent indicate that their metabolites may be useful

indications of exposure, provided the interaction of the components in the mixture does not interfere

with their metabolism. A correlation between exposure to 1,2,4-trimethylbenzene (a component of

white spirits) and a urinary concentration of 3,4-dimethylhippuric acid (a metabolite of 1,2,4-

trimethylbenzene) was reported in workers exposed at the TLV-TWA (25 ppm) (Fukaya et al. 1994).

Another study of humans exposed to white spirits found that levels of dimethylbenzoic acid, another

metabolite of trimethylbenzene, in the urine correlated to earlier exposure during the workday (Pfaffli

et al. 1985). A study of humans exposed to up to 2,500 mg/m3

 of Stoddard solvent found that
STODDARD SOLVENT 69

2. HEALTH EFFECTS

aliphatic and aromatic components remained in the blood roughly 1.5 hours after the termination of

exposure (Astrand 1975). Fischer-344 rats dosed by gavage with 800 mg/kg of t-butylcyclohexane, a

component of white spirits, were found to have seven metabolites in their urine (Henningsen et al.

1987). The primary metabolite was trans-4-t-butylcyclohexanol.

2.5.2 Biomarkers Used to Characterize Effects Caused by Stoddard Solvent

Since the effects of Stoddard solvent are not unique to this chemical, no specific biomarkers are

available to characterize the effects caused by Stoddard solvent. Headaches, fatigue, incoordination,

and skin irritation are general effects which may be encountered following exposure to Stoddard

solvent. It is expected that these effects would occur for short periods of time. Other effects, such as

bronchitis and pulmonary congestion or emphysema may occur over a longer period of time; their

onset is relatively fast and some of the effects are reversible when the person is removed from the

exposure situation. However, the durations of the health effects are not well documented in the data.

If Stoddard solvent is aspirated into the lungs following oral exposure, it is possible that pulmonary

damage may occur, as it does with other petroleum distillates, such as kerosene (Haddad and

Winchester 1990). Symptoms such as coughing, choking, or gagging might appear, along with clinical

signs such as fever. Chemical pneumonitis may be revealed by chest x-rays. The abnormal chest

x-rays may be present 30 minutes after aspiration. Radiological changes are usually detected up to

several days after exposure, but can remain evident for several weeks or months (Haddad and

Winchester 1990). However, there are numerous chemicals that may induce these effects. Therefore,

it would be difficult to identify Stoddard solvent as the cause based on these symptoms in cases of

unidentified chemical exposure.

2.6 INTERACTIONS WITH OTHER CHEMICALS

Although workers are often exposed to a variety of solvents with Stoddard solvent, there are no

available studies-specifically characterizing the interactions of Stoddard solvent with other chemicals.

Since Stoddard solvent may have adverse effects on the nervous system, it may compound the effects

of other chemicals that cause central nervous system depression, such as alcohol, barbiturates,

benzodiazapines, or medical anesthetics. Guinea pigs with a diet high in vitamin C survived a high

exposure to Stoddard solvent vapors better than those with a diet low in vitamin C (Jenkins et al
STODDARD SOLVENT 70

2. HEALTH EFFECTS

1971); however, it is not known how vitamin C levels might affect humans exposed to Stoddard

solvent.

2.7 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE

A susceptible population will exhibit a different or enhanced response to Stoddard solvent than will

most persons exposed to the same level of Stoddard solvent in the environment. Reasons include

genetic make-up, developmental stage, health and nutritional status, and chemical exposure history.

These parameters result in decreased function of the detoxification and excretory processes (mainly

hepatic and renal) or the pre-existing compromised function of target organs. For these reasons we

expect the elderly with declining organ function and the youngest of the population with immature and

developing organs will generally be more vulnerable to toxic substances than healthy adults.

Populations who are at greater risk due to their unusually high exposure are discussed in Section 5.6,

“Populations With Potentially High Exposure.”

There is no information on populations that may be unusually susceptible to Stoddard solvent.

Individuals with pre-existing neurological conditions are likely to be a population of concern due to

the neurological effects noted after exposure to Stoddard solvent and white spirits. Stoddard solvent

has been shown to be irritating to the eyes and possibly the respiratory system. Therefore, persons

susceptible to eye or respiratory diseases might be unusually susceptible to the effects of Stoddard

solvent. Because there is uncertainty about adverse renal effects occurring in humans due to exposure

to Stoddard solvent, persons with kidney diseases also may be unusually susceptible to the effects of

Stoddard solvent exposure. Glomerulonephritis is known to have a genetic component (Bombassei and Kaplan 1992;

Rambausek et al. 1993).

Additionally, persons with higher percentages of body fat might be more likely to store these solvents,

since the solvent lipophilicity is a pharmacokinetic characteristic. In general, there would be a

potentially greater storage in women, due to their increased relative volume of body fat, than in men

(Sato and Nakajima 1987).
STODDARD SOLVENT 71

2. HEALTH EFFECTS

2.8 METHODS FOR REDUCING TOXIC EFFECTS

This section will describe clinical practice and research concerning methods for reducing toxic effects

of exposure to Stoddard solvent. However, because some of the treatments discussed may be

experimental and unproven, this section should not be used as a guide for treatment of exposures to

Stoddard solvent. When specific exposures have occurred, poison control centers and medical

toxicologists should be consulted for medical advice.

2.8.1 Reducing Peak Absorption Following Exposure

Little information is available on specific methods for reducing absorption after exposure to Stoddard

solvent itself. However, it is a petroleum distillate, and information on related products is available.

Since the absorption from the gastrointestinal tract is likely to be poor, the use of activated charcoal or

cathartics would probably not be useful for alkane and cycloalkane components (Klein and Simon

1986; Litovitz and Greene 1988). Further data are required to determine if either activated charcoal or

cathartics will remove the aromatic components of Stoddard solvent. Gastric emptying by either

lavage or emesis is a controversial treatment since there is the danger of pulmonary aspiration and

subsequent pneumonitis (Ellenhorn and Barceloux 1988; Haddad and Winchester 1990; Klein and

Simon 1986; Litovitz and Greene 1988). Although the inhalation route is the most probable route of

exposure, the only known method to reduce exposure is to remove the person from the contaminated

area (Stutz and Janusz 1988). Excessive inhalation of solvents often leads to central nervous system

depression and may require assisted ventilation. The acute effects of central nervous system

depression, such as seizures, are often treated with naloxone and glucose. If pulmonary distress is

present, it has been suggested that positive end expiratory pressure be used therapeutically (Haddad

and Winchester 1990; Klein and Simon 1986). Washing with soapy water is suggested following

dermal contact, and ocular washing is suggested following eye exposure.

2.8.2 Reducing Body Burden

There are no effective methods to enhance elimination of Stoddard solvent and no known antidotes.

Since inhalation is the most probable route of exposure, removing the person from the contaminated

area may help to reduce the body burden (Stutz and Janusz 1988). Stoddard solvent can be stored in
STODDARD SOLVENT 72

2. HEALTH EFFECTS

adipose tissue; thus, the effects may continue for a few days after exposure has occurred as Stoddard

solvent is released from storage.

2.8.3 Interfering with the Mechanism of Action for Toxic Effects

The mechanism of action of Stoddard solvent on the target organ (i.e., the brain) is not known. Also,

no information was located that provided therapeutic measures designed to interfere with a possible

mechanism of action for Stoddard solvent. In the kidney, the mechanism of action of Stoddard solvent

appears to be specific to male rats, which synthesize α2μ-globulin, a protein not found in humans. This

protein is believed to interact with Stoddard solvent and to cause pathological changes in the P2

proximal tubule epithelium and other renal effects. Because the α2μ-globulin nephropathy is not

believed to affect humans, interfering with this particular mechanism of action would not be relevant.

2.9 ADEQUACY OF THE DATABASE

Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with

the Administrator of EPA and agencies and programs of the Public Health Service) to assess whether

adequate information on the health effects of Stoddard solvent is available. Where adequate

information is not available, ATSDR, in conjunction with the National Toxicology Program (NTP), is

required to assure the initiation of a program of research designed to determine the health effects (and

techniques for developing methods to determine such health effects) of Stoddard solvent.

The following categories of possible data needs have been identified by a joint team of scientists from

ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that, if met,

would reduce or eliminate the uncertainties of human health assessment. This definition should not be

interpreted to mean that all data needs discussed in this section must be filled. In the future, the

identified data needs will be evaluated and prioritized, and a substance-specific research agenda may

be proposed.
STODDARD SOLVENT 73

2. HEALTH EFFECTS

2.9.1 Existing Information on Health Effects of Stoddard Solvent

The existing data on health effects of inhalation, oral, and dermal exposure of humans and animals to

Stoddard solvent are summarized in Figure 2-2. The purpose of this figure is to illustrate the existing

information concerning the health effects of Stoddard solvent. Each dot in the figure indicates that

one or more studies provide information associated with that particular effect. The dot does not imply

anything about the quality of the study or studies. Gaps in this figure should not be interpreted as

“data needs” information (i.e., data gaps that must necessarily be filled).

2.9.2 Identification of Data Needs

Acute-Duration Exposure. The available data indicate that following a 6-hour exposure, there is a

lack of systemic or neurological effects in humans exposed to low levels (610 mg/m3

) via the

inhalation route (Pedersen and Cohr 1984a, 1984b). Humans and animals exposed to airborne,

completely vaporized Stoddard solvent at higher levels for acute periods had eye irritation (Carpenter

et al. 1975a, 1975b; Hastings et al. 1984) and neurological disturbances (Gamberale et al. 1975). A

neurological NOAEL was observed in humans exposed by inhalation to a time-weighted average of

1,563 mg/m3

 for 2 hours (Gamberale et al. 1975). Further information on levels that would be

expected to cause effects following acute, intermediate, or chronic exposure in the air would be useful.

No data on oral exposure were available for any duration in any species. Acute dermal exposure

resulted in skin irritation in humans (Nethercott et al. 1980) and animals (Anderson et al. 1986). The

data were not sufficient to derive an MRL for the oral or dermal routes of exposure. Specifically, data

are needed to establish a NOAEL for functional neurological tests in humans after inhalation exposure

for a duration longer than 2 hours.

More information is needed to follow up on the potential musculoskeletal toxicity, as indicated by

increased creatinine kinase levels, following acute human exposure to Stoddard solvent (Pedersen and

Cohr 1984b). Data from all routes of exposure, for all end points, would be useful in determining

levels that may be harmful to humans at hazardous waste sites. Furthermore, acute neurological

studies of longer durations would be useful since the studies located had exposures of 3 days or less.

In particular, studies are needed on upper respiratory/nasal effects observed that have included

respiratory depression (Carpenter et al. 1975a, 1975b), metaplasia and cilia1 loss in the nasal cavity

STODDARD SOLVENT 75

2. HEALTH EFFECTS

and trachea (Riley et al. 1984), and nasal irritation (Carpenter 1975a, 1975b; Larsen and Schumes

1974). Renal studies would be useful in elucidating whether the enzyme changes suggesting distal

tubular damage, noted after 10 days of exposure in rats, can be verified (Viau et al. 1986). This is the

only study suggesting injury to the kidney in a location other than the proximal tubule; however,

further studies are needed before distal tubule damage can be ruled out. It would also be useful to

have further data from muscular function tests that relate to increased serum creatinine kinase levels

(Pedersen and Cohr 1984b).

Intermediate-Duration Exposure. No studies are available regarding intermediate-duration human

exposure by any route. Intermediate-duration rat studies reveal damage to the male rat kidney

(Carpenter et al. 1975a, 1975b; Phillips 1983; Rector et al. 1966; Viau et al. 1984). It has not been

ascertained whether the hyaline droplets observed in the rat renal studies were composed of

α2μ-globulin instead of other resorbed proteins. This needs to be determined to ensure that Stoddard

solvent is indeed acting by inducing male rat-specific α-globulin nephropathy and not by another

mechanism which might have more relevance to humans. It would be helpful to know whether human

lipocalin proteins bind Stoddard solvent components or metabolites and if lipocalin renal catabolism is

affected. Since the renal damage may be exclusive to male rats, no human MRLs have been derived

from data regarding this end point. Other end points were studied in two major 13-week

(5 days/week) experiments and a 6-week experiment that used several species (Carpenter et al. 1975a,

1975b; Rector et al. 1966). No adverse systemic effects were found at exposures of up to

1,900 mg/m3

, but there were unexplained deaths in guinea pigs at 363 mg/m3, and, because study

interpretation was compromised, no MRL could be derived from this end point. No data are available

from animals for the oral or dermal routes. Further information for all routes would be necessary to

develop intermediate-duration MRLs.

Chronic-Duration Exposure and Cancer. The incidence of death was investigated in a single

retrospective cohort study among 14,457 workers at an aircraft maintenance facility following

exposure to very low levels of Stoddard solvent as well as numerous other chemicals for at least l

year (Spirtas et al. 1991). An exposure index was developed by evaluating patterns of use that

indicated comparative differences in exposure to various chemicals based on occupation. However,

exposures could not be quantitated from these methods. The study did not show a statistically

significant increase in mortality. Adverse neurological effects have been reported in humans

following inhalation or dermal (Daniel1 et al. 1988; Mergler et al. 1988) exposure. No adverse

reproductive effects were
STODDARD SOLVENT 76

2. HEALTH EFFECTS

noted (Tuohimaa and Wichmann 1981). However, the study was limited due to the small population

sample size, questionable accuracy of the exposure assessment, exposure to mixed solvents, and

variability of sperm parameters” Observations of systemic effects have been made in humans

following chronic exposure (Beving et al. 1991; Flodin et al. 1984; Hane et al. 1977; van der Laan

1980). No studies are available regarding chronic-duration animal exposures by the inhalation or oral

routes. Since none of the human studies provide quantitative data suitable for the derivation of an

MRL, further studies for all routes and end points would be useful in determining possible effects in

humans living near hazardous waste sites, particularly more studies addressing glomerulonephritis and

atrophy of the brain cortex, including development of animal models. To fully exclude glomerulonephritis as an effect

of Stoddard solvent exposure, epidemiological (case-control, cross-sectional, or prospective cohort) studies examining

renal outcomes in exposed workers would be particularly useful.

The only available study on cancer in humans is limited by its lack of statistical power (Siemiatycki et

al. 1987). The only chronic animal study is a briefly reported dermal study on possible carcinogenic

effects in mice that was limited by the use of a mixture containing Stoddard solvent (90% Stoddard

solvent, 7% calcium petroleum sulfonate, and 3% ethylene glycol monobutyl ether) (EPA 1984c). A

follow-up to this study, using Stoddard solvent alone, would be useful. Concerns have been raised

about the genotoxicity of some individual components of Stoddard solvent. Treatment of V79 Chinese

hamster cells by n-decane alone did not cause mutagenesis, but in combination with methylazoxylmethanol (MAM), it

appeared to promote mutagenesis (Lankas et al. 1978). Several studies have shown that some n-alkane components of

Stoddard solvent are promoters of carcinogenicity (Site 1966; Saffiotti and Shubik 1965; Van Duuren and

Goldschmidt 1976). Other studies raise questions about whether some of the n-alkane components may also be cocarcinogens (Bingham and Falk 1969; Horten et al. 1957, 1966, 1976; Van Duuren and Goldschmidt 1976).

Carcinogenicity studies utilizing Stoddard solvent mixtures containing these components would be useful.

Genotoxicity. Most of the available in vitro and in viva studies indicate that neither Stoddard

solvent nor white spirits pose a genotoxic threat (API 1978a, Conaway et al. 1984; Gochet et al.

1984). However, based on these few studies, it would be presumptuous to definitively state that

Stoddard solvent/white spirits is not genotoxic to humans, especially since some individual components of Stoddard

solvent are promoters of carcinogenicity. Extensive in vitro investigations, especially Ames testing, are probably not

necessary, but more mammalian in vivo and human occupational studies are required before a sound conclusion can be

reached.
STODDARD SOLVENT 77

2. HEALTH EFFECTS

Reproductive Toxicity. The only available human study shows no adverse effects on the sperm of

men exposed for a chronic period (Tuohimaa and Wichmann 1981). Further intermediate screening

tests assessing in vitro sperm fertilization ability would be useful in determining that this substance

poses no reproductive risk. More information on the effects of inhalation exposure on FSH levels is

needed In order to confirm that the decreases in FSH noted in men exposed for an acute period are

exposure related and not a result of individual variations or not just extremely transient (Pedersen and

Cohr 1984b). Multigenerational animal studies could be considered.

Developmental Toxicity. No human data are available regarding developmental toxicity. The only

available animal study reported no skeletal or visceral abnormalities in the offspring of rats following

inhalation exposure of the dams (API 1977). This study is not sufficient to determine that humans

have no risk of developmental effects Further animal studies using all routes of exposure would be

useful.

Immunotoxicity. The only study available regarding immunological effects showed no changes in

immunoglobulins in humans exposed to the alkane components for an acute period via the inhalation

route (Pedersen and Cohr 1984b). No intermediate- or chronic-duration studies are available in

humans, and no studies are available for animals for any route or duration. However, immunotoxicity

may have occurred in an individual who developed glomerulonephritis from chronic dermal and/or

inhalation exposure (Daniell et al. 1988). Although this is a renal effect, it may have been induced by

an immunotoxic reaction to Stoddard solvent as evidenced by the finding of antibodies to the

glomerular basement membrane. Therefore, data are needed to determine whether Stoddard solvent

affects the immune system to induce renal toxicity. Further studies for all duration categories in both

humans and animals would be useful to determine whether this substance poses an immunological

threat via the inhalation, oral, or dermal routes. For example, studies could be conducted to determine

whether animals or humans exposed to Stoddard solvent are more susceptible to infection or whether

Stoddard solvent induces a dermal sensitivity reaction; macrophage, T and B lymphocyte, and natural

killer cell function could be tested in animals and individuals exposed to Stoddard solvent.

Neurotoxicity. Acute-duration human studies via the inhalation route (Carpenter et al. 1975a, P975b; Gamberale et al.

1975; Hastings et al. 1984; Larsen and Schmunes 1974; Pedersen and Cohr 1984a, 1984b) as well as chronic-duration

human studies via the inhalation and dermal routes (Arlien-Soborg et al. 1979; Daniel1 et al. 1988; Flodin et al. 1984;

Gregersen et al. 1984; Hane et al. 1977; Mergler et
STODDARD SOLVENT 78

2. HEALTH EFFECTS

al. 1988; Mikkelsen et al. 1988; Olson 1982) are available. The chronic studies reported findings after

mixed solvent exposures. A NOAEL was found in humans exposed to a time weighted average of

1,563 mg/m3

 for 2 hours (Gamberale et al. 1975). No oral studies are available for humans. For

animals, neurological effects have been studied following acute-duration inhalation exposure only

(Carpenter et al. 1975a, 1975b). No animal data are available on neurological effects following

intermediate- or chronic-duration inhalation exposure. No animal data are available regarding oral or

dermal exposure. Since the nervous system appears to be a target organ in humans, further human and

animal studies of exposure via all three routes would be useful in determining safe levels for

inhalation, oral, or dermal exposure at hazardous waste sites.

Epidemiological and Human Dosimetry Studies. Although there have been studies of persons

exposed to Stoddard solvent or white spirits at the workplace, none have recorded exposure levels. A

prospective occupational study that provides exposure levels would be useful in determining standards

that would protect persons exposed at hazardous waste sites

Biomarkers of Exposure and Effect. There are no studies available to determine specific

biomarkers of exposure or effect. Components of Stoddard solvent can be measured in the blood, fat,

and breath. Fat appears to be the best compartment to sample for chronic exposure, since Stoddard

solvent is extremely lipid soluble (Pedersen et al. 1984, 1987). However, these chemicals can be

found in many types of petroleum distillates and are not specific to Stoddard solvent. Additional

research that identifies Stoddard solvent exposure using currently available breathalizer techniques with mass

spectroscopy would also be useful.

Similarly, the biomarkers of effects from Stoddard solvent are very general (headaches, fatigue,

incoordination, skin irritation, bronchitis, coughing, and abnormal chest x-rays) and cannot be used to

document exposure. Any further information on biomarkers of exposure or effect would be useful.

Absorption, Distribution, Metabolism, and Excretion. There are very few humanstudies

(Pedersen et al. 1984, 1987; Astrand et al. 1975), and no animal studies, regarding toxicokinetics,

although Astrand et al (1975) did study the absorption of Stoddard solvent in humans. Further studies

in both animals and humans would be very useful in determining possible adverse health effects at

hazardous waste sites. In particular, information on the rate and extent of absorption and mode of

excretion would be useful in predicting health effects as well as in determining possible mitigation
STODDARD SOLVENT 79

2. HEALTH EFFECTS

methods. For example, establishing methods for determining gastrointestinal absorption and molecular

weight cutoffs for lipophilic absorption would be useful. Also, better pharmacokinetic data on the

three main classes of Stoddard solvent components (i.e., alkanes, cycloalkanes, and aromatics) would

help predict the toxic properties of this chemical. Identification of the metabolic products of Stoddard

solvent components is also a data need.

Comparative Toxicokinetics. Since there is sparse data on animal toxicokinetics, there is no

information at all on comparative toxicokinetics. Studies of absorption, distribution, metabolism, or

excretion would be appropriate in multiple animal species for interspecies comparisons. Comparisons

between the pharmacokinetic properties of petroleum distillates of varying chain lengths and aromatics versus other

hydrocarbon classes would also be useful.

Methods for Reducing Toxic Effects. Very little information is available for Stoddard solvent

itself, or for petroleum distillates as a class. There are no known antidotes for these substances, and i

is unlikely that research to find a specific antidote to Stoddard solvent poisoning would be effective.

Since there are no human or animal data on oral exposure to Stoddard solvent, no treatment methods

have been attempted. Further studies regarding the effectiveness of gastric lavage and the

administration of activated charcoal would be useful. Additional studies regarding which Stoddard

solvent components are absorbed in the gastrointestinal tract and whether or not activated charcoal

absorbs them would also be beneficial. Further research on alternative treatment methods, such as

using negative pulmonary pressure, would be appropriate.

2.9.3 On-going Studies

There are no known on-going studies on Stoddard solvent.

STODDARD SOLVENT 81

3. CHEMICAL AND PHYSICAL INFORMATION

3.1 CHEMICAL IDENTITY

Information regarding the chemical identity of Stoddard solvent is located in Table 3- 1.

3.2 PHYSICAL AND CHEMICAL PROPERTIES

Information regarding the physical and chemical properties of Stoddard solvent is located in Table 3-2.

Stoddard solvent is a petroleum distillate mixture of C7-C12 hydrocarbons. The mixture consists of

three major groups of components: linear and branched alkanes, also known as paraffins (30-50% of

the total mixture); cycloalkanes, also called cycloparaffins or naphthenes (not to be confused with

naphthalenes which are bicyclic aromatics) (30-40%), and aromatic hydrocarbons (l0-20%) (Air Force

1989b; McDermott 1975). Stoddard solvent is a refinery blend of differently treated oil fractions. Its

composition varies somewhat, depending on the refinery and the time of production. Table 3-3 lists

some of the major components of several Stoddard solvent formulations. Petroleum distillates are

often distinguished by boiling or distilling temperatures. Stoddard solvent has a boiling range of

150-200°C (Scott et al. 1959). The 140 flash Stoddard solvent is composed of C5-C12 hydrocarbons

and has a boiling range of 185-207°C (Air Force 1989b). White spirits is a term somewhat

synonymous with Stoddard solvent since it has a hydrocarbon range between C7 and C11. Six types of

white spirits have been identified based on origin. Each type consists of the same components, but the

percentages vary (Scheffers et al. 1985). Possible contaminants of Stoddard solvent include lead

(<1 ppm) and sulfur (3.5 ppm) (Suntech 1978).

There are a number of related chemical mixtures with components that are different from those of

Stoddard solvent. For instance, high-flash aromatic naphtha is a generic term for petroleum distillates

primarily consisting of C9 aromatics (70-80%) with C8 or C10 aromatics comprising the rest. Stoddard

solvent, in contrast, is only l0-20% aromatic (Clark et al. 1989b; Schreiner et al. 1989). Naphtha is

also a general term for petroleum distillates containing predominantly C5-C13 aliphatic hydrocarbons

and distilling at 30-238°C (Tenenbein et al. 1984).



STODDARD SOLVENT 85

3. CHEMICAL AND PHYSICAL INFORMATION

Benzine and mineral spirits (other associated mixtures) are similar to but not exactly the same as

Stoddard solvent. Benzine consists of C5-C9 hydrocarbons (Takeuchi et al. 1975) and boils, on

average, at between 154°C and 204°C (Navarte et al. 1989). Benzine and Stoddard solvent distill at

about the same temperature range, but their hydrocarbon compositions differ. Mineral spirits have a

distillation range of 136-277°C. The distillation range of Stoddard solvent falls within that of mineral

spirits (Mehlman and Smart 1982). Therefore, Stoddard solvent may be considered a subset of

mineral spirits, but mineral spirits as a whole are not described in this profile.

STODDARD SOLVENT 87

4. PRODUCTION, IMPORT, USE, AND DISPOSAL

4.1 PRODUCTION

Stoddard solvent is a chemical mixture containing hydrocarbons that range from C7 to C12 with the

majority of hydrocarbons in the C9-C11 range (Air Force 1989b; Rothman and Emmett 1988). The

hydrocarbons composing Stoddard solvent are 30-50% alkanes, 30-40% cycloalkanes, and l0-20%

aromatics (Air Force 1989b; McDermott 1975). Stoddard solvent is considered to be a form of

mineral spirits, white spirits, and naphtha; however, not all forms of mineral spirits, white spirits, or

naphtha are considered to be Stoddard solvent. Stoddard solvent is produced from straight-run

distillate of paraffinic or mixed base crude oil (Air Force 1989b; Rothman and Emmett 1988) and

must meet the specifications of the American Society for Testing and Materials designation for Type I

mineral spirits (Stoddard solvent) (ASTM 1988, 1992). In 1990, the production volume of Stoddard

solvent was 38,325,834 pounds, down from a volume of 74,851,222 pounds in 1986 (EPA 1992). The

U.S. companies that produce and/or distribute Stoddard solvent are Ashland Chemical, Inc.; R.E.

Carroll, Inc.; Chemcentral Corporation; Coyne Chemicals; Holtrachem, Inc.; MacArthur Petroleum and Solvent

Company, Inc.; TEXACO Chemical Co.; Unocal Chemicals; and Van Waters and Rogers, Inc. (Hunter et al. 1992;

Van and Deyrup 1992). Since Stoddard solvent is not required to be reported under SARA Section 313, there are no

data for this compound in the 1990 Toxics Release Inventory (TRI90 1992).

4.2 IMPORT/EXPORT

No information regarding the import or export of Stoddard solvent was located.

4.3 USE

Stoddard solvent is a multipurpose petroleum solvent (McDermott 1975). Industrial uses include paint

vehicles; thinning agent for paints, coatings, and waxes; printing inks; adhesives; and as a solvent in

liquid photocopier toners (Air Force 1989b; McDermott 1975). Stoddard solvent is commonly used at

air fields as a degreaser for precision engine parts in machine shops and in automotive repair

applications.
STODDARD SOLVENT 88

4. PRODUCTION, IMPORT, USE, AND DISPOSAL

4.4 DISPOSAL

Disposal of Stoddard solvent should be in accordance with government regulations for the disposal of

petroleum distillates (IRPTC 1985; MSDS-CCOHS I992). Stoddard solvent has been designated as a

hazardous waste by the Department of Transportation and, as such, should not be poured down

domestic sewage drains. Carefully controlled incineration is one recommendation for proper disposal.

Authorized disposal services should perform or oversee the relegation procedure (MSDS-CCOHS

1992). Recycling, of course, is an alternative to disposal, and since recycling is a suggested waste

management technique for petroleum distillates, it should apply to Stoddard solvent as well (IRPTC

1985).
STODDARD SOLVENT 89

5. POTENTIAL FOR HUMAN EXPOSURE

5.1 OVERVIEW

Stoddard solvent is a mixture of hydrocarbons derived by refining crude oil; its environmental fate is

dependent on the physical and chemical properties of the individual components. The hydrocarbon

chain length ranges from C7 to C12, although a form of Stoddard solvent called 140 flash contains C5

and C6 hydrocarbons as well. These hydrocarbons consist primarily of linear and branched alkanes

(also called paraffins) (30-50% of the total mixture), cycloalkanes (30-40%), and aromatics (l0-20%).

Stoddard solvent may be released to the environment during its use as a solvent in dry cleaning plants

or as an industrial degreasing agent. It may also enter water or soil as a result of spills during use or

transportation or from leaking shipping and storage containers such as 55-gallon drums. The lower

molecular weight alkanes and aromatics may volatilize and undergo photodegradation in the

atmosphere, while higher-molecular-weight alkanes and cycloalkanes tend to be sorbed to organic

matter in soil or water. Lower-molecular-weight alkanes may also be sorbed to organic matter if

volatilization is not rapid. The higher-molecular-weight aromatic components may dissolve in surface

waters, or they may desorb from soil particles and leach into the groundwater. Biodegradation is

expected to be the primary fate process for Stoddard solvent in soil and water, except that fraction

which has volatilized. The rate of biodegradation is dependent on the ambient temperature, the

presence of a sufficient number of microorganisms capable of metabolizing these hydrocarbons, and

the concentration of Stoddard solvent in or on the soil or water. If biodegradation occurs under anoxic

conditions, then the availability of Fe(III) may influence the biodegradation of aromatics (Lovley et al.1994).

Exposure of the general population to Stoddard solvent may result primarily from inhalation or dermal

contact when it is used for such commercial purposes as dry cleaning, degreasing in machine shops,

and in paints. Individuals living in areas where Stoddard solvent may have contaminated the soil may

be exposed if it has entered their homes through volatilization from the soil, has been transported in

flowing groundwater, or if they play or otherwise come in direct contact with contaminated soil.

Inhalation of the volatile components of Stoddard solvent is likely to be the main route of occupational exposure for

individuals employed in dry cleaning plants where it is used as a cleaning solvent,
STODDARD SOLVENT 90

5. POTENTIAL FOR HUMAN EXPOSURE

machine shops where it is used as a degreasing agent, and other industries where Stoddard solvent is

used for a variety of purposes. Dermal exposure is also possible if machine parts that have been

degreased in Stoddard solvent are not dry when handled or protective clothing is not worn.

Stoddard solvent has been identified in at least 7 of the 1,397 hazardous waste sites on the EPA

National Priorities List (NPL) (HAZDAT 1994). The frequency of these sites within the United States

can be seen in Figure 5-1.

5.2 RELEASES TO THE ENVIRONMENT

Stoddard solvent may be released to the atmosphere in the exhaust emissions of dry cleaning plants.

Emissions from one plant were determined to be 2,100 ppm (measured as propane) (EPA 1980).

Fugitive emissions from other industrial or domestic uses (such as incompletely sealed or punctured

barrels) may contribute to levels of Stoddard solvent in the environment, including contributions to

general levels of volatile organic carbon. In addition, surface water contamination may occur as a

result of direct spills of Stoddard solvent onto surface waters, runoff from spills to soil with

subsequent transmission to nearby water sources, or from improper disposal, such as pouring Stoddard

solvent down drains. Accidental spills of Stoddard solvent to various media are reported to the

Emergency Response Notification System (ERNS) maintained by EPA. Total spill data for Stoddard

solvent are:

Year Media Quantity spilled in pounds Kilograms

1991 Land 2,020 918.2

Water 8,580 3,900

1992 Land 33 15

Water 0 0

No spills were reported to air, groundwater, at facilities, or for other types of releases. In addition, no

spills of Stoddard solvent were reported in 1993 (ERNS 1993).

Releases of Stoddard solvent are not required to be reported under SARA Section 313; consequently,

there are no data for this compound in the 1990 Toxics Release Inventory (TRI90 1992). There are

STODDARD SOLVENT 92

5. POTENTIAL FOR HUMAN EXPOSURE

seven NPL sites where Stoddard solvent is present in waste materials or containers. It is unknown

whether there have been releases to the environment from these sites (HAZDAT 1994).

5.2.1 Air

No information was located on releases of Stoddard solvent to the atmosphere.

5.2.2 Water

Stoddard solvent may be released to surface waters as a result of spills, in runoff from industrial

facilities where it is used as a solvent, or from the intentional disposal of excess solvent down drains.

Stoddard solvent is not listed in the Contract Laboratory Program Statistical Database (CLPSD) of

chemicals detected in groundwater and surface water samples taken only at NPL sites. Stoddard

solvent itself, as a hydrocarbon mixture, is not included as a target chemical at NPL sites, but some

components of the Stoddard solvent mixture such as alkanes, substituted benzenes, and naphthalenes

have been detected in groundwater and surface water samples (CLPSD 1989). However, the presence

of these compounds does not necessarily imply contamination by Stoddard solvent.

5.2.3 Soil

Stoddard solvent is not listed in the CLPSD of chemicals detected in soil samples taken only at NPL

sites; however, while Stoddard solvent, as a hydrocarbon mixture, is not included as a target chemical,

some components such as alkanes, substituted benzenes, and naphthalenes have been detected in soil

samples (CLPSD 1989). However, the presence of these compounds does not necessarily imply

contamination by Stoddard solvent.
STODDARD SOLVENT 93

5. POTENTIAL FOR HUMAN EXPOSURE

5.3 ENVIRONMENTAL FATE

5.3.1 Transport and Partitioning

The transport and partitioning of Stoddard solvent is dependent on the environmental fate of its

hydrocarbon components. Based on Mackay’s equilibrium partitioning model using low concentrations (below

maximum aqueous solubility) of Stoddard solvent, sorption to organic matter in soil or water is a major partitioning

process for all hydrocarbon classes (alkanes, cycloalkanes, and aromatics) with partitioning to the soil-vapor phase

being relatively unimportant. At low concentrations, the aromatic constituents of Stoddard solvent, particularly the

alkyl benzenes, are more water soluble than alkanes and cycloalkanes and may dissolve in infiltrating water with a

minimum of volatilization. As such, the model indicates, they may be transported through soil into the underlying

groundwater, although sorption to soil organic matter wilB retard this leaching process. For saturated deep soils that

contain no oxygen and little organic matter, the model predicts that some (20%) aromatic hydrocarbons will not

undergo biodegradation, but will be dissolved in the soil-water phase, and subsequently will be transported to

underlying groundwater (Air Force 1989b).

If a release of Stoddard solvent exceeds the sorptive capacity of the soil, the equilibrium partitioning

model is no longer applicable. Large quantities of Stoddard solvent may move through the soil with

gravity as bulk fluid and enter the groundwater. At the soil/groundwater interface, the soluble

components can dissolve in the water, while insoluble components with specific gravities of less than

1 will float on top of the water table and move horizontally along the soil/water interface (Air Force

1989a). In addition, horizontal movement of Stoddard solvent through the soil, particularly through

cracks and fissures in the soil material, is possible if the concentration is large enough to exceed the

sorptive capacity of the soil or if the release has occurred below the surface of the soil (for example

from a leaking underground storage tank).

Alkanes are likely to be sorbed to organic matter in the soil and are, therefore, unlikely to be dissolved

in water moving through soil. However, some of these compounds may volatilize more quickly than

they will bind to organic matter. Most aliphatic hydrocarbons have low water solubilities, but those

with higher water solubilities are likely to be dissolved in water and may be transported through soil

more rapidly, although the extent may be reduced by sorption to organic matter or volatilization (Air

Force 1989a).
STODDARD SOLVENT 94

5. POTENTIAL FOR HUMAN EXPOSURE

Laboratory studies have shown that mineral spirits are sorbed by fresh snow with a mean sorption ratio

of 1.5 g mineral spirits/g snow. This would indicate that if a spill occurred on a snow-covered site, not

only would sorption to soil be decreased if the ground were frozen, but drainage from the site

would be decreased due to snow sorption (Marte% and Nadeau 1994). When the snow melted, the

solvent would be expected to be transported in the same way as the melted snow.

No information was found on the bioaccumulation potential of Stoddard solvent in either aquatic or

terrestrial ecosystems. However, the potential for bioaccumulation of Stoddard solvent in either

ecosystem is dependent on the bioaccumulation potential of the individual hydrocarbon components.

In general, lower molecular weight alkanes do not tend to bioaccumulate, aromatics may have a

moderate tendency to bioaccumulate, and the higher molecular weight alkanes, such as cycloalkanes,

tend to bioaccumulate (Air Force 1989a). However, these bioaccumulation tendencies may not be true

for all compounds within a class. Water-soluble aliphatics and aromatics may be expected to have low

bioconcentration factors based on their octanol-water partition coefficients (Menzer 1991). Although

no information is available on the bioconcentration of Stoddard solvent directly, aquatic organisms

have been found to bioconcentrate some of the hydrocarbons found in fuel oils, many of which are

also found in Stoddard solvent. Mussels exposed to fuel oil no. 2 were found to have significantly

increased concentrations of alkanes, cycloalkanes, and aromatics in their tissue on the first day of

exposure although by day 5 after removal from exposure, the n-alkanes were barely detectable and by

day 21, concentrations of a mixture of alkanes and cycloalkanes had decreased to 30% of the day 1

concentrations. Aromatic hydrocarbons decreased more slowly, to about 35% of the day 1 value at

21 days. The half-life of naphthalenes substituted at C-2 and C-3 were 0.9 and 1.5 days, respectively

(Farrington et al. 1982).

5.3.2 Transformation and Degradation

5.3.2.1 Air

Volatilization from soil and surface waters with subsequent rapid photooxidation in the atmosphere is

expected to be an important fate process for several constituents of Stoddard solvent based on its vapor pressure of 3.0

mmHg (at 20°C) and also, by analogy, based on the environmental fate of jet fuel 4 (JP-4), which contains similar

classes of hydrocarbons (Air Force 1989a). This is particularly true for the alkane constituents of Stoddard solvent with

low water solubilities. Low ambient temperatures
STODDARD SOLVENT 95

5. POTENTIAL FOR HUMAN EXPOSURE

tend to reduce the volatilization process. Other less volatile constituents of Stoddard solvent, such as

alkylbenzenes, are more likely to be affected by processes such as sorption or biodegradation.

5.3.2.2 Water

The C5-C9 hydrocarbon components of Stoddard solvent released to surface waters are primarily lost

by evaporation to the atmosphere. Higher-molecular-weight hydrocarbon components are most likely

to undergo biodegradation. Microorganisms capable of degrading these hydrocarbons have been found

in surface waters (Air Force 1989a). In aquatic environments, C10-C25 n-alkanes are degraded by

microorganisms, although biodegradation decreases as the hydrocarbons become more complex

(Edgerton 1987). Cometabolism by bacterial species may occur, but the transformation is generally

slow and its rate does not increase over time (Alexander 1994).

In aqueous environments, photooxidation of trisubstituted benzenes and naphthalenes may be quite

rapid, while alkanes, benzenes, and monosubstituted benzenes are relatively resistant to photooxidation (Air Force

1989a).

5.3.2.3 Soil

Stoddard solvent released to soil surfaces will undergo “weathering” over time that will result in

changes in the concentrations of the constituent hydrocarbons. A high percentage of low-molecularweight

hydrocarbons (such as C5-C9 alkanes and aromatics), if not sorbed, are likely to evaporate from soil rather than be

biodegraded (Air Force 1989a). Loss of higher-molecular-weight aliphatic and aromatic constituents of Stoddard

solvent will occur by both slow evaporation and by biodegradation. Soil microorganisms may degrade certain

components of Stoddard solvent, with the rate of biodegradation being fast for low-molecular-weight aromatics.

Biodegradation is often slower for aliphatic hydrocarbons that are branched or cyclic or that contain 10 or more

carbons. The length of time required toachieve total degradation of Stoddard solvent may be substantial as

demonstrated by the degradation of another petroleum distillate, fuel oil no. 2, which was degraded by 86-90% after

1 year (Raymond et al. 1975, 1976). Sometimes, a small residual fraction may persist for many years.

Oxygen is used as an electron acceptor for microbial respiration and is a direct reactant in oxic

hydrocarbon oxidation (Lovley et al. 1994). In contaminated ground waters, oxygen may be added to
STODDARD SOLVENT 96

5. POTENTIAL FOR HUMAN EXPOSURE

enhance biodegradation. Anoxic conditions can occur after contamination of ground water. Watersoluble aromatic hydrocarbons can be degraded under anoxic conditions, although the rate of

degradation will be slower than under aerobic conditions (Lovley et al. 1994).

Fe(II1) oxides can act as electron acceptors during the biodegradation of aromatic hydrocarbons in

shallow aquifers; however, these Fe(II1) oxides are frequently not bioavailable to microorganisms The

addition of organic ligands, which bind Fe(II1) and thus increase the bioavailability of Fe(III), has been

reported to increase the rate of biodegradation of aromatic hydrocarbons (including benzene) under

anoxic conditions (Lovley et al. 1994). Thus, the use of Fe(III) ligands might be valuable in the

bioremediation of hydrocarbon-contaminated, anoxic aquifers (Lovley et al. 1994). However, the

effects on the biodegradation of Stoddard solvent or its constituents, such as alkylbenzene, are not

known.

Stoddard solvent, applied to soil at a toxic concentration of 100 gallons per acre, reduced the number

of soil microorganisms by more than half (Persidsky and Wilde 1956), indicating that in areas

contaminated with high concentrations of Stoddard solvent, biodegradation rates may be decreased.

In order to determine the potential hazard to operators of landfill sites where solvents may be

disposed, the evaporation of white spirits (Stoddard solvent) from a simulated landfill site (using

pulverized domestic waste) was studied. Evaporation of Stoddard solvent from the landfill was

compared with its evaporation from a holding lagoon (using a liquid pool of the solvent). The volatile

components of Stoddard solvent initially evaporated rapidly from both sites, although the rate of

evaporation was much greater from the waste site. After 6 hours, the loss of solvent from the waste

was still twice that from the pool of liquid, suggesting that land application may pose a greater initial

hazard to site operators from fumes than would disposal by lagooning; however, other disposal

methods, such as incineration, are preferred (Jones and McGugan 1977).

5.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT

5.4.1 Air

Stoddard solvent per se is not monitored in air; its volatile components, such as low-molecular-weight

alkanes and aromatics, are more likely to be detected as individual compounds in the air.
STODDARD SOLVENT 97

5. POTENTIAL FOR HUMAN EXPOSURE

Stoddard solvent, used in industrial paints for dump trucks, was present in the paint booth at

concentrations between 7.0 and 12.0 ppm (41.2-70.7 mg/m3

) as determined by personal sampling

apparatus; however, this was considerably below the threshold limit value (time-weighted average) of

100 ppm for occupational safety (Bradley and Bodsworth 1983).

The use of hazardous wastes as fuel for industrial and commercial boilers may result in significant

population exposures to hazardous air emissions, particularly when compared with disposal in

incinerators regulated under the Resource Conservation and Recovery Act (RCRA) which must

achieve a removal efficiency of at least 99.99%. Using EPA’s population exposure and air dispersion

models, the potential population exposure was measured for five combustion scenarios (one

commercial incinerator and four boilers with varying capacities and destruction efficiencies) using

Stoddard solvent and the trimethylbenzene component of Stoddard solvent as potential industrial

waste streams. Modeling results showed that the greatest exposure to emissions and the highest

emission concentrations were generated by a 15-million British thermal unit (Btu) boiler operating

at 97.0% destruction capacity. Under this scenario, the highest concentrations of Stoddard solvent and

trimethylbenzene to which people would be exposed were 103 μg /m3

 and 15.4 μg/m3, respectively.

By comparison, a 75million Btu incinerator operating at 99.99% destruction and removal efficiency

would expose people to concentrations several orders of magnitude less (exact number unspecified)

(Coyle and Potenta 1983).

5.4.2 Water

No information was located on levels of the Stoddard solvent as a hydrocarbon mixture monitored in

surface or groundwater. Although some hydrocarbon components of Stoddard solvent have been

detected in water samples, it is not evident whether the source was a release of Stoddard solvent or

some other hydrocarbon mixture or compound.

5.4.3 Soil

No monitoring studies for Stoddard solvent as a hydrocarbon mixture in soil were located. Although

some hydrocarbon components of Stoddard solvent have been detected in soil samples, it is not

evident whether the source was a release of Stoddard solvent or some other hydrocarbon mixture or

compound.
STODDARD SOLVENT 98

5. POTENTIAL FOR HUMAN EXPOSURE

5.4.4 Other Environmental Media

No monitoring studies for Stoddard solvent in other environmental media were located.

5.5 GENERAL POPULATION AND OCCUPATlONAL EXPOSURE

According to the National Occupational Exposure Survey conducted from 1981 to 1983 by NIOSH,

1,922,235 employees (including 230,356 females) in 404 plants were potentially exposed to Stoddard

solvent in the workplace (NOES 1992). Most exposure was for persons employed as cleaners or

janitors. It is expected that workers who use Stoddard solvent as a degreasing agent or who work in

dry cleaning establishments or print shops where it is used as a solvent may have significant exposure

potential.

Transport of Stoddard solvent through soil and into groundwater may result in general population

exposure through the ingestion of contaminated drinking water or through inhalation or dermal

exposure during showering or bathing. Inhalation exposure may also result from the volatilization of

Stoddard solvent components from contaminated soil, including the diffusion of volatile components

through soil and into the basements of buildings (Air Force 1989b).

Use of Stoddard solvent in dry cleaning may result in the occupational exposure of workers in these

establishments, either through inhalation or dermal exposure (Air Force 1989b). The use of Stoddard

solvent (mineral spirits) in commercial paints may result in inhalation exposure, particularly if the

paint is applied with a sprayer (Fidler et al. 1987), as well as dermal exposures if protective clothing is

not worn (Air Force 1989b).

5.6 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES

No studies were-located regarding populations with potentially high exposures; however, it is possible

that persons living or working near facilities that use Stoddard solvent may receive exposure to the

more volatile components.

Use of Stoddard solvent for painting and in printing inks increases the likelihood of exposure by

painters and others who work in areas where Stoddard solvent is used. In addition, people who use
STODDARD SOLVENT 99

5. POTENTIAL FOR HUMAN EXPOSURE

commercial products such as degreasers and paints which contain Stoddard solvent may also be

exposed by inhaling solvent vapors or by dermal contact with the product. Use of a respirator and

good ventilation can reduce exposure to the solvent vapors and protective clothing will help prevent

dermal contact.

5.7 ADEQUACY OF THE DATABASE

Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with

the Administrator of EPA and agencies and programs of the Public Health Service) to assess whether

adequate information on the health effects of Stoddard solvent is available. Where adequate

information is not available, ATSDR, in conjunction with NTP, is required to assure the initiation of a

program of research designed to determine the health effects (and techniques for developing methods

to determine such health effects) of Stoddard solvent.

The following categories of possible data needs have been identified by a joint team of scientists from

ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that, if met,

would reduce or eliminate the uncertainties of human health assessment. This definition should not be

interpreted to mean that all data needs discussed in this section must be filled. In the future, the

identified data needs will be evaluated and prioritized, and a substance-specific research agenda may

be proposed.

5.7.1 Identification of Data Needs

Physical and Chemical Properties. More information on the exact identity and properties of each of

the various formulations that are called Stoddard solvent would make it easier to distinguish

the toxicity and environmental effects caused by Stoddard solvent and to trace its fate based on levels

of distinguishing components, if any. Identification of components or ratios between different

components that may be used to distinguish Stoddard solvent from other hydrocarbon mixtures in

waste streams or other applications would be useful. See Table 3-3 for more information on possible

formulations of Stoddard solvent.

Production, Import/Export, Use, and Release and Disposal. Data on the potential for human exposure

are limited (Air Force 1989b; NOES 1992). Further information on current uses, production
STODDARD SOLVENT 100

5. POTENTIAL FOR HUMAN EXPOSURE

volumes, and releases of Stoddard solvent from industrial uses or as a result of its disposal would be

helpful in assessing the potential risk of exposure to this compound.

Environmental Fate. Stoddard solvent partitions to the various environmental compartments

according to the physical/chemical properties of its individual components. Major fate processes

include volatilization of low molecular weight alkanes and aromatics with photooxidation in the

atmosphere, sorption to soil and water organic matter for cycloalkanes and longer chain alkanes, and

dissolution of aromatic hydrocarbon constituents in water (Air Force 1989b). Biodegradation in soils

may be significant for the aliphatic and aromatic hydrocarbon components of Stoddard solvent that are

not primarily lost by evaporation (Air Force 1989a). The behavior of Stoddard solvent upon release to

the environment has not been well characterized. Limited information is available on the

environmental fate of the three hydrocarbon classes (linear and branched alkanes, cycloalkanes, and

aromatics) that comprise Stoddard solvent, although further study on the interactions of these classes,

particularly over time, would be useful in assessing the persistence and degradation of Stoddard

solvent in the environment. More data would be helpful on the use of Fe(III) ligands to increase

biodegradation of Stoddard solvent or its components under anoxic conditions in contaminated

aquifers. In addition, fate information regarding sorption to organic material in soil and water, derived

from the use of an equilibrium partitioning model, should be experimentally verified.

Bioavailability from Environmental Media. Since the factors characterizing the absorption of

Stoddard solvent are not known for humans or animals, the bioavailability is also unknown. There are

no data on whether Stoddard solvent released to soil or water will be absorbed by humans or animals

through contact with contaminated media. It is expected that the alkylbenzene components of

Stoddard solvent, being more water soluble than the alkanes and cycloalkanes, will be more readily

available for adsorption from contaminated waters. In addition, there are also no data to indicate

whether plants grown on contaminated soil or fish living in contaminated water are likely to absorb

Stoddard solvent or its constituents and thus enter the food chain. More data on possible rates and

extent of absorption through the inhalation, oral, and dermal routes would be useful in determining

bioavailability from environmental media.

Food Chain Bioaccumulation. No information was found on the bioaccumulation potential of

Stoddard solvent in either terrestrial or aquatic ecosystems; however, the individual components

making up the mixture may bioaccumulate depending on their individual properties. In general,
STODDARD SOLVENT 101

5. POTENTIAL FOR HUMAN EXPOSURE

polycyclic aromatic compounds may have the greatest tendency to bioaccumulate (Air Force 1989a).

Because these compounds account for such a small percentage of the mixture, bioaccumulation is not

expected to be a major exposure pathway for humans (Air Force 1989b). Research on the

biomagnification of Stoddard solvent would not be useful because it is not available to the food chain

as a mixture. It is possible that research on the biomagnification of some Stoddard solvent

components for which there is sparse data would be useful.

Exposure Levels in Environmental Media. There are very limited exposure data for air

concentrations of Stoddard solvent in areas where it is used as an industrial paint solvent (Bradley and

Bodsworth 1983). More data on levels in air resulting from other uses or storage or disposal would be

useful. Data on levels in contaminated surface water, groundwater, and soil are needed to assess the

potential risk from these likely sources of exposure.

Exposure Levels in Humans. Since characteristic ratios of the components of Stoddard solvent have not yet been

determined, monitoring information based on these ratios in the workplace or for the general population is not

available. Monitoring surveys that examine levels of Stoddard solvent in the workplace and for the populations living

or working in the vicinity of manufacturing or industrial use sites, or near disposal, dump, or leakage sites would be

useful in determining approximate levels of exposure for these populations, although there may be difficulties in

distinguishing exposure to Stoddard solvent versus other hydrocarbon mixtures, e.g., fuel oils or naphthas. Such

distinctions may be based on ratios of hydrocarbon components and determination of actual use of Stoddard solvent.

Exposure Registries. No exposure registries for Stoddard solvent were located. This substance is not

currently one of the compounds for which a subregistry has been established in the National

Exposure Registry. The substance will be considered in the future when chemical selection is made

for subregistries to be established. The information that is amassed in the National Exposure Registry

facilitates the epidemiological research needed to assess adverse health outcomes that may be related

to the exposure to this substance.

5.7.2 On-going Studies

No on-going studies were located.

STODDARD SOLVENT 103

6. ANALYTICAL METHODS

The purpose of this chapter is to describe the analytical methods that are available for detecting and/or

measuring and monitoring Stoddard solvent in environmental media and in biological samples. The

intent is not to provide an exhaustive list of analytical methods that could be used to detect and

quantify Stoddard solvent. Rather, the intention is to identify well-established methods that are used

as the standard methods of analysis. Many of the analytical methods used to detect Stoddard solvent

in environmental samples are the methods approved by federal organizations such as EPA and the

National Institute for Occupational Safety and Health (NIOSH). Other methods presented in this

chapter are those that are approved by groups such as the Association of Official Analytical Chemists

(AOAC) and the American Public Health Association (APHA). Additionally, analytical methods are

included that refine previously used methods to obtain lower detection limits, and/or to improve

accuracy and precision.

6.1 BIOLOGICAL MATERIALS

Stoddard solvent is a mixture of aliphatic and aromatic hydrocarbons. The primary method used to

detect hydrocarbons in biological materials is gas chromatography (GC) either alone or in combination with

a mass spectrometer (MS). GC has been used to detect white spirits (99% C8-C12 aliphatics) in expiratory air

from the lungs, blood, and human adipose tissue. GUMS can also identify aromatics or cycloalkanes, if

present. See Table 6-l for a summary of these methods. In general, hydrocarbon components, whether of

Stoddard solvent or other hydrocarbon mixtures such as fuel oils, have relatively simple sample preparation

procedures, which consist of adsorption of the volatilehydrocarbons to an adsorption column or charcoal,

followed by elution and injection into the gas chromatograph. Capillary columns that have been successfully

used include charcoal (Pedersen et al. 1984), Chromosorb G (Astrand et al. 1975), and Porapak or Chemipak

(Kimura et al. 1988). The error associated with detecting white spirits by these methods is between 4% for

adipose-tissue (Pedersen et al. 1984) and 8.3% for air and blood (Astrand et al. 1975). Wide-bore capillary

columns have also been used (Hara et al. 1988) for GUMS analysis combined with flame ionization detectors

(FID). This method determined levels of several volatile organic compounds in the blood, urine, and

stomach contents. The sensitivity and precision of this method was generally good (93-100%

recovery).

STODDARD SOLVENT 105

6. ANALYTICAL METHODS

6.2 ENVIRONMENTAL SAMPLES

As with biological materials, detection of Stoddard solvent in environmental samples is based on the

detection of component hydrocarbons. See Table 6-2 for a summary of the analytical methods used to

determine Stoddard solvent hydrocarbons in environmental samples.

The primary method for detecting volatile components of Stoddard solvent in air is GC using a flame

ionization detector (FID) (NIOSH 1984; Otson et al. 1983). Stoddard solvent in air may be

determined by absorption to an appropriate column such as charcoal, desorption in a solvent (carbon

disulfide is recommended), and subsequent quantification. Although the precision of this method is

good (greater than 10% relative standard deviation when the recovery is greater than 80%), in general, recovery tends

to be rather poor (18-80%) because of the slow volatilization of Stoddard solvent (Otson et al. 1983).

No analytical methods specific for Stoddard solvent in water or soil samples were located; however,

determination of Stoddard solvent may be assumed to be similar to the detection of comparable

hydrocarbon mixtures. Detection of Stoddard solvent in water is dependent on the identification and

quantification of the specific hydrocarbon components of the solvent. The primary method, GC either

alone or in combination with MS, may be used for the identification of the major hydrocarbon

components, i.e., n-alkanes, branched alkanes, cycloalkanes, and alkylbenzenes. Separation of the

aliphatic and aromatic fractions may be achieved by liquid-solid column chromatography followed by

dilution of the eluates with carbon disulfide. Aqueous samples may be extracted with

trichlorotrifluoroethane, while solid samples may be extracted by Soxhlet extraction or sonication

methods (Air Force 1989). Purgeable (volatile) aromatics may be determined with a purge-and-trap

apparatus. This method requires a trap with a Tenax/Chromosorb absorbent and the use of GC with a

photoionization detector (PID) (EPA 1991c), an ion trap detector (ITD), or FID (Thomas and Delfino

1991). A modification of the purge-and-trap method uses ambient temperature, has the advantage of

being applicable to a variety of waters, requires virtually no sample preparation (no solvents are

required for desorbing the hydrocarbons), and has an analysis time of approximately 30 minutes

(Bianchi et al. 1991). While this method may be used for determining the presence of industrial

solvent mixtures in water, it cannot distinguish between various sources of this contamination, e.g.,

gasoline, kerosene, Stoddard solvent.


 STODDARD SOLVENT 108

6. ANALYTICAL METHODS

Although no analytical methods were identified for determining the presence of Stoddard solvent in

soil samples, methods do exist for detecting other hydrocarbon mixtures, such as kerosene, and these

may be applicable to Stoddard solvent. Two methods that have been used for petroleum distillates

include GC/FID (Galin et al. 1990) and gas liquid chromatography (GLC) with FID (Midkiff and

Washington 1972). Soil samples are extracted with carbon tetrachloride. Recovery, sensitivity, and

levels of detection data were not reported. Quantification of oils and grease, by gross weight only, in

soils and sludges may be accomplished by extraction with a Soxhlet apparatus using either

trichlorotrifluoroethane (APHA 1985) or methylene chloride (Martin et al. 1991) as the solvent,

although this method is qualitative, not quantitative, and cannot be used to identify the type of oil or

grease bound to the soil.

While no analytical methods were located that are specific for detecting Stoddard solvent in sediment,

as with water and soil, methods that detect other hydrocarbon mixtures may be applicable. For

example, quantification of fuel oil hydrocarbons from sediments is a relatively involved process.

Following extraction, the saturated and olefinic hydrocarbon fraction is separated from the aromatic

hydrocarbon fraction using thin-layer chromatography or column chromatography. Fractions are

subsequently analyzed by GLC (Gearing et al. 1980).

6.3 ADEQUACY OF THE DATABASE

Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with

the Administrator of EPA and agencies and programs of the Public Health Service) to assess whether

adequate information on the health effects of Stoddard solvent is available. Where adequate

information is not available, ATSDR, in conjunction with NTP, is required to assure the initiation of a

program of research designed to determine the health effects (and techniques for developing methods

to determine such health effects) of Stoddard solvent.

The following categories of possible data needs have been identified by a joint team of scientists from

ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that, if met,

would reduce or eliminate the uncertainties of human health assessment. This definition should not be

interpreted to mean that all data needs discussed in this section must be filled. In the future, the

identified data needs will be evaluated and prioritized, and a substance-specific research agenda may

be proposed.
STODDARD SOLVENT 109

6. ANALYTICAL METHODS

6.3.1 Identification of Data Needs

Methods for Determining Biomarkers of Exposure and Effect. There are no known methods

for determining biomarkers of exposure or effect that are specific to Stoddard solvent. Components of

white spirit have been identified in human blood, fat, and alveolar air using GC-MS. Further

information of this type, including the possible identification of a trace compound(s) for Stoddard

solvent as well as information on its metabolites in humans, would be useful for determining whether

an individual has been exposed to Stoddard solvent. It has been suggested that elevated levels of

dimethylbenzoic acid or dimethylhippuric acid, metabolites of trimethylbenzene, in the urine may be

indicative to exposure to Stoddard solvent (Fukaya et al. 1994; Pfaffli et al. 1985). Metabolites of

t-butylcyclohexane, another component of white spirits, were found in rat urine (Henningsen et al.

1987). Further studies concerning the use of these compounds as biomarkers of exposure are needed.

Methods for Determining Parent Compounds and Degradation Products in Environmental Media. Although

no specific methods were located for measuring Stoddard solvent in soil or water, methods do exist for

measuring particular hydrocarbon components of Stoddard solvent, such as 2,6-dimethyloctane, based on

analysis with GC. In addition, it may be possible to identify Stoddard solvent based on characteristic ratios

of hydrocarbon components, but such ratios have not be established. An analytical method does exist for

determining Stoddard solvent in air using GC/FID (NIOSH 1984; Otson et al. 1983). The precision of the

method is good, but recovery is poor. Some methods for detecting hydrocarbon fractions for other hydrocarbon mixtures (e.g., gasoline, fuel oils) in environmental media may be applicable to Stoddard solvent

(Bianchi et al. 1991; Gearing et al.1980; Midkiff and Washington 1972) but should be subjected to further

analysis to determine their precision, recovery, and selectivity when used for Stoddard solvent. In addition,

methods should be developed to distinguish between contamination from Stoddard solvent versus other

petroleum distillates. At present, knowledge on the exact hydrocarbon components and their ratios in

various hydrocarbon mixtures (e.g., kerosene, Stoddard solvent, and paint thinners) is scarce, and more

precise numbers would facilitate the determination of the exact hydrocarbon mixture present in environmental

samples. This would be particularly useful for determining hydrocarbon wastes and contamination at

hazardous waste sites where several such mixtures may be present.
STODDARD SOLVENT 110

6. ANALYTICAL METHODS

6.3.2 On-going Studies

No on-going studies were located for Stoddard solvent.
STODDARD SOLVENT 111

7. REGULATIONS AND ADVISORIES

The international, national, and state regulations and guidelines regarding Stoddard solvent in air,

water, and other media are summarized in Table 7-1.

There is no EPA reference dose (RfD) or reference concentration (RfC) for Stoddard solvent.

Stoddard solvent contains volatile organic compounds (VOC) and may be regulated under the Clean

Air Act guidelines for reduction of VOC emissions from solvents (Clean Air Act 1990).

Under the Hazardous Materials Transportation Act, Stoddard solvent is designated as a hazardous

substance subject to special requirements for packaging, labeling, and transportation (DOT 1989a,

1989b).



 STODDARD SOLVENT 115

8. REFERENCES

*ACGIH. 1990. Threshold limit values and biological exposure indices for 1990-1991. American

Conference of Governmental Industrial Hygienists. Cincinnati, OH.

*ACGIH. 1991. Documentation of the threshold limit values and biological exposure indices. Sixth

edition Vol. III. American Conference of Government Industrial Hygienists. Cincinnati, OH,

1428-1430.

*Air Force. 1989a. JP-4 (Jet Fuel 4). In: The installation restoration program toxicology guide.

Volume 4. Contract no. DE-AC05840R21400. Wright-Patterson Air Force Base, OH: Air Force

Systems Command, Aerospace Medical Division, Harry G. Armstrong Aerospace Medical Research

Laboratory. DOE interagency agreement no. 1891-A076-Al. 64-1 - 64-46.

*Air Force. 1989b. Stoddard solvent. In: The installation restoration program toxicology guide.

Volume 4. Contract no. DE-AC05840R21400. Wright-Patterson Air Force Base, OH: Air Force

Systems Command, Aerospace Medical Division, Harry G. Armstrong Aerospace Medical Research

Laboratory. DOE interagency agreement no. 891-A076-Al. 67-l - 67-25.

*Alden CL. 1986. A review of unique male rat hydrocarbon nephropathy. Toxicol Pathol 14:109-11.

*Alexander M. 1994. Biodegradation and bioremediation. San Diego, CA: Academic Press, 177-195.

*Anderson C, Sundberg K, Groth 0. 1986. Animal model for assessment of skin irritancy. Contact

Dermatitis 15:143-151.

*Andrews LS, Snyder R. 1991. Toxic effects of solvents and vapors. In: Amdur MO, Doull J,

Klaassen CD, eds. Casarett and Doull’s Toxicology: The basic science of poisons. 4th ed. New York,

NY: Pergamon Press, 681-685.

*Annobil SH. 1988. Skin bullae following kerosene poisoning. Ann Trop Pediatr 8(1):45-47.

*APHA. 1985. Standard methods for the examination of water and wastewater. 16th ed. Washington,

DC: American Public Health Association.

*API. 1976. Detectability and irritability of hydrocarbons in human subjects. Final report to American

Petroleum Institute. Contract no. U-15-14-PS-5. Department of Environmental Health, College of

Medicine, University of Cincinnati, Cincinnati, OH.

*API. 1977. Teratology study in rats. Stoddard solvent final report. Washington, DC: American

Petroleum Institute. FYI-AX-01 83-0232 IN.

___________________________

*Cited in text
STODDARD SOLVENT 116

8. REFERENCES

*API. 1978a. Mutagenicity evaluation of Stoddard solvent. API Medical Research Publication: 26-

60010. Washington, DC: American Petroleum Institute. FYI-OTS-0684-0313 SU.

*API. 1978b. Teratology study in rats: Unleaded gasoline. Washington, DC: American Petroleum

Institute. EBI. Project no. 20698-6.

*API. 1979a. Inhalation/teratology study in rats: Fuel oil. Washington, DC: American Petroleum

Institute. Document no. FYI-AX-0183-0230.

*API. 1979b. Teratology study in rats: Diesel fuel. Washington, DC: American Petroleum Institute.

Document no. FYI-AX-01 83-0230.

*API. 1982. Mutagenicity study of thirteen petroleum fractions. Project no. U-150-14 (EA-1).

Washington, DC: American Petroleum Institute.

*API. 1987a. Acute inhalation toxicity evaluation of a petroleum derived hydrocarbon in rats - API

84-02 and API 85-01 with heavy thermal cracked naphtha, with cover letter dated 05/19/87. Project

no. 22235-14. Washington, DC: American Petroleum Institute.

*API. 1987b. Mutagenicity of API 8501, Stoddard solvent (CAS 8052-41-3) in a mouse lymphoma

mutation assay. Final report. Washington, DC: American Petroleum Institute.

*Arlien-Soborg P, Bruhn P, Gyldensted C, et al. 1979. Chronic painters’ syndrome: Chronic toxic

encephalopathy in house painters. Acta Neurol Stand 60: 149-156.

*ASTM. 1988. 1988 Annual book of ASTM standards: volume 6.03. Paints - Fatty oils and acids,

solvents, miscellaneous; aromatic hydrocarbons. Philadelphia, PA: American Society for Testing and

Materials. Designation:D 235-87.

*ASTM. 1992. Standard speciation for mineral spirits (petroleum spirits) (hydrocarbon dry cleaning

solvent). Philadelphia, PA: American Society for Testing and Materials, Designation: D 235-92, 2p.

*Astrand I, Kilbom A, Ovrum P. 1975. Exposure to white spirit: I. Concentration in alveolar air and

blood during rest and exercise. Stand J Work Environ Health 12: 15-30.

*ATSDR. 1989. Toxicological profile for benzene. Atlanta, GA: U.S. Department of Health and

Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry.

*ATSDR. 1990. Toxicological profile for toluene. Atlanta, GA: U.S. Department of Health and

Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry.

*ATSDR. 1991. Toxicological profile for naphthalene and 2-methylnaphthalene. Atlanta, GA: U.S

Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and

Disease Registry.

*ATSDR. 1993. Draft toxicological profile for gasoline; Draft toxicological profile for jet fuels JP-4

and JP-7; Draft toxicological profile for fuel oils. Atlanta, GA: U.S. Department of Health and Human

Services, Public Health Service, Agency for Toxic Substances and Disease Registry.
STODDARD SOLVENT 117

8. REFERENCES

Baker EL, Fine LJ. 1986. Solvent neurotoxicity. The current evidence. J Occup Med 28:126-129.

Baker RW, Yoshioka N, Mohr JM, et al. 1987. Separation of organic vapors from air. J Membr Sci

31:259-272.

*Barnes DG, Dourson M. 1988. Reference dose (RfD): Description and use in health risk

assessments. Regul Toxicol Pharmacol 8:471-486.

*Beck LS, Hepler DI, Hansen KL. 1983. The acute toxicology of selected petroleum hydrocarbons.

In: MacFarland HN, Holdsworth LE, MacGregor JA, et al., eds. Proceedings on the 1st Symposium on

the Toxicology of Petroleum Hydrocarbons, Washington, DC, May 1982. Washington, DC: American

Petroleum Institute, 1-l 2.

Beime GJ, Brennan JT. 1972. Glomemlonephritis associated with hydrocarbon solvents. Arch Environ

Health 25.365-369.

*Beliles RP, Mecler FJ. 1983. Inhalation teratology of jet fuel A: fuel oil and petroleum naphtha in

rats. In: MacFarland HN, Holdsworth LE, MacGregor JA, et al., eds. Proceedings of the Ist

Symposium on the Toxicology of Petroleum Hydrocarbons, Washington, DC, May 1982. Washington,

DC: American Petroleum Institute, 233-238.

Bernard A, Lauwerys R. 1991. Proteinuria changes and mechanisms in toxic nephropathies. Crit Rev

Toxicol 21(5):373-405.

Beving H, Malmgren R, Olsson P. 1988. Changed fatty acid composition in platelets from workers

with long term exposure to organic solvents. Br J Ind Med 45:565-567.

*Beving H, Tomling G, Olsson P. 199 1. Increased erythrocyte volume in car repair painters and car

mechanics. Br J Ind Med 48:499-501.

*Bianchi AP, Varney MS, Phillips J. 1991. Analysis of industrial solvent mixtures in water using a

miniature purge-and-trap device with thermal desorption and capillary gas chromatography-mass

spectrometry. J Chromatogr 557(1-2):429-439.

Biles RW, McKee RH. 1983. Toxicological testing for hazard identification in synthetic fuel

technology. Dev Toxicol Environ Sci 11:13-21.

*Bingham E, Falk HL. 1969. Environmental carcinogens: The modifying effect of carcinogens on the

threshold response. Arch Environ Health 19:779-783.

*Birmingham DJ. 1988. 9. Contact dermatitis and related dermatoses associated with petroleum

recovery and use: Occupational Medicine: State of the Art Reviews 3(3):511.

Bjerre A. 1989. Assessing exposure to solvent vapour during the application of paints, etc.--model

calculations versus common sense. Ann Occup Hyg 33:507-517.

Blair A, DeCoufle P, Grauman D. 1979. Cause of death among laundry and cleaning workers. Am J

Public Health 69(5):508-5 11.
STODDARD SOLVENT 118

8. REFERENCES

*Bocskei Z, Groom CR, Flower DR, et al. 1992. Pheromone binding to two rodent urinary proteins

revealed by X-ray crystallography. Nature 360: 186-l 88.

*Bombassei GJ, Kaplan AA. 1992. The association between hydrocarbon exposure and anti-glomerular

basement membrane antibody-mediated disease (Goodpasture’s Syndrome). Am J Ind Med 21:141-153.

*Borghoff SJ, Short BG, Swenberg JA. 1990. Biochemical mechanism and pathobiology of

α2μ- globulin nephropathy. Annu Rev Pharmacol Toxicol 30:349-367.

Bottomley WW, Sheehan-Dare RA, Hughes P, et al. 1993. A sclerodermatous syndrome with unusual

features following prolonged occupational exposure to organic solvents. Br J Dermatol 128:203-206.

*Bradley A, Bodsworth PL. 1983. Environmental control of a large paint booth. Ann Occup Hyg

27:223-224.

Bratton L, Haddow JE. 1975. Ingestion of charcoal lighter fluid. J Pediatr 87:633-636.

Braunstein LE. 1940. Subacute yellow atrophy of the liver due to solvent. JAMA 114: 136-138.

Brown D, Kaplan S. 1987. Retrospective cohort mortality study of dry cleaner workers using

perchloroethylene. J Occup Med 29(6):535-541.

*Bruhn P, Arlien-Soborg P, Gyldensted C, et al. 1981. Prognosis in toxic encephalopathy: A two-year

follow-up study in 26 house painters with occupational encephalopathy. Acta Neurol Stand 64:259-272.

Buckley JD, Robison LL, Swotinsky R, et al. 1989. Occupational exposures of parents of children with acute

nonlymphocytic leukemia: A report from the children’s cancer study group. Cancer Res

49:4030-4037.

*Budavari S, O’Neil MJ, Smith A, et al., eds. 1989. The Merck index: An encyclopedia of chemicals,

drugs, and biologicals. Eleventh edition. Rahway, NJ: Merck & Co., Inc., 976.

*Carpenter CP, Kinkead ER, Geary DL Jr., et al. 1975a. Petroleum hydrocarbon toxicity studies: I.

Methodology. Toxicol Appl Pharmacol 32:246-262.

*Carpenter CP, Kinkead ER, Geary DL Jr., et al. 1975b. Petroleum hydrocarbon toxicity studies: III.

Animal and human response to vapors of Stoddard solvent. Toxicol Appl Pharmacol 32:282-297.

Carpenter CP, Kinkead ER, Geary DL Jr., et al. 1975c. Petroleum hydrocarbon toxicity studies. VIII.

Animal and human response to vapors of “140° flash aliphatic solvent.” Toxicol Appl Pharmacol 413-429.

*CELDS. 1991. Army Corps of Engineers Construction Engineering Research Laboratory and

University of Illinois, Department of Urban and Regional Planning. Computer-aided Environmental

Legislative Data Systems [database]. June 1991.

Chelton CF, Zakraysek N, Lautner GM, et al. 1983. Evaluation of the performance and response of the

Bacharach TLV sniffer and H-nu photoionization gas analyzer to common hydrocarbon solvents. Am

Ind Hyg Assoc J 44:710-715.
STODDARD SOLVENT 119

8. REFERENCES

Cherry N, Waldron HA. 1983. The neuropsychological effects of solvent exposure. The Colt

Foundation, New Lane, Havant, Hampshire, PO9 2LY, United Kingdom, 205.

Churchill DN, Fine A, Gault MH. 1983. Association between hydrocarbon exposure and

glomerulonephritis: An appraisal of the evidence. Nephron 33: 169-172.

Clark CR, Walter MK, Ferguson PW, et al. 1988. Comparative dermal carcinogenesis of shale and

petroleum-derived distillates. Toxicol Ind Health 4: 1 I-22.

Clark CR, Ferguson PW, Katchen MA, et al. 1989a. Comparative acute toxicity of shale and

petroleum derived distillates. Toxicol Ind Health 5:1005-1016.

*Clark DG, Butterworth ST, Martin JG, et al. 1989b. Inhalation toxicity of high flash aromatic

naphtha. Toxicol Ind Health 51415-28.

*Clean Air Act. 1990. Washington, DC The Bureau of National Affairs, Inc. PL 101-549.

71:1159.1175-1188.

*CLPSD. 1989. Contract Laboratories Program Statistical Database. U.S. Environmental Protection

Agency, Washington, DC. July, 1989.

*Commonwealth of Massachusetts. 1990. Massachusetts Surface Water Quality Standards. Boston,

MA: Massachusetts Surface Water Quality Standards, Division of Water Pollution Control.

Massachusetts 314 CMR 4.00.

*Commonwealth of Virginia. 1990. Commonwealth of Virginia State Water Control Board

Regulations. Richmond, VA: Commonwealth of Virginia State Water Control Board Regulations,

Water Quality Standards.

*Conaway CC, Schreiner CA, Cragg ST. 1984. Mutagenicity evaluation of petroleum hydrocarbons.

In: MacFarland HN, Holdsworth CE, MacGregor JA, et al., eds. Advances in modem environmental

toxicology. Vol. 6: Applied toxicology of petroleum hydrocarbons. Princeton, NJ: Princeton

Scientific Publishers, Inc., 89-107.

*Coruh M, Inal H. 1966. Kerosene poisoning in children with special reference to lung complication.

Turk J Pediatr 8(1):36-42.

*Coyle JJ, Potenta EJ. 1983. Population exposure to hazardous air pollutants from waste combustion

in industrial boilers and RCRA regulated incinerators. In: Frederick ER, ed. Proceedings,

measurement, and monitoring of non-criteria (toxic) contaminants in air specialty conference, 1983.

Chicago, IL: Air Pollution Control Association, 138-149.

*Daniel1 WE, Couser WG, Rosenstock L. 1988. Occupational solvent exposure and

glomerulonephritis: A case report and review of the literature. JAMA 259:2280-2283.

Delzell E, Austin H, Cole P. 1988. 6. Epidemiologic studies of the petroleum institute. Occupational

Medicine: State of the Art Reviews 3(3):455-474.
STODDARD SOLVENT 120

8. REFERENCES

*Dice WH, Ward G, Kelley J, et al. 1982. Pulmonary toxicity following gastrointestinal ingestion of

kerosene. Ann Emerg Med 11: 138-142.

Dick RB. 1988. Short duration exposures to organic solvents: The relationship between

neurobehavioral test results and other indicators Neurotoxicol Teratol 10:39-50.

*Dossing M, Arlien-Soborg P, Petersen LM. 1983. Liver damage associated with occupational

exposure to organic solvents in house painters. Eur J Clin Invest 13:151-158.

*DOT. 1989a. Hazardous materials table. Department of Transportation. Code of Federal

Regulations. 49 CPR 172.101 Appendix A.

*DOT. 1989b. Hazardous materials table and hazardous materials communications regulations.

Department of Transportation Federal Register 54:39501-39505.

Duh R-W, Asal NR. 1984. Mortality among laundry and dry cleaning workers in Oklahoma. Am J

Public Health 74:1278-1280.

Edelfors S, Ravn-Jonsen A. 1992. Effect of organic solvents on nervous cell membrane as measured

by changes in the (Ca2+/Mg2+) ATPase activity and fluidity of synaptosomal membrane. Pharmacol

Toxicol 70:181-187.

*Edgerton SA, Coutant RW, Henley MV. 1987. Hydrocarbon fuel spill dispersion on water: A

literature review. Chemosphere 16(7):1475-1487.

*Ellenhorn MJ, Barceloux DG, eds. 1988. Medical toxicology: Diagnosis and treatment of humans

poisoning. New York, NY: Elsevier.

Enzminger JD, Ahlert RC. 1987. Environmental fate of polynuclear aromatic hydrocarbons in coal tar.

Environmental Technology Letters 8:269-278.

*EPA. 1980. Demonstration of carbon adsorption technology for petroleum dry cleaning plants.

Washington, DC: U.S. Environmental Protection Agency, Office of Toxic Substances. ISS

EPA-600/2-80-145, order no. PB80-221039.

EPA. 1981. Reevaluation of kidney sections from animals used in various solvent inhalation toxicity

studies, with attachments, cover sheets, and letter dated 01/28/81. Washington, DC: U.S. Environmental

Protection Agency. Documents no. 8EHQ-0281-0312; 88-8100181. OTS0200630.

EPA. 1982a. Mixed solvent vapor exposure, with cover letter. Washington, DC: U.S. Environmental

Protection Agency. U.S. EPA/OPTS public files 878210808. Microfiche no. OTS0206238.

EPA. 1982b. Product environmental data. Washington, DC: U.S. Environmental Protection Agency,

Office of Toxic Substances. NTIS/OTS0206107.

EPA. 1982c. Product environmental data. Washington, DC: U.S. Environmental Protection Agency,

Office of Toxic Substances. NTIS/OTS0206116.
STODDARD SOLVENT 121

8. REFERENCES

EPA. 1984a. Response to EPA document SEHQ-05840517 with attached summary of

histopathological findings of a lifetime skin painting study in mice. Washington, DC: U.S.

Environmental Protection Agency, Office of Toxic Substances. NTIS/OTS0509708.

EPA. 1984b. Review of toxicity information on Varsol 40 (Varsol 1). Washington, DC: U.S.

Environmental Protection Agency, Office of Toxic Substances. NTIS/OTS00003 13-0.

*EPA. 1984c. Summary of histopathology findings for dermal carcinogenesis lifetime skin painting

study of solvent-cutback type rust preventative. Washington, DC: U.S. Environmental Protection

Agency, Office of Toxic Substances” Document no. 88-8400629.

*EPA. 1984d. Follow up to TSCA Section 8(e) report on Isopar C and Varsol 40, with cover letter

dated 01/18/84. Washington, DC: U.S. Environmental Protection Agency. Document no. SEHQ-0184-

0312; 88-8400586. OTS0200630.

EPA. 1986a. A copy of a study on the genetic toxicity of Rust-Ban 392 and excerpts from the final

report, with cover letter dated 06/20/86. Washington, DC: U.S. Environmental Protection Agency,

Office of Toxic Substances. NTIS/OTS0509708-1.

EPA. 1986b. Oral toxicity, dermal toxicity, dermal irritation, eye irritation and dermal sensitization

studies performed with API 83-15, 85-01 & 83-20 (final report) with letter. Washington, DC: US.

Environmental Protection Agency, Office of Toxic Substances. NTIS/OTS00OO37l-5.

*EPA. 1986c. Quality criteria for water. Washington, DC: U.S. Environmental Protection Agency.

EPA 440/5-86-001.

EPA. 1987. 28-Day dermal toxicity study of API 85-01 in the rabbit (draft final report) with cover

letter dated 02/25/87. Washington, DC: U.S. Environmental Protection Agency, Office of Toxic

Substances. NTISIOTS0000533-0.

EPA. 1989. Pesticides required to be reregistered: List C. U.S. Environmental Protection Agency.

Federal Register 54 (104): 30846-30855.

*EPA 1990. Interim methods for development of inhalation reference concentrations. Washington,

DC: U.S. Environmental Protection Agency. EPA/600/8-90/066A.

*EPA. 1991a. α2μ- globulin: Association with chemically-induced renal toxicity and neoplasia in the

male rat. Review draft. Washington, DC: U.S. Environmental Protection Agency.

EPA/624/3-91/019A.

EPA. 1991b. C9 aromatic hydrocarbon fraction. U.S. Environmental Protection Agency. Code of

Federal Regulations. 40 CFR 799.2175.

*EPA. 1991~. Method 602 - Purgeable aromatics; Method 610 - Polynuclear aromatic hydrocarbons;

Method 625 - Base/neutrals and acids. U.S. Environmental Protection Agency. Code of Federal

Regulations. 40 CFR 136, Appendix A.
STODDARD SOLVENT 122

8. REFERENCES

*EPA. 1992a. Toxic Substances Control Act Inventory 1990 [Chemical Update System Database].

Washington, DC: U.S. Environmental Protection Agency, Office of Pollution Prevention and Toxics,

Information Management Division.

EPA. 1992b. U.S. Environmental Protection Agency. Code of Federal Regulations. 40 CFR 300.

Federal Register 57(26):4824-4830.

*ERNS. 1993. Emergency Response Notification System. Washington, DC: U.S. Environmental

Protection Agency, Office of Solid Waste and Emergency Response. June, 1993.

*Farrington JW, Davis AC, Frew NM, et al. 1982. No. 2 fuel oil components in Mytilis edulis:

Retention and release after an oil spill. Marine Biology 66:15-26.

*Fidler AT, Baker EL, Letz RE. 1987. Estimation of long term exposure to mixed solvents from

questionnaire data: A tool for epidemiological investigations. Br J Ind Med 44:133-141.

*Finn R, Fennerty A, Ahmad R. 1980. Hydrocarbon exposure and glomerulonephritis. Clin Nephrol

14:173-175.

*Flodin U, Edling C, Axelson 0. 1984. Clinical studies with psychoorganic syndromes among workers

with exposure to solvents. Am J Ind Med 5:287-295.

Franchini I, Cavatora A, Falzoi M, et al. 1983. Early indicators of renal damage in workers exposed to

organic solvents. Int Arch Occup Environ Health 52:1-9.

*Fukaya Y, Saito I, Matsumoto T, et al. 1994. Determination of 3,4-dimethylhippuric acid as a

biological monitoring index for trimethylbenzene exposure in transfer printing workers. Int Arch Occup

Environ Health 65:295-297.

*Galin T, Gerstl Z, Yaron B. 1990. Soil pollution by petroleum products: III. Kerosene stability in

soil columns as affected by volatilization. J Contam Hydrol 5(4):375-385.

*Gamberale F, Annwall G, Hultengren M. 1975. Exposure to white spirit: II. Psychological

functions. Stand J Work Environ Health 1:31-39.

*Gearing PJ, Gearing JN, Pruell RJ, et al. 1980. Partitioning of no. 2 fuel oil in controlled estuarine

ecosystems: Sediments and suspended particulate matter. Environmental Science and Technology

14(9):1129-1136.

Gill R, Warner HE, Broster CG, et al. 1991. The response of evidential breath alcohol testing

instruments with subj.ects exposed to organic solvents and gases. II. White spirit and nonane.

Medicine, Science, and the Law 31:201-13.

*Gochet B, de Meester C, Leonard A, et al. 1984. Lack of mutagenic activity of white spirit. Int Arch

Occup Environ Health 53:359-364.

Goodfield MJ, Saihan EM. 1988. Contact urticaria to naphtha present in a solvent. Contact Dermatitis

18:187.
STODDARD SOLVENT 123

8. REFERENCES

Grasso P. 1988. Neurotoxic and neurobehavioral effects of organic solvents on the nervous system.

State Art Rev Occup Med 3525539.

*Gregersen P. 1988. Neurotoxic effects of organic solvents in exposed workers: Two controlled

follow-up studies after 5.5 and 10.6 years. Am J Ind Med 14:681-702.

*Gregersen P, Angelsoe B, Nielson TE, et al. 1984. Neurotoxic effects of organic solvents in exposed

workers: An occupational, neuropsychological, and neurological investigation. Am J Ind Med 5:201-

225.

*Haddad LM, Winchester JF, eds. 1990. Clinical management of poisoning and drug overdose. 2nd

ed. Philadelphia, PA: W.B. Saunders Company, 1177-1183.

Hagmar L, Bellander T, Hoegstedt B, et al. 1988. Biological effects in a chemical factory with

mutagenic exposure: I. Cytogenetic and hematological parameters. Int Arch Occup Environ Health

60:437-444.

Halder CA, Holdsworth CE, Cockre11 BY, et al. 1985. Hydrocarbon nephropathy in male rats:

Identification of the nephrotoxic components of unleaded gasoline. Toxicol Ind Health 1:67-88.

*Hane M, Axelson O, Blume J, et al. 1977. Psychological function changes among house painters.

Stand J Work Environ Health 3:91-99.

Hansen MK, Larsen M, Cohr K-H. 1987. Waterborne paints: A review of their chemistry and

toxicology and the results of determinations made during their use. Stand J Work Environ Health

13:473-485.

*Hara K, Kageura M, Hieda Y, et al. 1988. Application of wide-bore capillary gas chromatography to

analyze volatile compounds in body fluids. Jpn J Legal Med 42(2):142-146.

Harrington JM, Whitby H, Gray CN, et al. 1989. Renal disease and occupational exposure to organic

solvents: A case referent approach. Br J Ind Med 46:643-650.

Hashimoto DM, Kelsey KT, Seitz T, et al. 1991. The presence of urinary cellular sediment and

albuminuria in newspaper pressworkers exposed to solvents. J Occup Med 33:516-526.

*Hastings L, Cooper GP, Burg W. 1984. Human sensory response to selected petroleum hydrocarbons. In:

MacFarland HN, Holdsworth CE, MacGregor JA, et al., eds. Advances in modern environmental toxicology.

Vol. VI: Applied toxicology of petroleum hydrocarbons. Princeton, NJ: Princeton Scientific Publishers, Inc.,

255-270.

Hauser SP. 1988. [Naphtha-B 100 to 140--petroleum. Documentation no. 12.1 Schweiz Rundsch Med

Prax 77:152-154. (German)

*Haydon DA, Hendry BM, Levinson SR. 1977. The molecular mechanisms of anaesthesia. Nature

268:356-358.

*HAZDAT. 1994. Agency for Toxic Substances and Disease Registry (ATSDR), Atlanta, GA.
STODDARD SOLVENT 124

8. REFERENCES

Hegewisch-Becker S, Szudra A, Hossfeld DK. 1993. Exposure to lipophilic industrial solvents leads to

increased P-glycoprotein expression in peripheral blood cells. Br J Haematol 85:220-222.

Heineman EF, Olsen JH, Pottem EM, et al. 1992. Occupational risk factors for multiple myeloma

among Danish men. Cancer Causes Control 3:555-568.

*Henningsen GM, Yu KO, Salomon RA, et al. 1987. The metabolism of t-butylcyclohexane in

Fischer-344 male rats with hyaline droplet nephropathy. Toxicol Lett 39:313-318.

Holmberg PC 1979. Central-nervous-system defects in children born to mothers exposed to organic

solvents during pregnancy. Lancet 2: 177- 179.

Holmberg PC, Nurminen M. 1980. Congenital defects of the central nervous system and occupational

factors during pregnancy: Case-referent study. Am J Ind Med 1:167-176.

*Horton AW, Denman DT, Trosset RP. 1957. Carcinogenesis of the skin. II. The accelerating

properties of aliphatic and related hydrocarbons. Cancer Research 17:758-766.

*Horton AW, Van Dreal PA, Bingham EL. 1966. Physicochemical mechanisms of acceleration of skin

carcinogenesis. In: Advances in Biology of the Skin (Montagna W; Dobson R; editors). Vol. 7.

Oxford, Pergamon Press. pp. 165-181.

*Horton AW, Eshleman DN, Schuff AR, Penman WH. 1976. Correlation of cocarcinogenic activity

among n-alkanes with their physical effects on phospholipid micelles. J Nat1 Cancer Inst. 56:387-91.

*Hunter D, Kislin AH, Kiesche E, et al., eds. 1992. Buyer’s guide: Special issue. Chemical Week

149:500, 589.

*IARC. 1989. Occupational exposures in petroleum refining. IARC monographs on the evaluation of

carcinogenic risks to humans. Occupational exposures in petroleum refining. Vol. 45: Crude oil and

major petroleum fuels, Lyon, France: World Health Organization, International Agency for Research

on Cancer, 39-117.

Iregren A, Gamberale F. 1990. Human behavioral toxicology central nervous effects of low-dose

exposure to neurotoxic substances in the work environment. Stand J Work Environ Health 16: 17-25.

*IRPTC. 1985. Treatment and disposal methods for waste chemicals: IRPTC file. Geneva,

Switzerland: United Nations Environment Programme, International Register of Potentially Toxic

Chemicals, 222.

Jakobsen BM, Hass U, Juul F, et al. 1986. Prenatal toxicity of white spirits inhalation inthe rat

[Abstract]. Teratology 34:415.

*Jenkins LJ Jr, Coon RA, Lyon JP, et al. 1971. Effect on experimental animals of long-term inhalation

exposure to mineral spirits: II. Dietary, sex and strain influences in guinea pigs. Toxicol Appl

Pharmacol 18:53-59..

*Jones CJ, McGugan PJ. 1978. An investigation of the evaporation of some volatile solvents from

domestic waste. Journal of Hazardous Materials 2:235-252.
STQDDARD SOLVENT 125

8. REFERENCES

*Kainz RJ, White LE. 1984. Depressant effects associated with the inhalation of uncombusted diesel

vapor. In: MacFarland HN, Holdsworth CE, MacGregor JA, et al., eds. Advances in modem

environmental toxicology. Volume VI: Applied toxicology of petroleum hydrocarbons Princeton, NJ:

Princeton Scientific Publishers, Inc.

Kastl J, Horacek J. 1982. [Primary myogenic skin tumours (multiple piloleiomyoma, subcutaneous

leiomyosarcoma).] Cesk Dermatol 57:205-207. (Czech)

Katz RM, Jowett D. 1981. Female laundry and dry cleaning workers in Wisconsin: A mortality

analysis. Am J Public Health 71(3):305-307.

*Kimura K, Nagata T, Hara K, et al. 1988. Gasoline and kerosene components in blood: A forensic

analysis. Hum Toxic01 7(4):299-305.

*Kimura H, Odani S, Nishi S, et al. 1991a. Primary structure and cellular distribution of two fatty

acid-binding proteins in adult rat kidneys. J Biol Chem 266:5963-5972.

Kimura K, Nagata T, Kudo K, et al. 199lb. Determination of kerosene and light oil components in

blood. Biol Mass Spectrom 20(8):493-497.

*Klaassen CD, Rozman K. 1991. Distribution, excretion, and absorption of toxicants. In: Amdur MO,

Doull J, Klaassen CD, eds. Casarett and Doull’s Toxicology: The basic science of poisons. 4th ed.

New York, NY: Pergamon Press, 50-57.

*Klein BL, Simon JE. 1986. Hydrocarbon poisonings. Pediatr Clin North Am 33(2):411-419.

*Knave B, Olson BA, Elofson S, et al. 1978. Long term exposure to jet fuel: II. A cross-sectional

epidemiologic investigation on occupationally exposed industrial workers with special reference to the

nervous system. Stand J Work Environ Health 4:19-45.

Koh D, Foulds IS, Aw TC. 1990. Dermatological hazards in the electronics industry. Contact

Dermatitis 22: 1-7.

Kopecni MM, Tarana MV, Cupic SD, et al. 1989. Gas chromatographic determination of phenols in

waste water-oil emulsions. J Chromatogr 462:392-397.

Kumar A, Sparks BD, Majid A. 1986. Recovery of organics from tailings pond sludge using coke for

agglomeration. Separation Science and Technology 21:3 15-326.

Kunkel DB, Sullivan JB, Jr. 1992. Carbon disulfide and select miscellaneous solvents. In: Sullivan,

JB Jr., Krieger, GR, eds. Hazardous materials toxicology: Clinical principles of environmental health.

Baltimore, MD: Williams & Wilkins, p.l117-1123.

Kurppa K, Vainio H. 1983. Study design liver disease and house painters exposure to organic solvents. Eur J

Clin Invest 13:113-114.

Kurppa K, Holmberg PC, Hemberg S, et al. 1983. Screening for occupational exposures and

congenital malformations: Preliminary results from a nationwide case-referent study. Scand J Work

Environ Health 9:89-93.
STODDARD SOLVENT 126

8. REFERENCES

Kyvik K, Brattebo G, Tysnes O-B, et al. 1992. Activation of blood platelets in workers exposed to

organic solvents. J Occup Med 34(7):687-692.

Kyyronen P, Taskinen H, Lindbohm ML, et al. 1989. Spontaneous abortions and congenital

malformations among women exposed to tetrachloroethylene in dry cleaning. J Epidemiol Community

Health 43:346-351.

*Lam HR, Lof A, Ladefoged 0. 1992. Brain concentrations of white spirit components and

neurotransmitters following a three week inhalation exposure of rats. Pharmacol Toxicol 70:394-396.

*Lam HR, Ostergaard G, Guo SX, et al. 1994. Three weeks' exposure of rats to dearomatized white

spirit modifies indices of oxidative stress in brain, kidney, and liver. Biochem Pharmacol 47(4):651-

657.

*Lankas GR, Baxter CS, Christian RT. 1978. Effect of alkane tumor-promoting agents on chemically

induced mutagenesis in cultured V79 Chinese hamster cells. J Toxicol Environ Health 4:37-41.

*Larsen LB, Schmunes E. 1974. OccupationaI health case report--no. 6: Stoddard solvent. J Occup

Med 16:276-278.

Lauwerys R, Bernard A, Viau C, et al. 1985. Kidney disorders and hematotoxicity from organic solvent

exposure. Stand J Work Environ Health 11(1):83-90.

Lebowitz H, Brusick D, Matheson D, et al. 1979. Commonly used fuels and solvents evaluated in a

battery of short-term bioassays [Abstract]. Environ Mutagen 1: 172-173.

*Lehman-McKeeman LD. 1993. Male rat-specific light hydrocarbon nephropathy. In: Target organ

toxicology series: Toxicology of the kidney. 2nd edition. New York: Raven Press, 477-494.

Linz DH, de Garmo PL, Morton WE, et al. 1986. Organic solvent-induced encephalopathy in industrial

painters. J Occup Med 28:119-125.

*Litovitz T, Greene AE. 1988. Health implications of petroleum distillate ingestion. Occupational

Medicine: State of the Art Review 3:555-567.

Litt IF, Cohen MI. 1969. “Danger...vapor harmful”: Spot-remover sniffing. N Engl J Med, Sept 4:543-

544.

*Lovley DR, Woodward JC, Chapelle FH. 1994. Stimulated anoxic biodegradation of aromatic

hydrocarbons using Fe (III) ligands [letter]. Nature 370:128-131.

Lundberg I. 1986. Mortality and cancer incidence among Swedish paint industry workers with long-term

exposure to organic solvents. Stand J Work Environ Health 12:108-l 13.

*Majeed HA, Bassyouni H, Kalaawy M, et al. 198 1. Kerosene poisoning in children: A clinicoradiological

study of 205 cases. Ann Trop Pediatr 12:123-130.

*Mann MD, Pirie DJ, Wolfsdorf J. 1977. Kerosene absorption in primates. J Pediatr 91(3):495-498.
STODDARD SOLVENT 127

8. REFERENCES

*Mattel CJ, Nadeau JM. 1994. Snow as an expedient sorbent for hazardous materials. J Environ Sci

Health A29( 1):237-247.

*Martin JH, Siebert AJ, Loehr RC. 1991. Estimating oil and grease content of petroleum-contaminated soil.

Journal of Environmental Engineering 117(3):291-299.

*McDermott HJ. 1975. Hygienic guide series: Stoddard solvent (mineral spirits, white spirits). Am

Ind Hyg Assoc J 36553-558.

McGovern JL. 1992. Four methods for predicting the flash point of alkyd paints containing VM&P

naphtha and mineral spirits-Part I. Journal of Coatings Technology 64(810):33-38.

McKee RH, Hinz JP. 1987. Evaluation of the subacute and subchronic toxicity of inhaled hydrotreated

naphtha in the rat. Fundam Appl Toxicol 9: 120-130.

McKee RH, Biles RW, Kapp RW, et al. 1984. The acute toxicity of coal liquefaction-derived

materials. J Appl Toxicol 4:198-205.

McKee RH, Hinz JP, Traul KA. 1986. Evaluation of the teratogenic potential and reproductive toxicity of

coal-derived naphtha. Toxicol Appl Pharmacol 84: 149- 158.

McKee RH, Schmitt S, Wong Z, et al. 1990a. The reproductive and developmental toxicity of high

flash aromatic naphtha. Toxicologist 10:41.

McKee RH, Wong ZA, Schmitt S, et al. 1990b. The reproductive and developmental toxicity of high

flash aromatic naphtha. Toxicol Ind Health 6:441-460.

*Mehlman MA, Smart CL. 1982. A comparative toxicological evaluation of paint solvents. In:

Englund A, Ringen K, Mehlman MA, eds. Occupational health hazards of solvents. Princeton, NJ:

Princeton Scientific Publishers, 53-67.

Melke D. 1987. [Measuring chemical pollutants in the air at the work site of watchmakers.] Z

Gesamte Hyg 33:640-641. (German)

Mellgren SI, Formoe T, Sundby R. 1988. Vibratory threshold in workers exposed to organic solvents

[Abstract]. Neurology 38(Suppl. 1):222.

*Mergler D, Belanger S, de Grosbois S, et al. 1988. Chromal focus of acquired chromatic

discrimination loss and solvent exposure among printshop workers. Toxicology 49:341-348.

*Menzer R. 1991. Water and Soil Pollutants. In: Amdur MO, Doull J, Klaassen CD, eds. Casarett

and Doull’s Toxicology: The basic science of poisons. 4th ed. New York, NY: Pergamon Press, 872-

878.

*Midkiff CR Jr, Washington WD. 1972. Gas chromatographic determination of traces of accelerants in

physical evidence. J Assoc Off Anal Chem 55(4):840-845.

Mikkelsen S. 1980. A cohort study of disability pension and death among painters with special regard

to disabling presenile dementia as an occupational disease. Stand J Soc Med Suppl 16:34-43.
STODDARD SOLVENT 128

8. REFERENCES

*Mikkelsen S, Jorgensen M, Browne E, et al. 1988. Mixed solvent exposure and organic brain

damage: A study of painters. Acta Neurol Stand Suppl 78:1-143.

*Mosconi G, Migliori M, Greco V, et al. 1988. Kerosene “burns”: A new case. Contact Dermatitis

19(4):314-315.

*MSDS-CCOHS. 1992. Mineral spirits. Material Safety and Data Sheet-Canadian Center for

Occupational Health and Safety. May 13, 1992.

*Narvarte J, Saba SR, Ramirez G. 1989. Occupational exposure to organic solvents causing chronic

tubulointerstitial nephritis Arch Intern Med 149:154-158.

*NBS/NRC. 1989. Biologic markers in reproductive toxicology. National Academy of

Sciences/National Research Council. Washington, DC: National Academy Press, 15-35.

*NATICH. 1991. National Air Toxics Information Clearinghouse. Data base report on state, local, and

EPA air toxics activities. U.S. Environmental Protection Agency, Office of Air Quality Planning and

Standards, Washington, D.C.: August 13, 199%.

*NESCAUM. 1989. Evaluation of the health effects from exposure to gasoline and gasoline vapors.

Final report. Northeast States for Coordinated Air Use Management.

*Nethercott J, Pierce JM, Likwornick G, et al. 1980. Genital ulceration due to Stoddard solvent. J

Occup Med 22:549-552.

Niemela R, Pfaffli P, Harkonen H. 1987. Ventilation and organic solvent exposure during car washing.

Scand J Work Environ Health 13:424-430.

Nierenberg DW, Horowitz MB, Harris KM, et al. 1991. Mineral spirits inhalation associated with

hemolysis, pulmonary edema, and ventricular fibrillation. Arch Intern Med 15 1: 1437- 1440.

NIOSH. 1977. Criteria for a recommended standard. Occupational exposure to refined petroleum

products. Washington DC: U.S. Department of Health, Education, and Welfare, Public Health Service,

Centers for Disease Control, National Institute for Occupational Safety and Health. DHEW (NIOSH)

publication no. 77-192.

*NIOSH. 1984. Manual of analytical methods. 3rd ed. Eller PM, ed. Cincinnati, OH: National

Institute for Occupational Safety and Health. Publication no. 84-100, method 1550.

NIOSH. 1987. Current Intelligence Bulletin #48: Organic solvent neurotoxicity. Cincinnati, OH:

National Institute for-Occupational Safety and Health. DHHS (NIOSH) publication no. 87-104.

*NIOSH. 1990. NIOSH pocket guide to chemical hazards. Washington, DC: U.S. Department of

Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for

Occupational Safety and Health. DHHS (NIOSH) publication no. 90-117.

*NIOSH. 1992a. NIOSH recommendations for occupational safety and health: Compendium of policy

documents and statements. Cincinnati, OH: National Institute for Occupational Safety and Health.

DHHS(NIOSH) publication no. 92-100.
STODDARD SOLVENT 129

8. REFERENCES

NIOSH. 1992b. Health hazard evaluation report HETA 91-051-2177, AVX Corporation, Myrtle Beach,

South Carolina. Cincinnati, OH: National Institute for Occupational Safety and Health, Hazard

Evaluations and Technical Assistance Branch. Report no. 91-051.

*NOES. 1992. National Occupational Exposure Survey. Cincinnati, OH: U.S. Department of Health

and Human Services, Public Health Service, Centers for Disease Control, National Institute for

Occupational Safety and Health, Division of Surveillance, Hazard Evaluations and Field Studies.

*Nouri L, Al-Rahim K. 1970. Kerosene poisoning in children. Postgrad Med J 46(532):71-75.

*Olson BA. 1982. Effects of organic solvents on behavioral performance of workers in the paint

industry. Neurobehav Toxicol Teratol 4:703-708.

*Olson MJ, Johnson JT, Reidy CA. 1990. A comparison of male rat and human urinary proteins:

Implications for human resistance to hyaline droplet nephropathy. Toxicol Appl Pharmacol 102:524-

536.

Ono Y, Takeuchi Y, Hisanaga N, et al. 1982. Neurotoxicity of petroleum benzine compared with

n-hexane. Int Arch Occup Environ Health 501219-229.

Orbaek P, Risberg J, Rosen I, et al. 1985. Effects of long-term exposure to solvents in the paint

industry. Stand J Work Environ Health 11: l-28.

OSHA. 1989a. Air contaminants. Occupational Safety and Health Administration. Code of Federal

Regulations. 29 CFR 1910.1000.

OSHA. 1989b. Air contaminants. Occupational Safety and Health Administration. Federal Register

54:2920-2960.

*OSHA. 1993. Air contaminants. Occupational Safety and Health Administration. Federal Register

58(124):35338-35351.

*Ostergaard G, Lam H, Ladefoged 0, et al. 1993. Effects of six months’ white spirit inhalation

exposure in adult and old rats. Pharmacol Toxic01 72:34-39.

*Otson R, Williams DT, Bothwell PD. 1983. Charcoal-tube technique for simultaneous determination

of selected organics in air. Am Ind Hyg Assoc J 44~489-494.

Overby ST, DeBano LF. 1990. New technique for measuring volumetric shrinkage in soils. Soil

Science Society of America Journal 54: 1797- 1799.

*Pedersen LM, Cohr’K-H. 1984a. Biochemical pattern in experimental exposure of humans to white

spirit: 1. The effects of a 6 hours single dose. Acta Pharmacol Toxicol 55:317-324.

*Pedersen LM, Cohr K-H. 1984b. Biochemical pattern in experimental exposure of humans to white

spirit: 2. The effects of repetitive exposures. Acta Pharmacol Toxicol 55:325-330.

Pedersen LM, Rasmussen JM. 1982. The hematological and biochemical pattern in occupational

organic solvent poisoning and exposure. Int Arch Occup Environ Health 51: 113-126.
STODDARD SOLVENT 130

8. REFERENCES

*Pedersen LM, Larsen K, Cohr C-H. 1984. Kinetics of white spirits in human fat and blood during

short-term experimental exposure. Acta Pharmacol Toxicol 55:308-316.

*Pedersen LM, Rasmussen S, Cohr C-H. 1987. Further evaluation of the kinetics of white spirits in

human volunteers. Pharmacol Toxicol 60: 135-B 39.

*Persidsky DJ, Wilde SA. 1956. Effect of eradicants on the microbiological properties of nursery soils.

Wisconsin Academy of Sciences, Arts and Letters 44:65-73.

Persson B, Dahlander A-M, Frediksson M, et al. 1989. Malignant lymphomas and occupational

exposure. Br J Ind Med 46:516-520.

*Persson B, Fredriksson M, Olsen K, et al. 1993. Some occupational exposures as risk factors for

malignant lymphomas. Cancer 72:1773-1778.

Petrone RL. 1988. Cancer mortality among petroleum solvent exposed Oklahoma dry cleaners. Diss

Abstr Int [B] 48:1955.

*Pfaffli P, Harkonen H, Savolainen H. 1985. IJrinary dimethylbenzoic-acid excretion as an indicator of

occupational exposure to white spirit. Journal of Chromatography, Biomedical Applications

337:146-150.

*Phillips RD. 1983. Effect of Stoddard solvent on kidney function and structure of Fischer 344 and

Sprague-Dawley rats. In: Proceedings of the 13th Conference on Environmental Toxicology, WrightPatterson Air Force Base, Nov. 16-l 8, 1982. Springfield, VA: Air Force Aerospace Medical Research

Laboratory, Aerospace Medical Division, Air Force Systems Command, 328-336.

*Phillips SC. 1984. A review of the human kidney effects of hydrocarbon exposure. In:

Mehlman MA, Hemstreet GP, Thorpe JJ, et al., eds. Renal effects of petroleum hydrocarbons:

Advances in modem environmental toxicology. Vol. VII. Princeton, NJ: Princeton Scientific

Publishers, Inc., 185-202.

*Phillips RD, Cockrell BY. 1984. Kidney structural changes in rats following inhalation exposure to

Cl0-Cl1 isoparaffinic solvent. Toxicology 331261-273.

Phillips RD, Egan GF. 1981. Teratogenic and dominant lethal investigation of two hydrocarbon

solvents [Abstract]. Toxicologist 1: 15.

*Phillips RD, Egan GF. 1984a. Effect of C10-C11 isoparaffinic solvent on kidney function in Fischer

344 rats during eight weeks of inhalation. Toxicol Appl Pharmacol 73:500-510.

*Phillips RD, Egan GF. 1984b. Subchronic inhalation exposure of dearomatized white spirits and

Cl0-Cl1 isoparaffinic hydrocarbon in Sprague-Dawley rats. Fundam Appl Toxicol 4:808-818.

Poklis A, Burkett CD. 1977. Gasoline sniffing: A review. Clin Toxicol 11:35-41.

Polakowska B. 1986. [Functional disorders of the nervous system of female workers in the rubber

industry exposed to benzine vapors.] Med Pr 37:42-46. (Polish)
STODDARD SOLVENT 131

8. REFERENCES

*Porter HO. 1990. Aviators intoxicated by inhalation of JP-5 fuel vapors. Aviat Space Environ Med

61(7):654-656.

Pottern LM, Heineman EF, Olsen JH, et al. 1992, Multiple myeloma among Danish women

Employment history and workplace exposures. Cancer Causes and Control 3:427-432.

*Prager D, Peters C. 1970. Development of aplastic anemia and the exposure to Stoddard solvent.

Blood 35:286-287.

Quinet B, Begue P, Baron S. 1987. [Specificities of pediatric poisoning.] J Pharm Clin 6:421-428.

(French) Radujkov Z, Ristic L, Mihajlov A, et al. 1982. [The incidence of hyperlipoproteinemia in workers

involved in the manufacture of naphtha and gas.] Med Pregl 35:27-31. (Serbo-Croatian)

*Rambausek MH, Waldherr R, Ritz E. 1993. Immunogenetic findings in glomernlonephritis. Kidney

International Vol. 43, Supp. 39, pp. S-3-S-8.

Ramirez G. 1990. Occupational exposure to organic solvents [letter; comment]. Arch Intern Med.

150:919.

Ratnoff WD, Gress RE. 1980. Familial occurrence of polycythemia Vera: Report of a father and son,

with consideration of the possible etiologic role of exposure to organic solvents, including

tetrachloroethylene. Blood 56:233-236.

Ravnskov U, Forsberg B, Skerfving S. 1979. Glomerulonephritis and exposure to organic solvents.

Acta Med Scan 205:575-579.

*Raymond RL, Hudson JO, Jamison VW. 1975. Assimilation of oil by soil bacteria. Proceeding of

the American Petroleum Institute, Refining Department, 40th Mid-Year Meeting, Volume 54.

Washington, DC: American Petroleum Institute, 429-455.

*Raymond RL, Hudson JO, Jamison VW. 1976. Oil degradation in soil. Appl Environ Microbial

31(4):522-535.

*Rector DE, Steadman BL, Jones RA, et al. 1966. Effects on experimental animals of long-term

inhalation exposure to mineral spirits. Toxicol Appl Pharmacol 9:257-268.

*Riley AJ, Collings AJ, Browne NA, et al. 1984. Responses of the upper respiratory tract of the rat to

white spirits vapor. Toxicol Lett 22: 125-132.

*Rothman N, Emmett EA. 1988. The carcinogenic potential of selected petroleum-derived products.

Occupational Medicine: State of the Art Review 3:475-494.

*Saffioti U, Shubik P. 1963. Studies on promoting action in skin carcinogenesis. Monogr Natl. Cancer

Inst 10:489-507.

*Sato A, Nakajima T. 1987. Pharmacokinetics of organic solvent vapors in relation to their toxicity.

Scand J Work Environ Health 13:81-93.
STODDARD SOLVENT 132

8. REFERENCES

Savolainen H, Pfaffli P. 1982. Neurochemical effects of extended exposure to white spirits vapour at

three concentration levels. Chem Biol Interact 39:l0l.

*Sax NI, Lewis RJ. 1989. Dangerous properties of industrial materials. Seventh edition” Volume III.

New York, NY: Van Nostrand Reinhold Co., 3117.

*Scheffers TML, Jongeneelen FJ, Bragt PC. 1985. Development of effect-specific limit values

(ESLVs) for solvent mixtures in painting. Ann Occup Hyg 29:191-199.

Schreiner CA. 1983, Petroleum and petroleum products: A brief review of studies to evaluate

reproductive effects. In: Christian MS, Galbraith WM, Voytek P, et al., eds. Advances in modern

environmental toxicology. Vol. 3: Assessment of reproductive and teratogenic hazards. Princeton, NJ:

Princeton Scientific Publishers, Inc., 29-45.

*Schreiner CA, Edwards DA, McKee RH, et al. 1989. The mutagenic potential of high flash aromatic

naphtha. Cell Biol Toxicol 5:169-188.

*Scott JL, Cartwright GE, Wintrobe MM. 1959. Acquired aplastic anemia - an analysis of thirty-nine

cases and review of the pertinent literature. Medicine 38:119-172.

Seppalainen AM, Husman K, Martenson C. 1978. Neurophysiological effects of long-term exposure

to a mixture of organic solvents. Stand J Work Environ Health 4:304-314.

*Shapiro LE, Sachchidananda J. 1982. Regulation of proteins by thyroid hormone and glucocorticoid:

The responses of hepatic α2μ- globulin and pituitary growth hormone differ in adult male hypothyroid

rats. Endocrinology 8:653-660.

Shirkey HC. 1971. Treatment of petroleum distillate ingestion. Mod Treat 8:580-592.

*Short BG, Burnett VL, Cox MG, et al. 1987. Site-specific renal cytotoxicity and cell proliferation in

male rats exposed to petroleum hydrocarbons. Lab Invest 57:564-577.

*Sice J. 1966. Tumor-promoting activity of n-alkanes and 1-alkanols. Toxic01 Appl Pharmacol 9:70-

74.

*Siemiatycki J, Dewar R, Nadon L, et al. 1987. Associations between several sites of cancer and

twelve petroleum-derived liquids: Results from a case-referent study in Montreal. Scand J Work

Environ Health 13:493-504.

Spencer PS, Schaumburg HH. 1985. Organic solvent neurotoxicity facts and research needs. Stand J

Work Environ Health 1 l(Supp1. 1):53-60.

*Spirtas R, Stewart PA, Lee JS, et al.1991. Retrospective cohort mortality study of workers at an

aircraft maintenance facility: I. Epidemiological results. Br J Ind Med 48:515-530.

Starek A, Golba W. 1984. [Analysis of naphtha vapors in the air by gas chromatography.] Med Pr

35:373-8. (Polish)
STODDARD SOLVENT 133

8. REFERENCES

*State of Alaska. 1989. Alaska water quality standards. Juneau, AL: Alaska Administrative Code,

Water Quality Standards, Amended 12/89. Alaska Title 18, Chapter 70.

*State of Arkansas. 1991. Regulation no. 2 as amended water quality standards for surface waters of

the State of Arkansas Little Rock, AK: Water Quality Standards for Surface Waters of the State of

Arkansas.

*State of Florida. 1992. Florida Water Quality Standards 1992. Tallahassee, FL: Florida Water

Quality Standards 17.-3.

*State of Nebraska. 1990. Nebraska water quality standards 1990. Lincoln, NE: Nebraska Water

Quality Standards for Surface Waters of the State, revised effective 1 l/90. Nebraska State, Title 117.

*State of South Dakota. 1992. South Dakota water quality standards 1992. Bismarck, SD: South

Dakota Surface Water Quality Standards, 10/92. Chapter 74:03:17.

*State of Wyoming. 1990. Wyoming water quality rules and regulations. Cheyenne, WY: Wyoming

Water Quality Standards. Cheyenne, WY: Wyoming Department of Environmental Quality, Water

Quality Standards for Wyoming Surface Waters, Chapter I.

Stewart PA, Lee JS, Marano DE, et al. 1991. Retrospective cohort mortality study of workers at an

aircraft maintenance facility: 2. Exposures and their assessment. Br J Ind Med 48:531-537.

Stewart RD, Erley DS, Schaffer AW, et al. 1961. Accidental vapor exposure to anesthetic

concentrations of a solvent containing tetrachloroethylene. Industrial Medicine and Surgery

30(8):327-330.

Strassner HT, Amolds CW. 1992. Environment and pregnancy. In: Elkayam U, Galbraith RM, Gall

SA, et al., eds. Principles and practice of medical therapy in pregnancy. 2nd ed. Norwalk, CT:

Appleton & Lange, 89-105.

Stricoff RS. 1983. Control of occupational health hazards in the dry cleaning industry. Instructor’s

guide. Washington, DC.: U.S. Department of Health and Human Services, Division of Training and

Manpower Development, National Institute for Occupational Safety and Health, 68.

Stubblefield WA, McKee RH, Kapp RW Jr, et al. 1989. An evaluation of the acute toxic properties of

liquids derived from oil sands. J Appl Toxicol 9:59-65.

*Stutz DR, Janusz SJ. 1988. Hazardous materials injuries: A handbook for pre-hospital care. 2nd ed.

Beltsville, MD: Bradford Communications Corporation, 360-361.

*Suntech Group. 1978. Written communication (February 23) to C. E. Holdworth, American

Petroleum Institute, regarding Stoddard solvent analysis. American Petroleum Institute, Washington,

DC.

*Swenberg JA, Short B, Borghoff S, et al. 1989. The comparative pathobiology of α2μ- globulin

nephropathy. Toxicol Appl Pharmacol 97:35-46.
STODDARD SOLVENT 134

8. REFERENCES

*Tagami H, Ogino A. 1973. Kerosine dermatitis: Factors affecting skin irritability to kerosine.

Dermatologica 146(2): 123-131.

*Takeuchi Y, Mabuchi C, Takagi S. 1975. Polyneuropathy caused by petroleum benzine. Int Arch

Arbeitsmed 34:185-198.

*Tegeris JS, Balster RL. 1994. A comparison of the acute behavioral effects of alkylbenzenes using a

functional observational battery in mice. Fund Appl Toxicol 22:240-250.

*Tenenbein M, deGroot W, Rajani KR. 1984. Peripheral neuropathy following intentional inhalation of

naphtha fumes. Can Med Assoc J 131:1077-1079.

*Thomas DH, Delfino JJ. 1991. A gas-chromatographic/chemical indicator approach to assessing

ground water contamination by petroleum products. Ground Water Monitoring Review 11(4):90-100.

Thorpe JJ. 1988. 1. Occupational medicine in the petroleum industry: An historical perspective.

Occupational Medicine: State of the Art Reviews 3(3):371-390.

*TRI90. 1992. Toxic Chemical Release Inventory. National Library of Medicine, National Toxicology

Information Program, Bethesda, MD.

Triebig G. 1989. Occupational neurotoxicology of organic solvents and solvent mixtures. Neurotox

Teratol 11:575-578.

*Tuohimaa P, Wichmann L. 1981. Sperm production of men working under heavy-metal or

organic-solvent exposure. In: Hemminki K, Sorsa M, Vainio H, eds. Occupational hazards and

reproduction. Washington, DC: Hemisphere Publishing Corp., 73-79.

Valciukas JA, Lilis R, Singer R, et al. 1985. Neurobehavioral changes among shipyard painters

exposed to solvents. Arch Environ Health 40:47-52.

*Van H, Deyrup CA, eds. 1992. OPD chemical buyers directory. 79th annual edition. New York,

NY: Schnell Publishing Company, Inc., 746.

*van der Laan G. 1980. Chronic glomerulonephritis and organic solvents. Int Arch Occup Environ

Health 47:1-8.

van der Wal JF, Moerkerken A. 1984. The performance of passive diffusion monitors for organic

vapours for personal sampling of painters. Ann Occup Hyg 28:39-47.

*Van Doren G, Mertens B, Heyns W, et al. 1983. Different forms of α2μ- globulin in male and female

rat urine. Eur J Biochem 134:175-181.

*Van Duuren BL, Goldschmidt BM. 1976. Carcinogenic and tumor-promoting agents in tobacco

carcinogenesis. J Nat1 Cancer Inst 56(6):1237-1242.

van Ert MD, Harris RL, Symons MJ, et al. 1980. Worker exposures to chemical agents in the

manufacture of rubber tires: Solvent vapor studies. Am Ind Hyg Assoc J 41:212-219.
STODDARD SOLVENT 135

8. REFERENCES

Vaziri ND, Smith PJ, Wilson A. 1980. Toxicity with intravenous injection of naphtha in man Clin

Toxicol 16:335-343.

*Verkkala E, Pfaffli P, Savolainen H. 1984. Comparison of local neurotoxicity of three white spirits

formulations by percutaneous exposure of rat tail nerve. Toxicol Lett 21:293-299.

*Vernot EH, Drew RT, Kane ML. 1990. Acute toxicologic evaluation of unleaded motor gasoline.

Acute Toxic Data 1:28. [Abstract]

*Viau C, Bernard A, Gueret F, et al. 1986. Isoparaffinic solvent-induced nephrotoxicity in the rat.

Toxicology 38:227-240.

*Viau C, Bernard A, Lauwerys R. 1984. Distal tubular dysfunction in rats chronically exposed to a

‘white spirit’ solvent. Toxicol Lett 21:49-52.

WHO. 1982. Environmental health criteria 20: Selected petroleum products. Geneva, Switzerland:

United Nations Environment Programme, International Labour Organization, World Health Organization.

*WHO. 1991. Environmental health criteria 119: Principles and methods for the assessment of

nephrotoxicity associated with exposure to chemicals. Geneva, Switzerland: United Nations

Environment Programme, International Labour Organization, World Health Organization.

Wilcosky TC, Checkoway H, Marshall EG, et al. 1984. Cancer mortality and solvent exposures in the

rubber industry. Am Ind Hyg Assoc J 45(12):809-811.

*Wolfsdorf J, Kundig H. 1972. Kerosene poisoning in primates. S Afr Med J 46(20):619-621.

Wright J, Shen Z, Rizkalla S. 1993. A three-year field and laboratory evaluation of linseed oil as a

concrete sealer. Can J Civ Eng 20:844-854.

*Yaqoob M, Bell GM, Percy DF, et al. 1992. Primary glomerulonephritis and hydrocarbon exposure:

A case-control study and literature review. Quarterly Journal of Medicine, New Series 83(301):409-

418.

*Zahlsen K, Eide I, Nilsen AM, et al. 1992. Inhalation kinetics of C6 and Cl0 aliphatic, aromatic and

naphthenic hydrocarbons in rat after repeated exposures. Pharmacol Toxic01 71: 144- 149.

*Zahlsen K, Nilsen AM, Eide I, et al. 1990. Accumulation and distribution of aliphatic (n-nonane),

aromatic (1,2,4-trimethylbenzene) and naphthenic (1,2,4-trimethylcyclohexane) hydrocarbons in the rat after

repeated inhalation. Pharmacol Toxicol 67:436-440.

Zimmerman SW, Groehlerk, Beime GJ. 1975. Hydrocarbon exposure and chronic glomemlonephritis.

Lancet: Aug 2, 1975.

STODDARD SOLVENT 137

9. GLOSSARY

Acute Exposure -- Exposure to a chemical for a duration of 14 days or less, as specified in the

Toxicological Profiles.

Adsorption Coefficient (KOC) -- The ratio of the amount of a chemical adsorbed per unit weight of

organic carbon in the soil or sediment to the concentration of the chemical in solution at equilibrium.

Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment or soil (i.e., the solid

phase) divided by the amount of chemical in the solution phase, which is in equilibrium with the solid

phase, at a fixed solid/solution ratio. It is generally expressed in micrograms of chemical sorbed per

gram of soil OH sediment.

Bioconcentration Factor (BCF) -- The quotient of the concentration of a chemical in aquatic

organisms at a specific time or during a discrete time period of exposure divided by the concentration

in the surrounding water at the same time or during the same period.

Cancer Effect Level (CEL) -- The lowest dose of chemical in a study, or group of studies, that

produces significant increases in the incidence of cancer (or tumors) between the exposed population

and its appropriate control.

Carcinogen -- A chemical capable of inducing cancer.

Ceiling Value -- A concentration of a substance that should not be exceeded, even instantaneously.

Chronic Exposure -- Exposure to a chemical for 365 days or more, as specified in the Toxicological

Profiles.

Developmental Toxicity -- The occurrence of adverse effects on the developing organism that may

result from exposure to a chemical prior to conception (either parent), during prenatal development, or

postnatally to the time of sexual maturation. Adverse developmental effects may be detected at any

point in the life span of the organism.

Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as a result of prenatal exposure

to a chemical; the distinguishing feature between the two terms is the stage of development during

which the insult occurred. The terms, as used here, include malformations and variations, altered

growth, and in utero death.

EPA Health Advisory-- An estimate of acceptable drinking water levels for a chemical substance

based on health effects information. A health advisory is not a legally enforceable federal standard,

but serves as technical guidance to assist federal, state, and local officials.

Immediately Dangerous to Life or Health (IDLH) -- The maximum environmental concentration of

a contaminant from which one could escape within 30 min without any escape-impairing symptoms or

irreversible health effects.
STQDDARD SOLVENT 138

9. GLOSSARY

Intermediate Exposure -- Exposure to a chemical for a duration of 15-364 days, as specified in the

Toxicological Profiles.

Immunologic Toxicity -- The occurrence of adverse effects on the immune system that may result

from exposure to environmental agents such as chemicals.

In Vitro -- Isolated from the living organism and artificially maintained, as in a test tube.

In Vivo -- Occurring within the living organism.

Lethal Concentration(LO)(LCLO) -- The lowest concentration of a chemical in air which has been

reported to have caused death in humans or animals.

Lethal Concentration(50)(LC50) -- A calculated concentration of a chemical in air to which exposure for a

specific length of time is expected to cause death in 50% of a defined experimental animal population.

Lethal Dose(LO) ( LDLO) -- The lowest dose of a chemical introduced by a route other than inhalation

that is expected to have caused death in humans or animals.

Lethal Dose(50) (LT50) -- The dose of a chemical which has been calculated to cause death in 50% of a

defined experimental animal population.

Lethal Time(50) (LT50) -- A calculated period of time within which a specific concentration of a

chemical is expected to cause death in 50% of a defined experimental animal population.

Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of chemical in a study, or

group of studies, that produces statistically or biologically significant increases in frequency or severity of

adverse effects between the exposed population and its appropriate control.

Malformations -- Permanent structural changes that may adversely affect survival, development, or

function.

Minimal Risk Level -- An estimate of daily human exposure to a dose of a chemical that is likely to

be without an appreciable risk of adverse noncancerous effects over a specified duration of exposure.

Mutagen -- A substance that causes mutations. A mutation is a change in the genetic material in a

body cell. Mutations can lead to birth defects, miscarriages, or cancer.

Neurotoxicity -- The occurrence of adverse effects on the nervous system following exposure to

chemical.

No-Observed-Adverse-Effect Level (NOAEL) -- The dose of chemical at which there were no

statistically or biologically significant increases in frequency or severity of adverse effects seen

between the exposed population and its appropriate control. Effects may be produced at this dose, but

they are not considered to be adverse.

Octanol-Water Partition Coefficient (KOW) -- The equilibrium ratio of the concentrations of a

chemical in n-octanol and water, in dilute solution.
STODDARD SOLVENT 139

9. GLOSSARY

Permissible Exposure Limit (PEL) -- An allowable exposure level in workplace air averaged over an 8-hour

shift.

q1* -- The upper-bound estimate of the low-dose slope of the dose-response curve as determined by

the multistage procedure. The q1* can be used to calculate an estimate of carcinogenic potency, the

incremental excess cancer risk per unit of exposure (usually μg/L for water, mg/kg/day for food, and

μg/m3

 for air).

Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps an order of magnitude) of

the daily exposure of the human population to a potential hazard that is likely to be without risk of

deleterious effects during a lifetime. The RfD is operationally derived from the NOAEL (from animal

and human studies) by a consistent application of uncertainty factors that reflect various types of data

used to estimate RfDs and an additional modifying factor, which is based on a professional judgment

of the entire database on the chemical. The RfDs are not applicable to nonthreshold effects such as

cancer.

Reportable Quantity (RfD) -- The quantity of a hazardous substance that is considered reportable

under CERCLA. Reportable quantities are (1) 1 pound or greater or (2) for selected substances, an

amount established by regulation either under CERCLA or under Sect. 311 of the Clean Water Act.

Quantities are measured over a 24-hour period.

Reproductive Toxicity -- The occurrence of adverse effects on the reproductive system that may

result from exposure to a chemical. The toxicity may be directed to the reproductive organs and/or the

related endocrine system. The manifestation of such toxicity may be noted as alterations in sexual

behavior, fertility, pregnancy outcomes, or modifications in other functions that are dependent on the

integrity of this system.

Short-Term Exposure Limit (STEL) -- The maximum concentration to which workers can be

exposed for up to 15 min continually. No more than four excursions are allowed per day, and there

must be at least 60 min between exposure periods. The daily TLV-TWA may not be exceeded.

Sister Chromatid Exchange (SCE) -- The result of DNA repair when the damaged piece of

chromosome is exchanged with the analogous piece on the corresponding sister chromatid.

Target Organ Toxicity -- This term covers a broad range of adverse effects on target organs or

physiological systems (e.g., renal, cardiovascular) extending from those arising through a single limited

exposure to those assumed over a lifetime of exposure to a chemical.

Teratogen -- A chemical that causes structural defects that affect the development of an organism.

Threshold Limit Value (TLV) -- A concentration of a substance to which most workers can be

exposed without-adverse effect. The TLV may be expressed as a TWA, as a STEL, or as a CL.

Time-Weighted Average (TWA) -- An allowable exposure concentration averaged over a normal 8-

hour workday or 40-hour workweek.

Toxic Dose (TD50) -- A calculated dose of a chemical, introduced by a route other than inhalation,

which is expected to cause a specific toxic effect in 50% of a defined experimental animal population.
STODDARD SOLVENT 140

9. GLOSSARY

Uncertainty Factor (UF) -- A factor used in operationally deriving the RfD from experimental data.

UFs are intended to account for (1) the variation in sensitivity among the members of the human

population, (2) the uncertainty in extrapolating animal data to the case of human, (3) the uncertainty in

extrapolating from data obtained in a study that is of less than lifetime exposure, and (4) the

uncertainty in using LOAEL data rather than NOAEL data. Usually each of these factors is set equal

to 10.
A-l

APPENDIX A

USER’S GUIDE

Chapter 1

Public Health Statement

This chapter of the profile is a health effects summary written in non-technical language. Its intended

audience is the general public especially people living in the vicinity of a hazardous waste site or

chemical release. If the Public Health Statement were removed from the rest of the document, it

would still communicate to the lay public essential information about the chemical.

The major headings in the Public Health Statement are useful to find specific topics of concern. The

topics are written in a question and answer format. The answer to each question includes a sentence

that will direct the reader to chapters in the profile that will provide more information on the given

topic.

Chapter 2

Tables and Figures for Levels of Significant Exposure (LSE)

Tables (2-1, 2-2, and 2-3) and figures (2-l and 2-2) are used to summarize health effects and illustrate

graphically levels of exposure associated with those effects. These levels cover health effects observed

at increasing dose concentrations and durations, differences in response by species, minimal risk levels

(MRLs) to humans for noncancer endpoints, and EPA’s estimated range associated with an,

upper-bound individual lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000. Use the LSE tables and

figures for a quick review of the health effects and to locate data for a specific exposure scenario. The

LSE tables and figures should always be used in conjunction with the text. All entries in these tables

and figures represent studies that provide reliable, quantitative estimates of No-Observed-AdverseEffect Levels (NOAELs), Lowest-Observed-Adverse-Effect Levels (LOAELs), or Cancer Effect Levels

(CELs).

The legends presented below demonstrate the application of these tables and figures. Representative

examples of LSE Table 2-l and Figure 2-l are shown. The numbers in the left column of the legends

correspond to the numbers in the example table and figure.

LEGEND

See LSE Table 2-1

1. Route of Exposure One of the first considerations when reviewing the toxicity of a substance

using these tables and figures should be the relevant and appropriate route of exposure. When

sufficient data exists, three LSE tables and two LSE figures are presented in the document. The three

LSE tables present data on the three principal routes of exposure, i.e., inhalation, oral, and dermal (LSE

Table 2-1, 2-2, and 2-3, respectively). LSE figures are limited to the inhalation (LSE Figure 2-l) and oral

(LSE Figure 2-2) routes. Not all substances will have data on each route of exposure and will not

therefore have all five of the tables and figures.
A-2

APPENDIX A

2. Exposure Period Three exposure periods - acute (less than 15 days), intermediate (15-364 days), and

chronic (365 days or more) are presented within each relevant route of exposure. In this example, an

inhalation study of intermediate exposure duration is reported. For quick reference to health effects

occurring from a known length of exposure, locate the applicable exposure period within the LSE table

and figure.

3. Health Effect The major categories of health effects included in LSE tables and figures are

death, systemic, immunological, neurological, developmental, reproductive, and cancer.

NOAELs and LOAELs can be reported in the tables and figures for all effects but cancer.

Systemic effects are further defined in the “System” column of the LSE table (see key number

18).

4. Key to Figure Each key number in the LSE table links study information to one or more data

points using the same key number in the corresponding LSE figure. In this example, the study

represented by key number 18 has been used to derive a NOAEL and a Less Serious LOAEL

(also see the 2 ” 18r” data points in Figure 2-l).

5. Species The test species, whether animal or human, are identified in this column. Section 2.4,

“Relevance to Public Health,” covers the relevance of animal data to human toxicity and Section

2.3, “Toxicokinetics,” contains any available information on comparative toxicokinetics.

Although NOAELs and LOAELs are species specific, the levels are extrapolated to equivalent

human doses to derive an MRL.

6. Exposure Frequency/Duration The duration of the study and the weekly and daily exposure

regimen are provided in this column. This permits comparison of NOAELs and LOAELs from

different studies. In this case (key number 18), rats were exposed to toxaphene via inhalation for

6 hours per day, 5 days per week, for 3 weeks. For a more complete review of the dosing

regimen refer to the appropriate sections of the text or the original reference paper, i.e., Nitschke

et al. 1981.

7. System This column further defines the systemic effects. These systems include: respiratory,

cardiovascular, gastrointestinal, hematological, musculoskeletal, hepatic, renal, and dermal/ocular.

“Other” refers to any systemic effect (e.g., a decrease in body weight) not covered in these systems. In

the example of key number 18, 1 systemic effect (respiratory) was investigated.

8. NOAEL A No-Observed-Adverse-Effect Level (NOAEL) is the highest exposure level at which

no harmful effects were seen in the organ system studied. Key number 18 reports a NOAEL of

3 ppm for the respiratory system which was used to derive an intermediate exposure, inhalation

MRL of 0.005 ppm (see footnote “b”).

9. LOAEL A Lowest-Observed-Adverse-Effect Level (LOAEL) is the lowest dose used in the

study that caused a harmful health effect. LOAELs have been classified into “Less Serious” and

“Serious” effects. These distinctions help readers identify the levels of exposure at which

adverse health effects first appear and the gradation of effects with increasing dose. A brief

description of the specific endpoint used to quantify the adverse effect accompanies the LOAEL.

The respiratory effect reported in key number 18 (hyperplasia) is a Less serious LOAEL of 10

ppm. MRLs are not derived from Serious LOAELs.

10. Reference The complete reference citation is given in chapter 8 of the profile.
A-3

APPENDIX A

11. CEL A Cancer Effect Level (CEL) is the lowest exposure level associated with the onset of

carcinogenesis in experimental or epidemiologic studies. CELs are always considered serious

effects. The LSE tables and figures do not contain NOAELs for cancer, but the text may report doses not

causing measurable cancer increases.

12. Footnotes Explanations of abbreviations or reference notes for data in the LSE tables are found in the

footnotes. Footnote “b” indicates the NOAEL of 3 ppm in key number 18 was used to derive an MRL of

0.005 ppm.

LEGEND

See Figure 2-1

LSE figures graphically illustrate the data presented in the corresponding LSE tables. Figures help the

reader quickly compare health effects according to exposure concentrations for particular exposure

periods.

13. Exposure Period The same exposure periods appear as in the LSE table. In this example, health effects

observed within the intermediate and chronic exposure periods are illustrated.

14. Health Effect These are the categories of health effects for which reliable quantitative data

exists. The same health effects appear in the LSE table.

15. Levels of Exposure concentrations or doses for each health effect in the LSE tables are

graphically displayed in the LSE figures. Exposure concentration or dose is measured on the log scale

“y” axis. Inhalation exposure is reported in mg/m’ or ppm and oral exposure is reported in mg/kg/day .

16. NOAEL In this example, 18r NOAEL is the critical endpoint for which an intermediate

inhalation exposure MRL is based. As you can see from the LSE figure key, the open-circle

symbol indicates to a NOAEL for the test species-rat. The key number 18 corresponds to the

entry in the LSE table. The dashed descending arrow indicates the extrapolation from the

exposure level of 3 ppm (see entry 18 in the Table) to the MRL of 0.005 ppm (see footnote “b” in the

LSE table).

17. CEL Key number 38r is 1 of 3 studies for which Cancer Effect Levels were derived. The

diamond symbol refers to a Cancer Effect Level for the test species-mouse. The number 38

corresponds to the entry in the LSE table.

18. Estimated Upper-Bound Human Cancer Risk Levels This is the range associated with the

upper-bound for lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000. These risk levels are

derived from the EPA’s Human Health Assessment Group’s upper-bound estimates’of the slope of the

cancer dose response curve at low dose levels (q1*).

19. Key to LSE Figure The Key explains the abbreviations and symbols used in the figure.


A-6

APPENDIX A

Chapter 2 (Section 2.4)

Relevance to Public Health

The Relevance to Public Health section provides a health effects summary based on evaluations of

existing toxicologic, epidemiologic, and toxicokinetic information. This summary is designed to

present interpretive, weight-of-evidence discussions for human health endpoints by addressing the

following questions.

 1. What effects are known to occur in humans?

 2. What effects observed in animals are likely to be of concern to humans?

 3. What exposure conditions are likely to be of concern to humans, especially around hazardous

 waste sites?

The section covers endpoints in the same order they appear within the Discussion of Health Effects by

Route of Exposure section, by route (inhalation, oral, dermal) and within route by effect. Human data

are presented first, then animal data. Both are organized by duration (acute, intermediate, chronic). In

vitro data and data from parenteral routes (intramuscular, intravenous, subcutaneous, etc.) are also

considered in this section. If data are located in the scientific literature, a table of genotoxicity

information is included.

The carcinogenic potential of the profiled substance is qualitatively evaluated, when appropriate, using

existing toxicokinetic, genotoxic, and carcinogenic data. ATSDR does not currently assess cancer potency or

perform cancer risk assessments. Minimal risk levels (MRLs) for noncancer endpoints (if derived) and the

endpoints from which they were derived are indicated and discussed.

Limitations to existing scientific literature that prevent a satisfactov evaluation of the relevance to

public health are identified in the Data Needs section.

Interpretation of Minimal Risk Levels

Where sufficient toxicologic information is available, we have derived minimal risk levels (MRLs) for

inhalation and oral routes of entry at each duration of exposure (acute, intermediate, and chronic).

These MRLs are not meant to support regulatory action; but to acquaint health professionals with

exposure levels at which adverse health effects are not expected to occur in humans. They should

help physicians and public health officials determine the safety of a community living near a chemical

emission, given the concentration of a contaminant in air or the estimated daily dose in water. MRLs

are based largely on toxicological studies in animals and on reports of human occupational exposure.

MRL users should tie familiar with the toxicologic information on which the number is based.

Chapter 2.4, “Relevance to Public Health,” contains basic information known about the substance.

Other sections such as 2.6, “Interactions with Other Substances,” and 2.7, “Populations that are

Unusually Susceptible” provide important supplemental information.

MRL users should also understand the MRL derivation methodology. MRLs are derived using a

modified version of the risk assessment methodology the Environmental Protection Agency (EPA)

provides (Barnes and Dourson 1988) to determine reference doses for lifetime exposure (RfDs).
A-7

APPENDIX A

To derive an MRL, ATSDR generally selects the most sensitive endpoint which, in its best judgement,

represents the most sensitive human health effect for a given exposure route and duration. ATSDR

cannot make this judgement or derive an MRL unless information (quantitative or qualitative) is

available for all potential systemic, neurological, and developmental effects. If this information and

reliable quantitative data on the chosen endpoint are available, ATSDR derives an MRL using the

most sensitive species (when information from multiple species is available) with the highest NOAEL

that does not exceed any adverse effect levels. When a NOAEL is not available, a

lowest-observed-adverse-effect level (LOAEL) can be used to derive an MRL, and an uncertainty

factor (UF) of 10 must be employed. Additional uncertainty factors of 10 must be used both for

human variability to protect sensitive subpopulations (people who are most susceptible to the health

effects caused by the substance) and for interspecies variability (extrapolation from animals to

humans). In deriving an MRL, these individual uncertainty factors are multiplied together. The

product is then divided into the inhalation concentration or oral dosage selected from the study.

Uncertainty factors used in developing a substance-specific MRL are provided in the footnotes of the

LSE Tables.